First Internet Bancorp (INBK) 10-K 15 Mar 22 2020 FY Annual report Financial data

Cover

Cover - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Mar. 07, 2022	Jun. 30, 2021
Class of Stock [Line Items]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2021
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	001-35750
Entity Registrant Name	First Internet Bancorp
Entity Incorporation, State or Country Code	IN
Entity Tax Identification Number	20-3489991
Entity Address, Address Line One	8701 E. 116th Street
Entity Address, City or Town	Fishers
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	46038
City Area Code	317
Local Phone Number	532-7900
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 284.3
ICFR Auditor Attestation Flag	true
Entity Common Stock, Shares Outstanding		9,683,727
Document Fiscal Period Focus (Q1,Q2,Q3,FY)	FY
Document Fiscal Year Focus	2020
Amendment Flag	false
Entity Central Index Key	0001562463
Documents Incorporated by Reference	Documents Incorporated By Reference Portions of our Proxy Statement for our 2022 Annual Meeting of Shareholders are incorporated by reference in Part III.
Common Stock
Class of Stock [Line Items]
Title of 12(b) Security	Common stock, without par value
Trading Symbol	INBK
Security Exchange Name	NASDAQ
6.0% Fixed to Floating Subordinated Notes due 2029
Class of Stock [Line Items]
Title of 12(b) Security	6.0% Fixed to Floating Subordinated Notes due 2029
Trading Symbol	INBKZ
Security Exchange Name	NASDAQ

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2021
Audit Information [Abstract]
Auditor Name	BKD, LLP
Auditor Location	Indianapolis, Indiana
Auditor Firm ID	686

Recent Accounting Pronouncement

Recent Accounting Pronouncements	12 Months Ended
	Dec. 31, 2021
Accounting Standards Update and Change in Accounting Principle [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (June 2016) The main objective of this update is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The amendments affect entities holding financial assets that are not accounted for at fair value through net income. The amendments affect loans, debt securities, off-balance-sheet credit exposures, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amendments in this update affect an entity to varying degrees depending on the credit quality of the assets held by the entity, their duration, and how the entity applies current GAAP. There is diversity in practice in applying the incurred loss methodology, which means that before transition some entities may be more aligned under current GAAP than others to the new measure of expected credit losses. The following describes the main provisions of this update. • Assets Measured at Amortized Cost: The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. The statements of income reflect the measurement of credit losses for newly recognized financial assets, as well as the expected increase or decrease of credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances. • Available-for-Sale Debt Securities: Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. Available-for-sale accounting recognizes that value may be realized either through collection of contractual cash flows or through sale of the security. Therefore, the amendments limit the amount of the allowance for credit losses to the amount by which fair value is below amortized cost because the classification as available-for-sale is premised on an investment strategy that recognizes that the investment could be sold at fair value if cash collection would result in the realization of an amount less than fair value. • In May 2019, the FASB issued ASU 2019-05 - Financial Instruments - Credit Losses (Topic 326) - Targeted Transition Relief . This ASU allows an option for preparers to irrevocably elect the fair value option, on an instrument-by-instrument basis, for eligible financial assets measured at amortized cost basis upon adoption of the credit losses standard. This increases the comparability of financial statement information provided by institutions that otherwise would have reported similar financial instruments using different measurement methodologies, potentially decreasing costs for financial statement preparers while providing more useful information to investors and other users. For public business entities that are SEC filers, the amendments in this update are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. All entities may early adopt the amendments in this update as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. In November 2019, the FASB issued ASU 2019-10 - Financial Instruments - Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) - Effective Dates. This ASU delayed the effective date for public companies to fiscal years beginning after December 15, 2022. An entity will apply the amendments in this update through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (that is, a modified-retrospective approach). A prospective transition approach is required for debt securities for which an OTTI had been recognized before the effective date. The effect of a prospective transition approach is to maintain the same amortized cost basis before and after the effective date of this update. The Company does not expect to early adopt and is currently evaluating the impact of the amendments on the Company’s consolidated financial statements. The Company currently cannot determine or reasonably quantify the impact of the adoption of the amendments due to the complexity and extensive changes. The Company intends to develop processes and procedures prior to the effective date to ensure it is fully compliant with the amendments at the adoption date. The Company has formed an implementation committee and has engaged a third-party consultant to assist in developing current expected credit losses (“CECL”) models using appropriate methodologies. ASU 2017-04 - Intangibles - Goodwill and other (Topic 350) - Simplifying the Test for Goodwill Impairment (January 2017) The amendments in this update simplify the goodwill impairment test by eliminating Step 2 of the goodwill impairment process, which requires an entity to determine the implied fair value of its goodwill by assigning fair value to all its assets and liabilities. Under the new guidance, an entity will record an impairment charge if a reporting unit’s carrying amount exceeds its fair value. Entities still have the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment is necessary. The amendments in this ASU are effective for public companies for annual and interim impairment tests performed in periods beginning after December 15, 2022. Early adoption is permitted. The Company adopted this guidance effective July 1, 2020 and it did not have a material impact on the consolidated financial statements. ASU 2018-13 - Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (August 2018) The amendments in this update modify the disclosure requirements on fair value measurements in ASC Topic 820. This ASU eliminates the requirements to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels and the valuation processes for Level 3 fair value measurements. In addition, this ASU requires entities that calculate net asset value to disclose the timing of liquidation of an investee’s assets and the date when restrictions from redemption might lapse only if the investee has communicated the timing to the entity or announced the timing publicly. This ASU also adds new requirements, which include the disclosure of the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments in this ASU were effective for public companies for fiscal years, and interim fiscal periods within those fiscal years, beginning after December 15, 2019. The adoption of this guidance did not have a material impact on the consolidated financial statements. ASU 2019-04 - Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments (April 2019) The amendments in this ASU clarify or correct the guidance in ASC Topic 326, Topic 815 and Topic 825. With respect to Topic 326, ASU 2019-04 addresses a number of issues as it relates to the CECL standard including consideration of accrued interest, recoveries, variable-rate financial instruments, prepayments, extension and renewal options, among other things, in the measurement of expected credit losses. The amendments to Topic 326 have the same effective dates as ASU 2016-13 and the Company is currently evaluating the potential impact of these amendments on the consolidated financial statements. With respect to Topic 815, ASU 2019-04 clarifies issues related to partial-term hedges, hedged debt securities, and transitioning from a quantitative method of assessing hedge effectiveness to a more simplified method. The amendments to Topic 815 are effective for interim and annual reporting periods beginning after December 15, 2019 and are not expected to have a material impact on the consolidated financial statements. With respect to Topic 825, ASU 2019-04 addresses the scope of the guidance, the requirement for remeasurement under ASC Topic 820 when using the measurement alternative, certain disclosure requirements, and which equity securities must be remeasured at historical exchanges rates. The amendments to Topic 825 were effective for interim and annual reporting periods beginning after December 15, 2019 and the adoption of this guidance did not have a material impact on the consolidated financial statements. Coronavirus Aid, Relief and Economic Security Act (“CARES Act”) In March 2020 in connection with the implementation of the CARES Act and related provisions, the Company adopted the temporary relief issued under the CARES Act, thereby suspending the guidance in ASC 310-40 on accounting for TDRs to loan modifications related to COVID-19. Section 4013 of the CARES Act specifies that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief are in effect from the period beginning March 1, 2020 until the earlier of December 31, 2020 or 60 days after the date on which the national emergency related to the COVID-19 pandemic formally terminates. See the “Non-TDR Loan Modifications due to COVID-19” section of Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations for more information. ASU 2020-04 - Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (March 2020) In March 2020, FASB issued ASU 2020-04 to ease the potential burden in accounting for the transition away from LIBOR on financial reporting. The ASU provides optional expedients and exceptions for applying GAAP to contract modification and hedge accounting relationships. The guidance is effective March 12, 2020 through December 31, 2022. The Company is still evaluating the impact of reference rate reform and does not believe the adoption of this guidance will have a material impact on the consolidated financial statements.

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Assets
Cash and due from banks	$ 7,492	$ 7,367
Interest-bearing demand deposits	435,468	412,439
Total cash and cash equivalents	442,960	419,806
Securities available-for-sale - at fair value (amortized cost of $606,507 in 2021 and $497,004 in 2020)	603,044	497,628
Securities held-to-maturity - at amortized cost (fair value of $61,468 in 2021 and $69,452 in 2020)	59,565	68,223
Loans held-for-sale (includes $23,233 in 2021 and $26,341 in 2020 at fair value)	47,745	39,584
Loans	2,887,662	3,059,231
Allowance for loan losses	(27,841)	(29,484)
Net loans	2,859,821	3,029,747
Accrued interest receivable	16,037	17,416
Federal Home Loan Bank of Indianapolis stock	25,650	25,650
Cash surrender value of bank-owned life insurance	38,900	37,952
Premises and equipment, net	59,842	37,590
Goodwill	4,687	4,687
Servicing asset, at fair value	4,702	3,569
Other real estate owned	1,188	0
Accrued income and other assets	46,853	64,304
Total assets	4,210,994	4,246,156
Liabilities
Noninterest-bearing deposits	117,531	96,753
Interest-bearing deposits	3,061,428	3,174,132
Total deposits	3,178,959	3,270,885
Advances from Federal Home Loan Bank	514,922	514,916
Subordinated debt, net of unamortized discounts and debt issuance costs of $2,769 in 2021 and $2,397 in 2020	104,231	79,603
Accrued interest payable	2,018	1,439
Accrued expenses and other liabilities	30,526	48,369
Total liabilities	3,830,656	3,915,212
Commitments and Contingencies
Shareholders’ equity
Preferred stock, no par value; 4,913,779 shares authorized; issued and outstanding - none	0	0
Retained earnings	172,431	126,732
Accumulated other comprehensive loss	(11,039)	(17,196)
Total shareholders’ equity	380,338	330,944
Total liabilities and shareholders’ equity	4,210,994	4,246,156
Voting Common Stock
Shareholders’ equity
Voting and nonvoting common stock	218,946	221,408
Nonvoting Common Stock
Shareholders’ equity
Voting and nonvoting common stock	$ 0	$ 0

Consolidated Balance Sheets _Pa

Consolidated Balance Sheets [Parenthetical] - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Amortized cost, at fair value	$ 606,507	$ 497,004
Held-to-maturity securities, fair value	61,468	69,452
Loans held-for-sale, Fair Value	23,233	26,341
Unamortized discounts and debt issuance costs	$ 2,769	$ 2,397
Preferred Stock, Par or Stated Value (in dollars per share)	$ 0	$ 0
Preferred stock, shares authorized (in shares)	4,913,779	4,913,779
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Voting Common Stock
Common Stock, Par or Stated Value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized (in shares)	45,000,000	45,000,000
Common stock, shares issued (in shares)	9,754,455	9,800,569
Common stock, shares outstanding (in shares)	9,754,455	9,800,569
Nonvoting Common Stock
Common Stock, Par or Stated Value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized (in shares)	86,221	86,221
Common stock, shares issued (in shares)	0	0
Common stock, shares outstanding (in shares)	0	0

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Interest income
Loans	$ 123,467	$ 120,628	$ 122,228
Securities – taxable	7,970	11,123	13,807
Securities – non-taxable	1,017	1,728	2,595
Other earning assets	1,429	3,380	8,784
Total interest income	133,883	136,859	147,414
Interest expense
Deposits	29,822	55,976	69,313
Other borrowed funds	17,505	16,342	15,134
Total interest expense	47,327	72,318	84,447
Net interest income	86,556	64,541	62,967
Provision for loan losses	1,030	9,325	5,966
Net interest income after provision for loan losses	85,526	55,216	57,001
Noninterest income
Gain on sale of loans	11,598	8,298	2,074
Gain (loss) on sale of securities	0	139	(458)
Gain on sale of premises and equipment	2,523	0	0
Other	1,694	1,655	2,581
Total noninterest income	32,844	36,336	16,789
Noninterest expense
Salaries and employee benefits	38,223	34,231	27,014
Marketing, advertising and promotion	3,261	1,654	1,800
Consulting and professional fees	4,054	3,511	3,669
Data processing	1,649	1,528	1,338
Loan expenses	2,112	2,036	1,142
Premises and equipment	7,063	6,396	6,059
Deposit insurance premium	1,213	1,810	1,903
Write-down of other real estate owned	0	2,065	0
Other	4,223	4,423	3,709
Total noninterest expense	61,798	57,654	46,634
Income before income taxes	56,572	33,898	27,156
Income tax provision	8,458	4,445	1,917
Net income	$ 48,114	$ 29,453	$ 25,239
Income Per Share of Common Stock (in dollars per share)
Basic (in dollars per share)	$ 4.85	$ 2.99	$ 2.51
Diluted (in dollars per share)	$ 4.82	$ 2.99	$ 2.51
Weighted-average number of common shares outstanding
Basic (shares)	9,918,083	9,840,205	10,041,581
Diluted (shares)	9,976,261	9,842,425	10,044,483
Dividends Declared Per Share (in dollars per share)	$ 0.24	$ 0.24	$ 0.24
Service charges and fees
Noninterest income
Noninterest income	$ 1,114	$ 824	$ 885
Loan servicing revenue
Noninterest income
Noninterest income	1,934	1,159	166
Mortgage banking activities
Noninterest income
Noninterest income	15,050	24,693	11,541
Loan Servicing Asset Revaluation
Noninterest income
Noninterest income	$ (1,069)	$ (432)	$ 0

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 48,114	$ 29,453	$ 25,239
Other comprehensive income (loss)
Net unrealized holding (losses) gains on securities available-for-sale recorded within other comprehensive income before income tax	(4,087)	6,551	12,072
Reclassification adjustment for (gains) losses realized	0	(139)	458
Net unrealized holding gains (losses) on cash flow hedging derivatives recorded within other comprehensive income before income tax	11,138	(10,248)	(9,071)
Other comprehensive income (loss) before tax	7,051	(3,836)	3,459
Income tax provision (benefit)	894	(831)	1,109
Other comprehensive income (loss) - net of tax	6,157	(3,005)	2,350
Comprehensive income	$ 54,271	$ 26,448	$ 27,589

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common StockVoting and Nonvoting Common Stock	Retained Earnings	Retained EarningsCumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive LossCumulative Effect, Period of Adoption, Adjustment
Balance at Dec. 31, 2018	$ 288,735		$ 227,587	$ 77,689		$ (16,541)
Balance (Accounting Standards Update 2018-02 and 2106-01) at Dec. 31, 2018		$ (821)			$ (821)		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	25,239			25,239
Other comprehensive income (loss)	2,350					2,350
Cash dividends declared	(2,426)			(2,426)
Repurchase of common stock	(9,784)		(9,784)
Recognition of the fair value of share-based compensation	1,680		1,680
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	34		34
Common stock redeemed for the net settlement of share-based awards	(94)		(94)
Balance at Dec. 31, 2019	$ 304,913		219,423	99,681		(14,191)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2017-08 [Member]
Net income	$ 29,453			29,453
Other comprehensive income (loss)	(3,005)					(3,005)
Cash dividends declared	(2,402)			(2,402)
Recognition of the fair value of share-based compensation	2,110		2,110
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	27		27
Common stock redeemed for the net settlement of share-based awards	(152)		(152)
Balance at Dec. 31, 2020	330,944		221,408	126,732		(17,196)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Retained earnings	126,732
Net income	48,114			48,114
Other comprehensive income (loss)	6,157					6,157
Cash dividends declared	(2,415)			(2,415)
Repurchase of common stock	(4,436)		(4,436)
Recognition of the fair value of share-based compensation	2,393		2,393
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	21		21
Common stock redeemed for the net settlement of share-based awards	(440)		(440)
Balance at Dec. 31, 2021	380,338		$ 218,946	$ 172,431		$ (11,039)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Retained earnings	$ 172,431

Consolidated Statements of Sh_2

Consolidated Statements of Shareholders' Equity [Parenthetical] - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of Stockholders' Equity [Abstract]
Cash dividends declared (in dollars per share)	$ 0.24	$ 0.24	$ 0.24

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Operating activities
Net income	$ 48,114	$ 29,453	$ 25,239
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	8,775	7,831	6,926
Write-down of other real estate owned	0	2,065	0
Increase in cash surrender value of bank-owned life insurance	(948)	(950)	(943)
Provision for loan losses	1,030	9,325	5,966
Share-based compensation expense	2,393	2,110	1,680
(Gain) loss from sale of available-for-sale securities	0	(139)	458
Loans originated for sale	(814,671)	(1,009,266)	(627,597)
Proceeds from sale of loans originated for sale	832,089	1,054,873	601,215
Gain on sale of loans	(29,401)	(31,124)	(12,349)
Decrease (increase) in fair value of loans held-for-sale	718	94	(538)
Loss (gain) on derivatives	1,513	(2,069)	(671)
Settlement of derivatives	(1,859)	(46,109)	0
Gain on sale of premises and equipment	(2,523)	0	0
Net change in servicing asset	1,069	(1,088)	(2,481)
Deferred income tax	2,434	(4,118)	(4,402)
Net change in other assets	7,028	7,163	(42,079)
Net change in other liabilities	(921)	(4,983)	5,999
Net cash provided by (used in) operating activities		13,068	(43,577)
Investing activities
Net loan activity, excluding sales and purchases	316,002	46,787	(191,070)
Proceeds from sales of other real estate owned	0	0	554
Net proceeds from sales of portfolio loans	21,093	207,475	293,708
Maturities of securities available-for-sale	166,260	179,724	92,610
Proceeds from sales of securities available-for-sale	0	16,986	30,137
Purchase of securities available-for-sale	(282,226)	(144,091)	(171,997)
Maturities and calls of securities held-to-maturity	8,525	0	0
Purchase of securities held-to-maturity	0	(2,000)	(39,208)
Net proceeds from sale of premises and equipment	8,116	0	0
Purchase of Federal Home Loan Bank of Indianapolis stock	0	0	(2,025)
Purchase of premises and equipment	(29,892)	(25,559)	(4,105)
Loans purchased	(168,438)	(324,131)	(332,945)
Other investing activities	4,434	0	11,068
Net cash provided by (used in) investing activities		(44,809)	(313,273)
Financing activities
Net change in deposits	(91,926)	116,922	482,612
Cash dividends paid	(2,415)	(2,349)	(2,418)
Net proceeds from issuance of subordinated debt	58,658	9,765	35,418
Repayment of subordinated debt	(35,000)	0	0
Repurchase of common stock	(4,436)	0	(9,784)
Proceeds from advances from Federal Home Loan Bank	440,000	440,000	595,000
Repayment of advances from Federal Home Loan Bank	(440,000)	(440,000)	(605,000)
Other, net	(441)	(152)	(329)
Net cash provided by financing activities		124,186	495,499
Net increase in cash and cash equivalents	23,154	92,445	138,649
Cash and cash equivalents, beginning of year	419,806	327,361	188,712
Cash and cash equivalents, end of year	442,960	419,806	327,361
Supplemental disclosures of cash flows information
Initial recognition of right-of-use asset	0	0	2,096
Initial recognition of operating lease liabilities	0	0	2,096
Cash paid during the year for interest	46,748	74,646	81,788
Cash paid during the year for taxes	7,045	5,912	4,561
Loans transferred to other real estate owned	1,188	0	0
Loans transferred to held-for-sale from portfolio	20,145	204,647	291,152
Cash dividends declared, not paid	585	588	585
Securities purchases settled in subsequent period	0	5,547	0
Transfer of available-for-sale municipal securities to held-to-maturity municipal securities	$ 0	$ 4,479	$ 0

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies The accounting policies of First Internet Bancorp and its subsidiaries (the “Company”) conform to accounting principles generally accepted in the United States of America (“GAAP”). A summary of the Company’s significant accounting policies follows: Description of Business The Company was incorporated on September 15, 2005, and consummated a plan of exchange on March 21, 2006, by which the Company became a bank holding company and 100% owner of First Internet Bank of Indiana (the “Bank”). The Bank offers a wide range of commercial, small business, consumer and municipal banking products and services. The Bank conducts its consumer and small business deposit operations primarily through digital channels on a nationwide basis and has no traditional branch offices. Residential mortgage products are offered nationwide primarily through a digital direct-to-consumer platform and are supplemented with Central Indiana-based mortgage and construction lending. Consumer lending products are primarily originated on a nationwide basis through relationships with dealerships and financing partners. The Bank is subject to competition from other financial institutions. The Bank is regulated by certain state and federal agencies and undergoes periodic examinations by those regulatory authorities. The Bank has three wholly owned subsidiaries. JKH Realty Services, LLC was established on August 20, 2012 as a single member limited liability company wholly owned by the Bank to manage other real estate owned properties as needed. First Internet Public Finance Corp., a wholly-owned subsidiary of the Bank, was incorporated on March 6, 2017 and was established to provide municipal finance lending and leasing products to government entities and to purchase, manage, service, and safekeep municipal securities. SPF15, Inc., a wholly-owned subsidiary of the Bank, was incorporated on August 31, 2018 and was established to acquire and hold real estate. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its direct and indirect subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The Company’s business activities are currently limited to one reporting unit and reportable segment, which is commercial banking. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company utilizes processes that involve the use of significant estimates and the judgment of management in determining the amount of the Company’s allowance for loan losses, income taxes, valuation and impairments of investment securities and goodwill, as well as fair value measurements of derivatives, loans held-for-sale and other real estate owned. Actual results could differ from those estimates. Securities The Company classifies its securities in one of three categories and accounts for the investments as follows: • Securities that the Company has the positive intent and ability to hold to maturity are classified as “held-to-maturity” and reported at amortized cost. • Securities that are acquired and held principally for the purpose of selling them in the near term with the objective of generating economic profits on short-term differences in market characteristics are classified as “trading securities” and reported at fair value, with unrealized gains and losses included in earnings. The Company had no securities classified as “trading securities” at December 31, 2021 or 2020. • Securities not classified as either “held-to-maturity” or “trading securities” are classified as “available-for-sale” and reported at fair value, with unrealized gains and losses, after applicable taxes, excluded from earnings and reported in a separate component of shareholders’ equity. Declines in the value of debt securities and marketable equity securities that are considered to be other-than-temporary are recorded as an other-than-temporary impairment of securities available-for-sale with other-than-temporary impairment losses recorded in the consolidated statements of income. Interest and dividend income, adjusted by amortization of premium or discount, is included in earnings using the effective interest rate method. Purchases and sales of securities are recorded in the consolidated balance sheets on the trade date. Gains and losses from the sale or disposal of securities are recognized as of the trade date in the consolidated statements of income for the period in which securities are sold or otherwise disposed of. Gains and losses on sales of securities are determined using the specific-identification method. Loans Held-for-Sale Loans originated and intended for sale in the secondary market under best-efforts pricing agreements are carried at the lower of cost or fair value in the aggregate. Net unrealized losses, if any, are recognized through a valuation allowance by charges to noninterest income. Loans originated and intended for sale in the secondary market under mandatory pricing agreements are carried at fair value to facilitate hedging of the loans. Gains and losses resulting from changes in fair value are recognized in noninterest income. Gains and losses on loan sales are recorded in noninterest income, and direct loan origination costs and fees are deferred at origination of the loan and are recognized in noninterest income upon sale of the loan. Revenue Recognition The Company recognizes revenues as they are earned based on contractual terms, as transactions occur, or as services are provided and collectability is reasonably assured. The Company's principal source of revenue is interest income from loans and leases and investment securities. Interest income on loans is accrued as earned using the interest method based on unpaid principal balances except for interest on loans in nonaccrual status. Interest on loans in nonaccrual status is recorded as a reduction of loan principal when received. Premiums and discounts are amortized using the effective interest rate method. Loan fees, net of certain direct origination costs, primarily salaries and wages, are deferred and amortized to interest income as a yield adjustment over the life of the loan. The Company also earns noninterest income through a variety of financial and transaction services provided to corporate and consumer clients such as deposit account, debit card, mortgage banking, portfolio loan sales and sales of the government-guaranteed portion of U.S. Small Business Administration loans. Revenue is recorded for noninterest income based on the contractual terms for the service or transaction performed. In certain circumstances, noninterest income is reported net of associated expenses. Loans Loans that management intends to hold until maturity are reported at their outstanding principal balance adjusted for unearned income, charge-offs, the allowance for loan losses (“ALLL”), any unamortized deferred fees or costs on originated loans, unamortized premiums or discounts on purchased loans and any carrying value adjustments related to terminated interest rate swaps associated with loans. For loans recorded at cost, interest income is accrued based on the unpaid principal balance. Loan origination fees, net of certain direct origination costs, as well as premiums and discounts, are deferred and amortized as a level yield adjustment over the respective term of the loan. Allowance for Loan Losses Methodology Company policy is designed to maintain an adequate ALLL. Primary responsibility for ensuring that the Company has processes in place to consistently assess the adequacy of the ALLL rests with the Board of Directors (the “Board”). The Board has charged management with responsibility for establishing the methodology to be used and to assess the adequacy of the ALLL. The Board reviews recommendations from management on a quarterly basis to adjust the allowance as appropriate. The methodology employed by management for each portfolio segment, at a minimum, contains the following: 1. Loans are segmented by type of loan. 2. The required ALLL for types of performing homogeneous loans which do not have a specific reserve is determined by applying a factor based on historical losses averaged over the past sixteen quarters. In those instances where the Company’s historical experience is not available, management develops factors based on industry experience and best practices. 3. All criticized, classified and impaired loans are tested for impairment by applying one of three methodologies: a. Present value of future cash flows; b. Fair value of collateral less costs to sell; or c. The loan’s observable market price. 4. All troubled debt restructurings (“TDR”) are considered impaired loans. 5. Loans tested for impairment are removed from other pools to prevent layering (double-counting). 6. The required ALLL for each group of loans are added together to determine the total required ALLL for the Company. The required ALLL is compared to the existing ALLL to determine the provision required to increase the ALLL or credit to decrease the ALLL. The historical loss experience is determined by portfolio segment and considers two weighted average net charge-off trends: 1) the Company’s average loss history over the previous sixteen quarters; and 2) the average loss history over the previous sixteen quarters for a peer group. Management believes the historical loss experience methodology is appropriate in the current economic environment, as it captures loss rates that are comparable to the current period being analyzed. The Company also factors in the following qualitative considerations: 1. Changes in national, regional, and local economic and business conditions; 2. Changes in national, regional, and local unemployment rates; 3. The existence and effect of any concentrations of credit, and changes in the levels of such concentrations; 4. Changes in the nature and volume of the portfolio, and in the terms of loans; 5. Changes in the risk grades assigned to loans; 6. The levels of and trends in charge-offs and recoveries; 7. The levels of and trends in delinquencies, nonaccrual loans, and impaired loans; and 8. Changes in lending policies and procedures, including changes in underwriting standards and collection, charge-off, and recovery practices. Provision for Loan Losses A provision for estimated losses on loans is charged to income based upon management’s evaluation of the potential losses. Such an evaluation, which includes a review of all loans for which full repayment may not be reasonably assured, considers, among other matters, the estimated net realizable value of the underlying collateral, as applicable, economic conditions, loan loss experience, and other factors that are particularly susceptible to changes that could result in a material adjustment in the near term. While management attempts to use the best information available in making its evaluations, future allowance adjustments may be necessary if economic conditions change substantially from the assumptions used in making the evaluations. Nonaccrual Loans Any loan which becomes 90 days delinquent or for which the full collection of principal and interest may be in doubt will be considered for nonaccrual status. At the time a loan is placed on nonaccrual status, all accrued but unpaid interest will be reversed from interest income. Placing the loan on nonaccrual status does not relieve the borrower of the obligation to repay interest. A loan placed on nonaccrual status may be restored to accrual status when all delinquent principal and interest has been brought current, and the Company expects full payment of the remaining contractual principal and interest. Impaired Loans A loan is designated as impaired, in accordance with the impairment accounting guidance when, based on current information or events, it is probable that the Company will be unable to collect all amounts due (principal and interest) according to the contractual terms of the loan agreement. Payments with delays generally not exceeding 90 days outstanding are not considered impaired. Certain nonaccrual and substantially all delinquent loans more than 90 days past due may be considered to be impaired. Generally, loans are placed on nonaccrual status at 90 days past due and accrued interest is reversed against earnings, unless the loan is well secured and in the process of collection. The accrual of interest on impaired and nonaccrual loans is discontinued when, in management’s opinion, the borrower may be unable to meet payments as they become due. Impaired loans include nonperforming loans but also include loans modified in TDRs where concessions have been granted to borrowers experiencing financial difficulties. These concessions could include a reduction in the interest rate on the loan, payment extensions, forgiveness of principal, forbearance, or other actions intended to maximize collection. Accounting Standards Codification (“ASC”) Topic 310, Receivables , requires that impaired loans be measured based on the present value of expected future cash flows discounted at the loans’ effective interest rates or the fair value of the underlying collateral, less costs to sell, and allows existing methods for recognizing interest income. Troubled Debt Restructurings The loan portfolio includes certain loans that have been modified in a TDR, where economic concessions have been granted to borrowers who have experienced financial difficulties. These concessions typically result from loss mitigation efforts and could include reductions in the interest rate, payment extensions, forgiveness of principal, forbearance or other actions. Certain TDRs are classified as nonperforming at the time of restructuring and typically are returned to performing status after considering the borrower’s sustained repayment performance for a reasonable period, generally not less than six months. When loans are modified in a TDR, any possible impairment similar to other impaired loans is evaluated based on either the present value of expected future cash flows, discounted at the contractual interest rate of the original loan agreement, or the current fair value of the collateral, less selling costs for collateral-dependent loans. If it is determined that the value of the modified loan is less than the recorded balance of the loan, impairment is recognized through a specific ALLL or charge-off to the ALLL. In periods subsequent to modification, all TDRs, including those that have payment defaults, are evaluated for possible impairment, and impairment is recognized through the ALLL. Policy for Charging Off Loans The Company’s policy is to charge off a loan at any point in time when it no longer can be considered a bankable asset, meaning collectible within the parameters of policy. A secured loan is generally charged down to the estimated fair value of the collateral, less costs to sell, no later than when it is 120 days past due as to principal or interest. An unsecured loan generally is charged off no later than when it is 180 days past due as to principal or interest. A home improvement loan generally is charged off no later than when it is 90 days past due as to principal or interest. Federal Home Loan Bank (“FHLB”) of Indianapolis Stock Federal law requires a member institution of the FHLB system to hold common stock of its district FHLB according to a predetermined formula. This investment is stated at cost, which represents redemption value, and may be pledged as collateral for FHLB advances. Premises and Equipment Premises and equipment is stated at cost, less accumulated depreciation. Depreciation is computed on the straight-line method over the estimated useful lives, which range from three Other Real Estate Owned Other real estate owned represents real estate acquired through foreclosure or deed in lieu of foreclosure and is recorded at its fair value less estimated costs to sell. When property is acquired, it is recorded at its fair value at the date of acquisition with any resulting write-down charged against the ALLL. Any subsequent deterioration of the property is charged directly to operating expense. Costs relating to the development and improvement of other real estate owned are capitalized, whereas costs relating to holding and maintaining the property are charged to expense as incurred. Derivative Financial Instruments The Company uses derivative financial instruments to help manage exposure to interest rate risk and the effects that changes in interest rates may have on net income and the fair value of assets and liabilities. The Company enters into interest rate swap agreements as part of its asset liability management strategy to help manage its interest rate risk position. Additionally, the Company enters into forward contracts for the future delivery of mortgage loans to third-party investors and enters into interest rate lock commitments (“IRLCs”) with potential borrowers to fund specific mortgage loans that will be sold into the secondary market. The forward contracts are entered into in order to economically hedge the effect of changes in interest rates resulting from the Company’s commitment to fund the loans. Designating an interest rate swap as an accounting hedge allows the Company to recognize gains and losses, less any ineffectiveness, in the income statement within the same period that the hedged item affects earnings. The Company includes the gain or loss on the hedged items in the same line item as the offsetting loss or gain on the related interest rate swaps. For derivative instruments that are designated and qualify as cash flow hedges, any gains or losses related to changes in fair value are recorded in accumulated other comprehensive loss, net of tax. The fair value of interest rate swaps with a positive fair value are reported in accrued income and other assets in the consolidated balance sheets while interest rate swaps with a negative fair value are reported in accrued expenses and other liabilities in the consolidated balance sheets. The IRLCs and forward contracts are not designated as accounting hedges, and are recorded at fair value with changes in fair value reflected in noninterest income in the consolidated statements of income. The fair value of derivative instruments with a positive fair value are reported in accrued income and other assets in the consolidated balance sheets, while derivative instruments with a negative fair value are reported in accrued expenses and other liabilities in the consolidated balance sheets. Fair Value Measurements The Company records or discloses certain assets and liabilities at fair value. ASC Topic 820, Fair Value Measurements , defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value measurements are classified within one of three levels in a valuation hierarchy. ASC Topic 820 describes three levels of inputs that may be used to measure fair value: Level 1 Quoted prices in active markets for identical assets or liabilities Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities Level 3 Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities There were no transfers that occurred and, therefore, recognized, between any of the fair value hierarchy levels at December 31, 2021 or 2020. Income Taxes Deferred income tax assets and liabilities reflect the impact of temporary differences between amounts of assets and liabilities for financial reporting purposes and the basis of such assets and liabilities as measured by tax laws and regulations. Deferred income tax expense or benefit is based upon the change in deferred tax assets and liabilities from period to period, subject to an ongoing assessment of realization of deferred tax assets. Deferred tax assets are reduced by a valuation allowance if, based on the weight of evidence available, it is more likely than not that some portion or all of a deferred tax asset will not be realized. The Company files income tax returns in the U.S. federal, Indiana, and other state jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal, state and local examinations by tax authorities for years before 2017. ASC Topic 740-10, Accounting for Uncertainty in Income Taxes , prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. It also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company did not identify any material uncertain tax positions that it believes should be recognized in the consolidated financial statements. Earnings Per Share Earnings per share of common stock is based on the weighted average number of basic shares and dilutive shares outstanding during the year. The following is a reconciliation of the weighted average common shares for the basic and diluted earnings per share computations. Year Ended December 31, 2021 2020 2019 Basic earnings per share Net income available to common shareholders $ 48,114 $ 29,453 $ 25,239 Weighted average common shares 9,918,083 9,840,205 10,041,581 Basic earnings per common share $ 4.85 $ 2.99 $ 2.51 Diluted earnings per share Net income available to common shareholders $ 48,114 $ 29,453 $ 25,239 Weighted average common shares 9,918,083 9,840,205 10,041,581 Dilutive effect of equity compensation 58,178 2,220 2,902 Weighted average common and incremental shares 9,976,261 9,842,425 10,044,483 Diluted earnings per common share (1) $ 4.82 $ 2.99 $ 2.51 (1) Potential dilutive common shares are excluded from the computation of diluted EPS in the periods where the effect would be antidilutive. Excluded from the computation of diluted EPS were weighted average antidilutive shares totaling 28, 18,524 and 15,758 for the years ended December 31, 2021, 2020 and 2019, respectively. Share-based Compensation The Company has a share-based compensation plan using the fair value recognition provisions of ASC Topic 718, Compensation - Stock Compensation . The plan is described more fully in Note 11. Comprehensive Income Comprehensive income consists of net income and other comprehensive income (loss). Other comprehensive income (loss) includes unrealized gains and losses on securities available-for-sale and unrealized gains and losses on cash flow hedges. Reclassification adjustments have been determined for all components of other comprehensive income or loss reported in the consolidated statements of changes in shareholders’ equity. Statements of Cash Flows Cash and cash equivalents are defined to include cash on-hand, noninterest and interest-bearing amounts due from other banks and federal funds sold. Generally, federal funds are sold for one-day periods. The Company reports net cash flows for customer loan transactions and deposit transactions. Bank-Owned Life Insurance Bank-owned life insurance policies are carried at their cash surrender value. The Company recognizes tax-free income from the periodic increases in the cash surrender value of these policies and from death benefits. Goodwill Goodwill is tested at least annually for impairment. If the implied fair value of goodwill is lower than its carrying amount, goodwill impairment is indicated and goodwill is written down to its implied fair value. Subsequent increases in goodwill value are not recognized in the consolidated financial statements. Servicing Asset The servicing asset is related to small business lending loans sold. The servicing asset is recognized at the time of sale when servicing is retained and the income statement effect is recorded in loan servicing revenue. Servicing assets are recorded at fair value in accordance with ASC 860. Fair value is based on a third-party valuation model that calculates the present value of net servicing revenue. Reclassifications Certain reclassifications have been made to the 2020 and 2019 financial statements to conform to the 2021 financial statement presentation. These reclassifications had no effect on net income. Revision of Previously Issued Financial Statements The Company has revised amounts reported in previously issued notes to financial statements for the periods presented in this Annual Report on Form 10-K due to immaterial clerical errors. The clerical errors caused the fair value associated with interest rate swap liabilities to be understated in the notes to financial statements for the period ended December 31, 2020 and had no impact on the consolidated balance sheet, income statement or statement of cash flows. The Company evaluated the impact of the clerical errors to our previously issued financial statements in accordance with SEC Staff Accounting Bulletins No. 99 and No. 108 and, based upon quantitative and qualitative factors, determined that the clerical errors were not material to the previously issued financial statements and disclosures included in our Annual Report on Form 10-K for the year ended December 31, 2020.

Cash and Cash Equivalents

Cash and Cash Equivalents	12 Months Ended
	Dec. 31, 2021
Cash and Cash Equivalents [Abstract]
Cash and Cash Equivalents	Cash and Cash Equivalents At December 31, 2021, the Company’s interest-bearing and noninterest-bearing cash accounts at other institutions exceeded the limits for full FDIC insurance coverage by $56.1 million. In addition, approximately $361.8 million and $18.7 million of cash was held by the Federal Reserve Bank of Chicago and the FHLB of Indianapolis, respectively, which are not federally insured.

Securities

Securities	12 Months Ended
	Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Securities	Securities The following tables summarize securities available-for-sale and securities held-to-maturity as of December 31, 2021 and 2020. December 31, 2021 Amortized Gross Unrealized Fair Cost Gains Losses Value Securities available-for-sale U.S. Government-sponsored agencies $ 50,013 $ 164 $ (1,137) $ 49,040 Municipal securities 75,158 1,940 (65) 77,033 Agency mortgage-backed securities - residential (1) 377,928 960 (5,652) 373,236 Agency mortgage-backed securities - commercial 36,024 441 (139) 36,326 Private label mortgage-backed securities - residential 15,902 122 (3) 16,021 Asset-backed securities 5,000 4 — 5,004 Corporate securities 46,482 597 (695) 46,384 Total available-for-sale $ 606,507 $ 4,228 $ (7,691) $ 603,044 December 31, 2021 Amortized Gross Unrealized Fair Cost Gains Losses Value Securities held-to-maturity Municipal securities $ 13,992 $ 717 $ — $ 14,709 Corporate securities 45,573 1,186 — 46,759 Total held-to-maturity $ 59,565 $ 1,903 $ — $ 61,468 (1) Includes $0.8 million of additional premium related to terminated interest rate swaps associated with agency mortgage-backed securities - residential as of December 31, 2021. December 31, 2020 Amortized Gross Unrealized Fair Cost Gains Losses Value Securities available-for-sale U.S. Government-sponsored agencies $ 61,765 $ 432 $ (1,652) $ 60,545 Municipal securities 82,757 463 (731) 82,489 Agency mortgage-backed securities - residential 213,408 3,387 (2,465) 214,330 Agency mortgage-backed securities - commercial 28,387 1,204 — 29,591 Private label mortgage-backed securities - residential 57,268 850 (2) 58,116 Asset-backed securities 5,000 — (39) 4,961 Corporate securities 48,419 771 (1,594) 47,596 Total available-for-sale $ 497,004 $ 7,107 $ (6,483) $ 497,628 December 31, 2020 Amortized Gross Unrealized Fair Cost Gains Losses Value Securities held-to-maturity Municipal securities $ 14,571 $ 746 $ — $ 15,317 Corporate securities 53,652 610 (127) 54,135 Total held-to-maturity $ 68,223 $ 1,356 $ (127) $ 69,452 The carrying value of securities at December 31, 2021 is shown below by their contractual maturity date. Actual maturities will differ because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Available-for-Sale Amortized Fair Within one year $ — $ — One to five years 36,314 34,866 Five to ten years 58,962 58,602 After ten years 76,377 78,989 171,653 172,457 Agency mortgage-backed securities - residential 377,928 373,236 Agency mortgage-backed securities - commercial 36,024 36,326 Private label mortgage-backed securities - residential 15,902 16,021 Asset-backed securities 5,000 5,004 Total $ 606,507 $ 603,044 Held-to-Maturity Amortized Fair One to five years $ 7,289 $ 7,465 Five to ten years 41,135 42,502 After ten years 11,141 11,501 Total $ 59,565 $ 61,468 There were no gross realized gains or losses resulting from the sale of available-for-sale securities recognized during the twelve months ended December 31, 2021. There were gross realized gains of $0.1 million resulting from sales of available-for-sale securities recognized during the twelve months ended December 31, 2020 and there were gross realized losses of $0.5 million resulting from sales of available-for-sale securities recognized during the twelve months ended December 31, 2019. As of December 31, 2021, the fair value of available-for-sale investment securities pledged as collateral was $475.1 million. The Company pledged the securities for various types of transactions, including FHLB advances and derivative financial instruments. Certain investments in debt securities are reported in the consolidated financial statements at an amount less than their historical cost. As of December 31, 2021 and 2020, the Company had 179 and 121 securities, respectively, with market values below their cost basis. The total fair value of these investments at December 31, 2021 and 2020 was $403.2 million and $226.5 million, which is approximately 61% and 40%, respectively, of the Company’s available-for-sale and held-to-maturity securities portfolio. These declines resulted primarily from fluctuations in market interest rates after purchase. Management believes the declines in fair value for these securities are temporary. Should the impairment of any of these securities become other than temporary, the cost basis of the investment will be reduced with the resulting loss recognized in net income in the period the other-than-temporary impairment is identified. U.S. Government-Sponsored Agencies, Municipal Securities, and Corporate Securities The unrealized losses on the Company’s investments in securities issued by U.S. Government-sponsored agencies, municipal organizations and corporate entities were caused by interest rate changes. The contractual terms of those investments do not permit the issuer to settle the securities at a price less than the amortized cost bases of the investments. Because the Company does not intend to sell the investments and it is not likely that the Company will be required to sell the investments before recovery of their amortized cost bases, which may not be until maturity, the Company does not consider those investments to be other-than-temporarily impaired at December 31, 2021. Agency Mortgage-Backed and Private Label Mortgage-Backed Securities The unrealized losses on the Company’s investments in agency mortgage-backed and private label mortgage-backed were caused by interest rate changes. The Company expects to recover the amortized cost bases over the term of the securities. Because the Company does not intend to sell the investments and it is not likely that the Company will be required to sell the investments before recovery of their amortized cost bases, which may not be until maturity, the Company does not consider those investments to be other-than-temporarily impaired at December 31, 2021. The following tables show the securities portfolio’s gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position at December 31, 2021 and 2020: December 31, 2021 Less Than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Securities available-for-sale U.S. Government-sponsored agencies $ 2,921 $ (79) $ 40,305 $ (1,058) $ 43,226 $ (1,137) Municipal securities 5,721 (65) — — 5,721 (65) Agency mortgage-backed securities - residential (1) 287,820 (3,694) 40,840 (1,958) 328,660 (5,652) Agency mortgage-backed securities - commercial 3,944 (139) — — 3,944 (139) Private label mortgage-backed securities - residential 374 (3) — — 374 (3) Corporate securities 11,813 (187) 9,491 (508) 21,304 (695) Total $ 312,593 $ (4,167) $ 90,636 $ (3,524) $ 403,229 $ (7,691) December 31, 2020 Less Than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Securities available-for-sale U.S. Government-sponsored agencies $ — $ — $ 52,351 $ (1,652) $ 52,351 $ (1,652) Municipals 18,731 (114) 23,519 (617) 42,250 (731) Agency mortgage-backed securities - residential 38,987 (276) 45,297 (2,189) 84,284 (2,465) Private label mortgage-backed securities - residential 1,277 (1) 558 (1) 1,835 (2) Asset-backed securities — — 4,961 (39) 4,961 (39) Corporate securities — — 20,406 (1,594) 20,406 (1,594) Total $ 58,995 $ (391) $ 147,092 $ (6,092) $ 206,087 $ (6,483) December 31, 2020 Less Than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Securities held-to-maturity Corporate securities $ 17,456 $ (126) $ 2,999 $ (1) $ 20,455 $ (127) Total $ 17,456 $ (126) $ 2,999 $ (1) $ 20,455 $ (127) Amounts reclassified from accumulated other comprehensive loss and the affected line items in the consolidated statements of income during the years ended December 31, 2021, 2020 and 2019 were as follows: Details About Accumulated Other Comprehensive Loss Components Amounts Reclassified from Affected Line Item in the 2021 2020 2019 Unrealized gains and losses on securities available-for-sale Gain (loss) realized in earnings $ — $ 139 $ (458) Gain (loss) on sale of securities Total reclassified amount before tax — 139 (458) Income before income taxes Tax expense (benefit) — 38 (124) Income tax provision Total reclassifications out of accumulated other comprehensive loss $ — $ 101 $ (334) Net Income

Loans

Loans	12 Months Ended
	Dec. 31, 2021
Receivables [Abstract]
Loans	Loans Categories of loans include: December 31, 2021 2020 Commercial loans Commercial and industrial $ 96,008 $ 75,387 Owner-occupied commercial real estate 66,732 89,785 Investor commercial real estate 28,019 13,902 Construction 136,619 110,385 Single tenant lease financing 865,854 950,172 Public finance 592,665 622,257 Healthcare finance 387,852 528,154 Small business lending 108,666 125,589 Franchise finance 81,448 — Total commercial loans 2,363,863 2,515,631 Consumer loans Residential mortgage 186,770 186,787 Home equity 17,665 19,857 Other consumer 265,478 275,692 Total consumer loans 469,913 482,336 Total commercial and consumer loans 2,833,776 2,997,967 Net deferred loan origination costs, premiums and discounts on purchased loans, and other (1) 53,886 61,264 Total loans 2,887,662 3,059,231 Allowance for loan losses (27,841) (29,484) Net loans $ 2,859,821 $ 3,029,747 (1) Includes carrying value adjustments of $37.5 million and $42.7 million related to terminated interest rate swaps associated with public finance loans as of December 31, 2021 and 2020, respectively. The risk characteristics of each loan portfolio segment are as follows: Commercial and Industrial: Commercial and industrial loans’ sources of repayment are primarily based on the identified cash flows of the borrower and secondarily on the underlying collateral provided by the borrower. The cash flows of borrowers, however, may not be as expected, and the collateral securing these loans may fluctuate in value. Loans are made for working capital, equipment purchases, or other purposes. Most commercial and industrial loans are secured by the assets being financed and may incorporate a personal guarantee. This portfolio segment is generally concentrated in the Midwest and Southwest regions of the United States. Owner-Occupied Commercial Real Estate: The primary source of repayment is the cash flow from the ongoing operations and activities conducted by the borrower, or an affiliate of the borrower, who owns the property. This portfolio segment is generally concentrated in the Midwest and Southwest regions of the United States and its loans are often secured by manufacturing and service facilities, as well as office buildings. Investor Commercial Real Estate: These loans are underwritten primarily based on the cash flow expected to be generated from the property and are secondarily supported by the value of the real estate. These loans typically incorporate a personal guarantee from the primary sponsor or sponsors. This portfolio segment generally involves larger loan amounts with repayment primarily dependent on the successful leasing and operation of the property securing the loan or the business conducted on the property securing the loan. Investor commercial real estate loans may be more adversely affected by changing economic conditions in the real estate markets, industry dynamics or the overall health of the local economy where the property is located. The properties securing the Company’s investor commercial real estate portfolio tend to be diverse in terms of property type and are generally located in the Midwest and Southwest region of the United States. Management monitors and evaluates commercial real estate loans based on property financial performance, collateral value, guarantor strength, economic and industry conditions together with other risk grade criteria. As a general rule, the Company avoids financing special use projects unless other underwriting factors are present to mitigate these additional risks. Construction: Construction loans are secured by land and related improvements and are made to assist in the construction of new structures, which may include commercial (retail, industrial, office, and multi-family) properties or single family residential properties offered for sale by the builder. These loans generally finance a variety of project costs, including land, site preparation, architectural services, construction, closing and soft costs and interim financing needs. The cash flows of builders, while initially predictable, may fluctuate with market conditions, and the value of the collateral securing these loans may be subject to fluctuations based on general economic changes. This portfolio segment is generally concentrated in the Midwest and Southwest region of the United States. Single Tenant Lease Financing: These loans are made on a nationwide basis to property owners of real estate subject to long-term lease arrangements with single tenant operators. The real estate is typically operated by regionally, nationally or globally branded businesses. The loans are underwritten based on the financial strength of the borrower, characteristics of the real estate, cash flows generated from the lease arrangements and the financial strength of the tenant. Similar to the other loan portfolio segments, management monitors and evaluates these loans based on borrower and tenant financial performance, collateral value, industry trends and other risk grade criteria. Public Finance: These loans are made on a nationwide basis to governmental and not-for-profit entities to provide both tax-exempt and taxable loans for a variety of purposes including: short-term cash-flow needs; debt refinancing; economic development; quality of life projects; infrastructure improvements; renewable energy projects; and equipment financing. The primary sources of repayment for public finance loans include pledged revenue sources including but not limited to: general obligations; property taxes; income taxes; tax increment revenue; utility revenue; gaming revenues; sales tax; and pledged general revenue. Certain loans may also include an additional collateral pledge of mortgaged property or a security interest in financed equipment. Healthcare Finance: These loans are made on a nationwide basis to healthcare providers, primarily dentists, for practice acquisition financing or refinancing that occasionally includes owner-occupied commercial real estate and equipment purchases. The sources of repayment are primarily based on the identified cash flows from operations of the borrower and related entities and secondarily on the underlying collateral provided by the borrower. Small Business Lending: These loans are made on a nationwide basis to small businesses and generally carry a partial guaranty from the U.S. Small Business Administration (“SBA”) under its 7(a) loan program. We generally sell the government guaranteed portion of SBA loans into the secondary market while retaining the non-guaranteed portion of the loan and the servicing rights. Loans in the small business lending portfolio have sources of repayment that are primarily based on the identified cash flows of the borrower and secondarily on any underlying collateral provided by the borrower. Loans may, but do not always, have a collateral shortfall. For SBA loans where the guaranteed portion is retained, the SBA guaranty provides a tertiary source of repayment to the Bank in event of borrower default. Cash flows of borrowers, however, may not be as expected and collateral securing these loans may fluctuate in value. Loans are made for a broad array of purposes including, but not limited to, providing operating cash flow, funding ownership changes, and facilitating equipment purchases. These loans also include loans originated by the Bank under the SBA’s Paycheck Protection Program, which are fully guaranteed by the SBA. Franchise Finance: These loans are made on a nationwide basis through our partnership with ApplePie Capital, which through their deep relationships with franchise brands provides franchisees with financing options for new franchise units, recapitalization, expansion, equipment and working capital. The sources of repayment are either based on identified cash flows from existing operations of the borrower or pro forma cash flow for new franchise locations. Residential Mortgage: With respect to residential loans that are secured by 1-to-4 family residences and are generally owner occupied, the Company typically establishes a maximum loan-to-value ratio and requires private mortgage insurance if that ratio is exceeded. Repayment of these loans is primarily dependent on the financial circumstances of the borrowers, which can be impacted by economic conditions in their market areas such as unemployment levels. Repayment can also be impacted by changes in residential property values. Risk is mitigated by the fact that the loans are of smaller individual amounts and spread over a large number of borrowers in geographically diverse locations throughout the country. Home Equity: Home equity loans and lines of credit are typically secured by a subordinate interest in 1-to-4 family residences. The properties securing the home equity portfolio segment are generally geographically diverse as the Company offers these products on a nationwide basis. Repayment of these loans and lines of credit is primarily dependent on the financial circumstances of the borrowers and may be impacted by changes in unemployment levels and property values on residential properties, among other economic conditions in the market. Other Consumer: These loans primarily consist of consumer loans and credit cards. Consumer loans may be secured by consumer assets such as horse trailers or recreational vehicles. Some consumer loans are unsecured, such as small installment loans, home improvement loans and certain lines of credit. Repayment of consumer loans is primarily dependent upon the personal income of the borrowers, which can be impacted by economic conditions in their market areas such as unemployment levels. Risk is mitigated by the fact that the loans are of smaller individual amounts and spread over a large number of borrowers in geographically diverse locations throughout the country. The following tables present changes in the balance of the ALLL during the twelve months ended December 31, 2021, 2020, and 2019 Twelve Months Ended December 31, 2021 Balance, Beginning of Period Provision (Credit) Charged to Expense Losses Charged Off Recoveries Balance, End of Period Allowance for loan losses: Commercial and industrial $ 1,146 $ 684 $ (28) $ 89 $ 1,891 Owner-occupied commercial real estate 1,082 (340) — — 742 Investor commercial real estate 155 173 — — 328 Construction 1,192 420 — — 1,612 Single tenant lease financing 12,990 (214) (2,391) — 10,385 Public finance 1,732 44 — — 1,776 Healthcare finance 7,485 (1,545) — — 5,940 Small business lending 628 901 (222) 80 1,387 Franchise finance — 1,083 — — 1,083 Residential mortgage 519 67 (6) 63 643 Home equity 48 60 (51) 7 64 Other consumer 2,507 (303) (529) 315 1,990 Total $ 29,484 $ 1,030 $ (3,227) $ 554 $ 27,841 Twelve Months Ended December 31, 2020 Balance, Beginning of Period Provision (Credit) Charged to Expense Losses Charged Off Recoveries Balance, End of Period Allowance for loan losses: Commercial and industrial $ 1,521 $ 80 $ (461) $ 6 $ 1,146 Owner-occupied commercial real estate 561 545 (24) — 1,082 Investor commercial real estate 109 46 — — 155 Construction 380 812 — — 1,192 Single tenant lease financing 11,175 1,815 — — 12,990 Public finance 1,580 152 — — 1,732 Healthcare finance 3,247 4,894 (743) 87 7,485 Small business lending 54 665 (110) 19 628 Residential mortgage 657 (122) (20) 4 519 Home equity 46 (9) — 11 48 Other consumer 2,510 447 (804) 354 2,507 Total $ 21,840 $ 9,325 $ (2,162) $ 481 $ 29,484 Twelve Months Ended December 31, 2019 Balance, Beginning of Period Provision (Credit) Charged to Expense Losses Charged Off Recoveries Balance, End of Period Allowance for loan losses: Commercial and industrial $ 1,384 $ 1,029 $ (921) $ 29 $ 1,521 Owner-occupied commercial real estate 783 (222) — — 561 Investor commercial real estate 61 48 — — 109 Construction 251 129 — — 380 Single tenant lease financing 8,827 2,348 — — 11,175 Public finance 1,670 (90) — — 1,580 Healthcare finance 1,264 1,983 — — 3,247 Small business lending 203 (154) — 5 54 Residential mortgage 1,079 (350) (76) 4 657 Home equity 53 51 (68) 10 46 Other consumer 2,321 1,194 (1,292) 287 2,510 Total $ 17,896 $ 5,966 $ (2,357) $ 335 $ 21,840 The following tables present the balance in the allowance for loan losses and the recorded investment in loans based on portfolio segment and impairment method as of December 31, 2021 and 2020. Loans Allowance for Loan Losses December 31, 2021 Ending Balance: Ending Balance: Ending Balance Ending Balance: Ending Balance: Ending Balance Commercial and industrial $ 95,364 $ 644 $ 96,008 $ 1,441 $ 450 $ 1,891 Owner-occupied commercial real estate 63,387 3,345 66,732 742 — 742 Investor commercial real estate 28,019 — 28,019 328 — 328 Construction 136,619 — 136,619 1,612 — 1,612 Single tenant lease financing 864,754 1,100 865,854 10,290 95 10,385 Public finance 592,665 — 592,665 1,776 — 1,776 Healthcare finance 386,926 926 387,852 5,417 523 5,940 Small business lending 106,682 1,984 108,666 994 393 1,387 Franchise finance 81,448 — 81,448 1,083 — 1,083 Residential mortgage 183,852 2,918 186,770 643 — 643 Home equity 17,651 14 17,665 64 — 64 Other consumer 265,469 9 265,478 1,990 — 1,990 Total $ 2,822,836 $ 10,940 $ 2,833,776 $ 26,380 $ 1,461 $ 27,841 Loans Allowance for Loan Losses December 31, 2020 Ending Balance: Ending Balance: Ending Balance Ending Balance: Ending Balance: Ending Balance Commercial and industrial $ 74,870 $ 517 $ 75,387 $ 1,146 $ — $ 1,146 Owner-occupied commercial real estate 87,947 1,838 89,785 1,082 — 1,082 Investor commercial real estate 13,902 — 13,902 155 — 155 Construction 110,385 — 110,385 1,192 — 1,192 Single tenant lease financing 942,848 7,324 950,172 9,900 3,090 12,990 Public finance 622,257 — 622,257 1,732 — 1,732 Healthcare finance 527,144 1,010 528,154 7,485 — 7,485 Small business lending 125,589 — 125,589 628 — 628 Residential mortgage 185,241 1,546 186,787 519 — 519 Home equity 19,857 — 19,857 48 — 48 Other consumer 275,642 50 275,692 2,507 — 2,507 Total $ 2,985,682 $ 12,285 $ 2,997,967 $ 26,394 $ 3,090 $ 29,484 The Company utilizes a risk grading matrix to assign a risk grade to each of its commercial loans. A description of the general characteristics of the risk grades is as follows: • “Pass” - Higher quality loans that do not fit any of the other categories described below. • “Special Mention” - Loans that possess some credit deficiency or potential weakness which deserve close attention. • “Substandard” - Loans that possess a defined weakness or weaknesses that jeopardize the liquidation of the debt. Loans characterized by the distinct possibility that the institution will sustain some loss if the deficiencies are not corrected. Loans that are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any. • “Doubtful” - Such loans have been placed on nonaccrual status and may be heavily dependent upon collateral possessing a value that is difficult to determine or based upon some near-term event which lacks clear certainty. These loans have all of the weaknesses of those classified as Substandard; however, based on existing conditions, these weaknesses make full collection of the principal balance highly improbable. • “Loss” - Loans that are considered uncollectible and of such little value that continuing to carry them as assets is not warranted. The following tables present the credit risk profile of the Company’s commercial and consumer loan portfolios based on rating category and payment activity as of December 31, 2021 and 2020. December 31, 2021 Pass Special Mention Substandard Total Commercial and industrial $ 82,412 $ 12,952 $ 644 $ 96,008 Owner-occupied commercial real estate 59,369 4,018 3,345 66,732 Investor commercial real estate 28,019 — — 28,019 Construction 124,578 12,041 — 136,619 Single tenant lease financing 859,612 5,142 1,100 865,854 Public finance 591,630 1,035 — 592,665 Healthcare finance 386,337 589 926 387,852 Small business lending 99,250 7,432 1,983 108,666 Franchise finance 81,448 — — 81,448 Total commercial loans $ 2,312,655 $ 43,209 $ 7,998 $ 2,363,863 December 31, 2021 Performing Nonaccrual Total Residential mortgage $ 185,544 $ 1,226 $ 186,770 Home equity 17,651 14 17,665 Other consumer 265,469 9 265,478 Total $ 468,664 $ 1,249 $ 469,913 December 31, 2020 Pass Special Mention Substandard Total Commercial and industrial $ 74,138 $ 732 $ 517 $ 75,387 Owner-occupied commercial real estate 84,292 3,655 1,838 89,785 Investor commercial real estate 13,902 — — 13,902 Construction 110,385 — — 110,385 Single tenant lease financing 932,830 10,018 7,324 950,172 Public finance 622,257 — — 622,257 Healthcare finance 526,517 627 1,010 528,154 Small business lending 117,474 2,930 5,185 125,589 Total commercial loans 2,481,795 17,962 15,874 2,515,631 December 31, 2020 Performing Nonaccrual Total Residential mortgage $ 185,604 $ 1,183 $ 186,787 Home equity 19,857 — 19,857 Other consumer 275,646 46 275,692 Total $ 481,107 $ 1,229 $ 482,336 The following tables present the Company’s loan portfolio delinquency analysis as of December 31, 2021 and 2020. December 31, 2021 30-59 60-89 90 Days Total Current Total loans Nonaccrual Total Loans Commercial and industrial $ — $ — $ — $ — $ 96,008 $ 96,008 $ 674 $ — Owner-occupied commercial real estate — — — — 66,732 66,732 — — Investor commercial real estate — — — — 28,019 28,019 3,419 — Construction — — — — 136,619 136,619 — — Single tenant lease financing — — — — 865,854 865,854 1,100 — Public finance — — — — 592,665 592,665 — — Healthcare finance — — — — 387,852 387,852 — — Small business lending — — 657 657 108,009 108,666 959 — Franchise Finance — — — — 81,448 81,448 — — Residential mortgage 51 226 106 383 186,387 186,770 1,226 — Home equity — — — — 17,665 17,665 14 — Other consumer 68 18 — 86 265,392 265,478 9 — Total $ 119 $ 244 $ 763 $ 1,126 $ 2,832,650 $ 2,833,776 $ 7,401 $ — December 31, 2020 30-59 60-89 90 Days Total Current Total loans Nonaccrual Total Loans Commercial and industrial $ — $ — $ — $ — $ 75,387 $ 75,387 $ — $ — Owner-occupied commercial real estate — — — — 89,785 89,785 1,838 — Investor commercial real estate — — — — 13,902 13,902 — — Construction — — — — 110,385 110,385 — — Single tenant lease financing — — 4,680 4,680 945,492 950,172 7,116 — Public finance — — — — 622,257 622,257 — — Healthcare finance — — — — 528,154 528,154 — — Small business lending — — — — 125,589 125,589 — — Residential mortgage 49 — 269 318 186,469 186,787 1,183 — Home equity — 15 — 15 19,842 19,857 — — Other consumer 176 51 5 232 275,460 275,692 46 — Total $ 225 $ 66 $ 4,954 $ 5,245 $ 2,992,722 $ 2,997,967 $ 10,183 $ — The following tables present the Company’s impaired loans as of December 31, 2021 and 2020. December 31, 2021 December 31, 2020 Recorded Unpaid Specific Recorded Unpaid Specific Loans without a specific valuation allowance Commercial and industrial $ — $ — $ — $ 517 $ 517 $ — Owner-occupied commercial real estate 3,345 3,466 — 1,838 1,850 — Single tenant lease financing — — — 1,315 1,334 — Healthcare finance $ — $ — $ — $ 1,010 $ 1,010 $ — Small business lending 959 1,193 — — — Residential mortgage 2,918 3,063 — 1,546 1,652 — Home equity 14 15 — — — — Other consumer 9 44 — 50 120 — Total 7,245 7,781 — 6,276 6,483 — Loans with a specific valuation allowance Commercial and industrial $ 644 $ 677 $ 450 $ — $ — $ — Construction — — — — — — Single tenant lease financing 1,100 1,123 95 6,009 6,036 3,090 Healthcare finance 926 926 523 — — — Small business lending 1,025 1,025 393 — — — Total 3,695 3,751 1,461 6,009 6,036 3,090 Total impaired loans $ 10,940 $ 11,532 $ 1,461 $ 12,285 $ 12,519 $ 3,090 The following table presents average balances and interest income recognized for impaired loans during the twelve months ended December 31, 2021, 2020, and 2019. Twelve Months Ended December 31, 2021 December 31, 2020 December 31, 2019 Average Interest Average Interest Average Interest Loans without a specific valuation allowance Commercial and industrial $ 194 $ 9 $ 1,037 $ 57 $ 3,293 $ 289 Owner-occupied commercial real estate 3,324 — 3,790 60 3,292 170 Single tenant lease financing 75 5 — — — — Healthcare finance 252 — 386 16 — — Small business lending 1,215 — — — 331 94 Residential mortgage 2,264 67 1,333 — 2,265 — Home equity 13 — — — 10 — Other consumer 29 — 57 — 68 1 Total 7,366 81 6,603 133 9,259 554 Loans with a specific valuation allowance Commercial and industrial 675 — 169 3 1,077 — Owner-occupied commercial real estate 355 — — — — — Single tenant lease financing 3,931 — 5,671 4 1,464 — Healthcare finance 841 131 — — — — Small business lending 644 — — — — — Total 6,446 131 5,840 7 2,541 — Total impaired loans $ 13,812 $ 212 $ 12,443 $ 140 $ 11,800 $ 554 The Company had $1.2 million in other real estate owned (“OREO”) as of December 31, 2021, which consisted of one commercial property. The Company did not have any OREO as of December 31, 2020. There was one loan for $0.1 million and no loans in the process of foreclosure at December 31, 2021 and December 31, 2020, respectively. Troubled Debt Restructurings The loan portfolio includes TDRs, which are loans that have been modified to grant economic concessions to borrowers who have experienced financial difficulties. These concessions typically result from loss mitigation efforts and could include reductions in the interest rate, payment extensions, forgiveness of principal, forbearance, or other actions. Certain TDRs are classified as nonperforming at the time of restructuring and typically are returned to performing status after considering the borrower’s sustained repayment performance for a reasonable period, generally not less than six consecutive months. When loans are modified in a TDR, any possible impairment similar to other impaired loans is evaluated based on the present value of expected future cash flows, discounted at the contractual interest rate of the original loan agreement, or using the current fair value of the collateral, less selling costs, for collateral-dependent loans. If it is determined that the value of the modified loan is less than the recorded balance of the loan, impairment is recognized through a specific allowance or charge-off to the allowance. In periods subsequent to modification, all TDRs, including those that have payment defaults, are evaluated for possible impairment, and impairment is recognized through the allowance. In the course of working with troubled borrowers, the Company may choose to restructure the contractual terms of certain loans in an effort to work out an alternative payment schedule with the borrower in order to optimize the collectability of the loan. Any loan modification is reviewed by the Company to identify whether a TDR has occurred when the Company grants a concession to the borrower that it would not otherwise consider based on economic or legal reasons related to a borrower’s financial difficulties. Terms may be modified to fit the ability of the borrower to repay in line with its current financial status or the loan may be restructured to secure additional collateral and/or guarantees to support the debt, or a combination of the two. There were two new portfolio residential mortgage loans classified as a new TDRs during the twelve months ended December 31, 2021 with a pre-modification and post-modification outstanding recorded investment of $1.6 million. The Company did not allocate a specific allowance for these loans as of December 31, 2021. The modifications consisted of interest-only payments for a period of time. There were three commercial and industrial loans classified as new TDRs during the twelve months ended December 31, 2020 with a pre-modification and post-modification outstanding recorded investment of $2.6 million. The Company did not allocate a specific allowance for these loans as of December 31, 2020 and the modifications consisted of interest only payments for a period of time and an extension of the maturity date. There were four commercial and industrial loans classified as new TDRs during the twelve months ended December 31, 2019 with a pre-modification and post-modification outstanding recorded investment of $2.0 million. The Company did not allocate a specific allowance for these loans as of December 31, 2019 and the modifications consisted of interest only payments for a period of time. There were no performing TDRs which had payment defaults within the twelve months following modification during the years ended December 31, 2021, 2020 and 2019. Non-TDR Loan Modifications due to COVID-19 The “Interagency Statement on Loan Modifications and Reporting for Financial Institutions Working with Customers Affected by the Coronavirus” was issued by our banking regulators on March 22, 2020. This guidance encourages financial institutions to work prudently with borrowers who are or may be unable to meet their contractual payment obligations due to the effects of COVID-19. Additionally, Section 4013 of the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) provides that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief were in effect from the period beginning March 1, 2020 until January 1, 2022. As of December 31, 2021, the Company had eleven loans totaling $10.5 million in non-TDR loan modifications due to COVID-19.

Premises and Equipment

Premises and Equipment	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Premises and Equipment	Premises and Equipment The following table summarizes premises and equipment at December 31, 2021 and 2020. December 31, 2021 2020 Land $ — $ 2,500 Construction in process 57,469 28,754 Right of use leased asset 208 819 Building and improvements 1,090 5,819 Furniture and equipment 7,800 10,671 Less: accumulated depreciation (6,725) (10,973) $ 59,842 $ 37,590 In December 2018, the Bank’s subsidiary, SPF15, Inc., entered into a project agreement with the City of Fishers, Indiana, and it’s Redevelopment Commission, among others, to construct an office building to include the Company’s future headquarters and associated parking garage on property the Bank had acquired. The City agreed to reimburse SPF15, Inc. a total of $11.2 million for the cost of the land and $15.0 million for the construction of the parking garage.

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	GoodwillAs of December 31, 2021 and 2020, the carrying amount of goodwill was $4.7 million. There have been no changes in the carrying amount of goodwill for the three years ended December 31, 2021, 2020, and 2019. Goodwill is tested for impairment on an annual basis as of August 31, or whenever events or changes in circumstances indicate the carrying amount of goodwill exceeds its implied fair value. The annual test indicated no impairment existed as of August 31, 2021 and no events or changes in circumstances have occurred since the August 31, 2021 annual impairment test that would suggest it was more likely than not goodwill impairment existed.

Servicing Asset

Servicing Asset	12 Months Ended
	Dec. 31, 2021
Transfers and Servicing [Abstract]
Servicing Asset	Servicing Asset Activity for the servicing asset and the related changes in fair value for the twelve months ended December 31, 2021, 2020 and 2019 are shown in the table below. Twelve Months Ended December 31, 2021 December 31, 2020 December 31, 2019 Beginning balance $ 3,569 $ 2,481 $ — Additions: Originated and purchased servicing 2,202 1,520 2,481 Subtractions: Paydowns (820) (524) — Changes in fair value due to changes in valuation inputs (249) 92 — Loan servicing asset revaluation (1,069) (432) — Ending balance $ 4,702 $ 3,569 $ 2,481 Loans serviced for others are not included in the consolidated balance sheets. The unpaid principal balances of these loans serviced for others as of December 31, 2021 and December 31, 2020 are shown in the table below. December 31, 2021 December 31, 2020 Loan portfolios serviced for: SBA guaranteed loans $ 230,514 $ 165,961 Total $ 230,514 $ 165,961 Loan servicing revenue totaled $1.9 million during the twelve months ended December 31, 2021 and $1.2 million during the twelve months ended December 31, 2020. Loan servicing asset revaluation, which represents paydowns and the change in fair value of the servicing asset, resulted in a $1.1 million and $0.4 million downward valuation for twelve months ended December 31, 2021 and December 31, 2020, respectively. The fair value of servicing rights is highly sensitive to changes in underlying assumptions. Though fluctuations in prepayment speeds and changes in secondary market premiums generally have the most substantial impact on the fair value of servicing rights, other influencing factors include changing economic conditions, changes to the discount rate assumption and the weighted average life of the servicing portfolio. Measurement of fair value is limited to the conditions existing and the assumptions used as of a particular point in time; however, those assumptions may change over time. Refer to Note 16 - Fair Value of Financial Instruments for further details.

Deposits

Deposits	12 Months Ended
	Dec. 31, 2021
Deposits [Abstract]
Deposits	Deposits The following table presents the composition of the Company’s deposit base as of December 31, 2021 and 2020. December 31, 2021 2020 Noninterest-bearing demand deposit accounts $ 117,531 $ 96,753 Interest-bearing demand deposit accounts 247,967 188,645 Savings accounts 59,998 43,200 Money market accounts 1,483,936 1,350,566 Certificates of deposits 970,107 1,289,319 Brokered deposits 299,420 302,402 Total deposits $ 3,178,959 $ 3,270,885 Time deposits greater than $250 $ 327,490 $ 403,253 The following table presents time deposit maturities by year as of December 31, 2021. Certificates of Deposits Brokered Certificates of Deposits 2022 $ 618,091 $ 129,461 2023 190,045 18,628 2024 97,940 1,490 2025 29,452 — 2026 34,579 — $ 970,107 $ 149,579

FHLB Advances

FHLB Advances	12 Months Ended
	Dec. 31, 2021
Federal Home Loan Banks [Abstract]
FHLB Advances	FHLB Advances The Company had outstanding FHLB advances of $514.9 million and $514.9 million as of December 31, 2021 and 2020, respectively. As of December 31, 2021, the stated interest rates on the Company’s outstanding FHLB advances ranged from 0.25% to 3.26%, with a weighted average interest rate of 1.65%. All advances are collateralized by residential mortgage loans and commercial real estate loans pledged and held by the Company and investment securities pledged by the Company and held in safekeeping with the FHLB. Residential mortgage loans pledged were approximately $128.8 million and $125.1 million as of December 31, 2021 and 2020, respectively, and commercial real estate loans pledged were approximately $920.9 million and $960.5 million as of December 31, 2021 and 2020, respectively. The fair value of investment securities pledged to the FHLB was approximately $474.5 million and $351.0 million as of December 31, 2021 and 2020, respectively. Based on this collateral and the Company’s holdings of FHLB stock, the Company is eligible to borrow up to an additional $579.9 million at year-end 2021. As of December 31, 2021, the Company had $125.0 million of putable advances with the FHLB. The Company’s FHLB advances are scheduled to mature according to the following schedule: Amount 2022 $ 110,000 2023 35,000 2024 145,014 2025 90,000 2026 10,000 Thereafter 124,908 $ 514,922

Subordinated Debt

Subordinated Debt	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Subordinated Debt	Subordinated Debt In October 2015, the Company entered into a term loan in the principal amount of $10.0 million, evidenced by a term note due 2025 (the “2025 Note”). The 2025 Note had a fixed interest rate of 6.4375% per year, payable quarterly, and was scheduled to mature on October 1, 2025. The 2025 Note was an unsecured subordinated obligation of the Company and was eligible to be repaid, without penalty, on any interest payment date on or after October 15, 2020. The 2025 Note was intended to qualify as Tier 2 capital under regulatory guidelines. The Company redeemed the 2025 Note in full on January 4, 2021. In September 2016, the Company issued $25.0 million aggregate principal amount of 6.0% Fixed-to-Floating Rate Subordinated Notes due 2026 (the “2026 Notes”) in a public offering. The 2026 Notes initially bear a fixed interest rate of 6.00% per year to, but excluding, September 30, 2021, and thereafter a floating rate equal to the then-current three-month London Interbank Offered Rate (“LIBOR”) plus 4.85%. All interest on the 2026 Notes was payable quarterly. The 2026 Notes were scheduled to mature on September 30, 2026. The 2026 Notes were unsecured subordinated obligations of the Company eligible to be repaid, without penalty, on any interest payment date on or after September 30, 2021. The 2026 Notes were intended to qualify as Tier 2 capital under regulatory guidelines. The Company redeemed the 2026 Notes in full on September 30, 2021. In June 2019, the Company issued $37.0 million aggregate principal amount of 6.0% Fixed-to-Floating Rate Subordinated Notes due 2029 (the “2029 Notes”) in a public offering. The 2029 Notes initially bear a fixed interest rate of 6.0% per year to, but excluding, June 30, 2024, and thereafter a floating rate equal to the then-current benchmark rate (initially three-month LIBOR rate) plus 4.11%. All interest on the 2029 Notes is payable quarterly. The 2029 Notes are scheduled to mature on June 30, 2029. The 2029 Notes are unsecured subordinated obligations of the Company and may be repaid, without penalty, on any interest payment date on or after June 30, 2024. The 2029 Notes are intended to qualify as Tier 2 capital under regulatory guidelines. In October 2020, the Company entered into a term loan in the principal amount of $10.0 million, evidenced by a term note due 2030 (the “2030 Note”). The 2030 Note initially bears a fixed interest rate of 6.0% per year to, but excluding, November 1, 2025 and thereafter at a floating rate equal to the then-current benchmark rate (initially three-month Term SOFR plus 5.795%). The 2030 Note is scheduled to mature on November 1, 2030. The 2030 Note is an unsecured subordinated obligation of the Company and may be repaid, without penalty, on any interest payment date on or after November 1, 2025. The 2030 Note is intended to qualify as Tier 2 capital under regulatory guidelines. The Company used the net proceeds from the issuance of the 2030 Note to redeem the 2025 Note as discussed above. In August 2021, the Company issued $60.0 million aggregate principal amount of 3.75% Fixed-to-Floating Rate Subordinated Notes due 2031 (the “2031 Notes”) in a private placement. The 2031 Notes initially bear a fixed interest rate of 3.75% per year to, but excluding, September 1, 2026, and thereafter a floating rate equal to the then-current benchmark rate (initially three-month Term SOFR plus 3.11%). The 2031 Notes are scheduled to mature on September 1, 2031. The 2031 Notes are unsecured subordinated obligations of the Company and may be repaid, without penalty, on any interest payment date on or after September 1, 2026. The 2031 Notes are intended to qualify as Tier 2 capital under regulatory guidelines. The Company used a portion of the net proceeds from the issuance of the 2031 Notes to redeem the 2026 Notes. Pursuant to the terms of a Registration Rights Agreement between the Company and the initial purchasers of the 2031 Notes, the Company offered to exchange the 2031 Notes for subordinated notes that are registered under the Securities Act of 1933, as amended, and have substantially the same terms as the 2031 Notes. The offering period to exchange the unregistered 2031 Notes for registered 2031 Notes expired on December 30, 2021. The following table presents the principal balance and unamortized discount and debt issuance costs for the 2025 Note, the 2026 Notes, the 2029 Notes, the 2030 Note, and the 2031 Notes as of December 31, 2021 and 2020. December 31, 2021 December 31, 2020 Principal Unamortized Discount and Debt Issuance Costs Principal Unamortized Discount and Debt Issuance Costs 2025 Note $ — $ — $ 10,000 $ (114) 2026 Notes — — 25,000 (715) 2029 Notes 37,000 (1,178) 37,000 (1,337) 2030 Note 10,000 (208) 10,000 (231) 2031 Notes 60,000 (1,383) — — Total $ 107,000 $ (2,769) $ 82,000 $ (2,397)

Benefit Plans

Benefit Plans	12 Months Ended
	Dec. 31, 2021
Retirement Benefits [Abstract]
Benefit Plans	Benefit Plans 401(k) Plan The Company has a 401(k) plan established for substantially all full-time employees, as defined in the plan. Employee contributions are limited to the maximum established by the Internal Revenue Service on an annual basis. The Company has elected to match contributions equal to 100% of the first 1% of employee deferrals and then 50% on deferrals over 1% up to a maximum of 6% of an individual’s total eligible salary, as defined in the plan, which vests immediately. Discretionary employer-matching contributions begin vesting immediately at a rate of 50% per year of employment and are fully vested after the completion of two years of employment. Contributions totaled approximately $0.9 million, $0.8 million and $0.6 million in the twelve months ended December 31, 2021, 2020 and 2019, respectively. Employment Agreement The Company has entered into an employment agreement with its Chief Executive Officer that provides for an annual base salary and an annual bonus, if any, as determined from time to time by the Compensation Committee. The annual bonus is to be determined with reference to the achievement of annual performance objectives established by the Compensation Committee for the Chief Executive Officer and other senior officers. The agreement also provides that the Chief Executive Officer may be awarded additional compensation, benefits or consideration as the Compensation Committee may determine. The agreement provides for the continuation of salary and certain other benefits for a specified period of time upon termination of his employment under certain circumstances, including his resignation for “good reason” or termination by the Company without “cause” at any time or any termination of his employment for any reason within twelve months following a “change in control,” along with other specific conditions. 2013 Equity Incentive Plan The 2013 Equity Incentive Plan (“2013 Plan”) authorizes the issuance of up to 750,000 shares of the Company’s common stock in the form of equity-based awards to employees, directors, and other eligible persons. Under the terms of the 2013 Plan, the pool of shares available for issuance may be used for available types of equity awards under the 2013 Plan, which includes stock options, stock appreciation rights, restricted stock awards, stock unit awards, and other share-based awards. All employees, consultants, and advisors of the Company or any subsidiary, as well as all non-employee directors of the Company, are eligible to receive awards under the 2013 Plan. The Company recorded $2.4 million, $2.1 million, and $1.7 million of share-based compensation expense for the years ended December 31, 2021, 2020, and 2019, respectively, related to awards made under the 2013 Plan. The following table summarizes the status of the 2013 Plan awards as of December 31, 2021, and activity for the year ended December 31, 2021: Restricted Stock Units Weighted-Average Grant Date Fair Value Per Share Restricted Stock Awards Weighted-Average Grant Date Fair Value Per Share Deferred Stock Units Weighted-Average Grant Date Fair Value Per Unit Unvested at January 1, 2021 112,985 $ 27.76 — $ — — $ — Granted 60,111 30.42 14,180 30.54 8 32.18 Vested (60,274) 29.64 (13,123) 30.58 (8) 32.18 Forfeited — — (1,057) 30.13 — — Unvested at December 31, 2021 112,822 $ 28.18 — $ — — $ — As of December 31, 2021, the total unrecognized compensation cost related to unvested awards was $2.0 million, with a weighted-average expense recognition period of 1.6 years. Directors Deferred Stock Plan Until January 1, 2014, the Company had a stock compensation plan for non-employee members of the Board of Directors (“Directors Deferred Stock Plan”). The Company reserved 180,000 shares of common stock that could have been issued pursuant to the Directors Deferred Stock Plan. The plan provided directors the option to elect to receive up to 100% of their annual retainer in either common stock or deferred stock rights. Deferred stock rights were to be settled in common stock following the end of the deferral period payable on the basis of one share of common stock for each deferred stock right. The following table summarizes the status of deferred stock rights related to the Directors Deferred Stock Plan for the year ended December 31, 2021. Deferred Rights Outstanding, beginning of year 83,835 Granted 701 Exercised — Outstanding, end of year 84,536

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The provision for income taxes consists of the following: December 31, 2021 2020 2019 Current $ 6,024 $ 8,563 $ 6,319 Deferred 2,434 (4,118) (4,402) Total $ 8,458 $ 4,445 $ 1,917 Income tax provision is reconciled to the statutory 21% rate applied to pre-tax income. December 31, 2021 2020 2019 Statutory rate times pre-tax income $ 11,880 $ 7,119 $ 5,703 (Subtract) add the tax effect of: Income from tax-exempt securities and loans (4,217) (4,464) (4,881) State income tax, net of federal tax effect 865 1,765 1,285 Bank-owned life insurance (199) (200) (198) Tax credits (175) (178) (181) Other differences 304 403 189 Total income taxes $ 8,458 $ 4,445 $ 1,917 The net deferred tax asset at December 31, 2021 and 2020 consists of the following: December 31, 2021 2020 Deferred tax assets (liabilities) Allowance for loan losses $ 7,517 $ 7,961 Net unrealized losses on available-for-sale securities and hedged items 4,835 5,800 Fair value adjustments (618) 1,117 Depreciation (100) (107) Deferred compensation and accrued payroll 1,577 1,533 Loan origination costs (1,311) (1,281) Prepaid assets (641) (553) Other 149 337 Total deferred tax assets, net $ 11,408 $ 14,807

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions In the normal course of business, the Company may enter into transactions with various related parties. In management’s opinion, such loans, other extensions of credit, and deposits were made in the ordinary course of business and were made on substantially the same terms (including interest rates and collateral) as those prevailing at the time for comparable transactions with other persons. Further, in management’s opinion, these loans did not involve more than the normal risk of collectability or present other unfavorable features. Management evaluated related party loans and extensions of credit at December 31, 2021 and 2020, and deemed the balances immaterial. Deposits from related parties held by the Company at December 31, 2021 and 2020 totaled $40.2 million and $33.0 million, respectively.

Regulatory Capital Requirements

Regulatory Capital Requirements	12 Months Ended
	Dec. 31, 2021
Mortgage Banking [Abstract]
Regulatory Capital Requirements	Regulatory Capital Requirements The Company and the Bank are subject to various regulatory capital requirements administered by state and federal banking agencies. Capital adequacy guidelines and, additionally for banks, prompt corrective action regulations, involve quantitative measures of assets, liabilities, and certain off-balance sheet items calculated under regulatory accounting practices. Capital amounts and classifications are also subject to qualitative judgments by regulators about components, risk weighting and other factors. The Basel III Capital Rules became effective for the Company and the Bank on January 1, 2015, subject to a phase-in period for certain provisions. Quantitative measures established by the Basel III Capital Rules to ensure capital adequacy require the maintenance of minimum amounts and ratios of Common Equity Tier 1 capital, Tier 1 capital and Total capital, as defined in the regulations, to risk-weighted assets, and of Tier 1 capital to adjusted quarterly average assets (“Leverage Ratio”). The Basel III Capital Rules were fully phased in on January 1, 2019 and require the Company and the Bank to maintain: 1) a minimum ratio of Common Equity Tier 1 capital to risk-weighted assets of 4.5%, plus a 2.5% “capital conservation buffer” (resulting in a minimum ratio of Common Equity Tier 1 capital to risk-weighted assets of 7.0%); 2) a minimum ratio of Tier 1 capital to risk-weighted assets of 6.0%, plus the capital conservation buffer (resulting in a minimum Tier 1 capital ratio of 8.5%); 3) a minimum ratio of Total capital to risk-weighted assets of 8.0%, plus the capital conservation buffer (resulting in a minimum Total capital ratio of 10.5%); and 4) a minimum Leverage Ratio of 4.0%. The capital conservation buffer is designed to absorb losses during periods of economic stress. Failure to maintain the minimum Common Equity Tier 1 capital ratio plus the capital conservation buffer will result in potential restrictions on a banking institution’s ability to pay dividends, repurchase stock and/or pay discretionary compensation to its employees. The following tables present actual and required capital ratios as of December 31, 2021 and 2020 for the Company and the Bank under the Basel III Capital Rules. The minimum required capital amounts presented include the minimum required capital levels as of December 31, 2021 and 2020 based on the Basel III Capital Rules. Capital levels required to be considered well capitalized are based upon prompt corrective action regulations, as amended to reflect the changes under the Basel III Capital Rules. Actual Minimum Capital Required - Basel III Minimum Required to be Considered Well Capitalized Capital Amount Ratio Capital Amount Ratio Capital Amount Ratio As of December 31, 2021: Common equity tier 1 capital to risk-weighted assets Consolidated $ 384,499 12.93 % $ 208,202 7.00 % N/A N/A Bank 432,181 14.55 % 207,913 7.00 % 193,062 6.50 % Tier 1 capital to risk-weighted assets Consolidated 384,499 12.93 % 252,817 8.50 % N/A N/A Bank 432,181 14.55 % 252,466 8.50 % 237,615 8.00 % Total capital to risk-weighted assets Consolidated 516,571 17.37 % 312,303 10.50 % N/A N/A Bank 460,022 15.49 % 311,870 10.50 % 297,019 10.00 % Leverage ratio Consolidated 384,499 9.22 % 166,824 4.00 % N/A N/A Bank 432,181 10.37 % 166,693 4.00 % 208,366 5.00 % Actual Minimum Capital Required - Basel III Minimum Required to be Considered Well Capitalized Capital Amount Ratio Capital Amount Ratio Capital Amount Ratio As of December 31, 2020: Common equity tier 1 capital to risk-weighted assets Consolidated $ 342,159 11.31 % $ 211,828 7.00 % N/A N/A Bank 377,678 12.49 % 211,612 7.00 % 196,497 6.50 % Tier 1 capital to risk-weighted assets Consolidated 342,159 11.31 % 257,220 8.50 % N/A N/A Bank 377,678 12.49 % 256,957 8.50 % 241,842 8.00 % Total capital to risk-weighted assets Consolidated 451,246 14.91 % 317,742 10.50 % N/A N/A Bank 407,162 13.47 % 317,418 10.50 % 302,303 10.00 % Leverage ratio Consolidated 342,159 7.95 % 172,154 4.00 % N/A N/A Bank 377,678 8.78 % 172,036 4.00 % 215,045 5.00 %

Commitments and Credit Risk

Commitments and Credit Risk	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Credit Risk	Commitments and Credit Risk In the normal course of business, the Company makes various commitments to extend credit which are not reflected in the accompanying consolidated financial statements. At December 31, 2021 and 2020, the Company had outstanding loan commitments totaling approximately $324.3 million and $263.9 million, respectively. Capital Commitments Capital expenditures contracted for at the balance sheet date but not yet recognized in the financial statements are associated with the construction of premises intended to house our corporate headquarters. The Company has entered into construction-related contracts in the amount of $68.3 million. As of December 31, 2021, $14.8 million of such contract commitments had not yet been incurred. These commitments are due within one year.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments ASC Topic 820, Fair Value Measurements , defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASU Topic 820 also specifies a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value: Level 1 Quoted prices in active markets for identical assets or liabilities Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities Level 3 Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities Following is a description of the valuation methodologies and inputs used for assets measured at fair value on a recurring basis and recognized in the accompanying consolidated balance sheets, as well as the general classification of such assets pursuant to the valuation hierarchy. Available-for-Sale Securities Where quoted market prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities include highly liquid mutual funds. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows. Level 2 securities include U.S. Government-sponsored agencies, municipal securities, mortgage and asset-backed securities and certain corporate securities. Matrix pricing is a mathematical technique widely used in the banking industry to value investment securities without relying exclusively on quoted prices for specific investment securities but also on the investment securities’ relationship to other benchmark quoted investment securities. In certain cases where Level 1 or Level 2 inputs are not available, securities are classified within Level 3 of the hierarchy. Fair values are calculated using discounted cash flows. Discounted cash flows are calculated based off of the anticipated future cash flows updated to incorporate loss severities. Rating agency and industry research reports as well as default and deferral activity are reviewed and incorporated into the calculation. The Company did not own any securities classified within Level 3 of the hierarchy as of December 31, 2021 or 2020. Loans Held-for-Sale (mandatory pricing agreements) The fair value of loans held-for-sale is determined using quoted prices for similar assets, adjusted for specific attributes of that loan (Level 2). Servicing Asset Fair value is based on a loan-by-loan basis taking into consideration the origination to maturity dates of the loans, the current age of the loans and the remaining term to maturity. The valuation methodology utilized for the servicing asset begins with generating estimated future cash flows for each servicing asset, based on their unique characteristics and market-based assumptions for prepayment speeds and costs to service. The present value of the future cash flows is then calculated utilizing market-based discount rate assumptions (Level 3). Interest Rate Swap Agreements The fair values of interest rate swap agreements are estimated using current market interest rates as of the balance sheet date and calculated using discounted cash flows that are observable or that can be corroborated by observable market data (Level 2). Forward Contracts The fair values of forward contracts on to-be-announced securities are determined using quoted prices in active markets, or benchmarked thereto (Level 1). Interest Rate Lock Commitments The fair values of IRLCs are determined using the projected sale price of individual loans based on changes in market interest rates, projected pull-through rates (the probability that an IRLC will ultimately result in an originated loan), the reduction in the value of the applicant’s option due to the passage of time, and the remaining origination costs to be incurred based on management’s estimate of market costs (Level 3). The following tables present the fair value measurements of assets and liabilities recognized in the accompanying consolidated balance sheets measured at fair value on a recurring basis and the level within the fair value hierarchy in which the fair value measurements fall at December 31, 2021 and 2020. December 31, 2021 Fair Value Measurements Using Fair Quoted Prices Significant Significant U.S. Government-sponsored agencies $ 49,040 $ — $ 49,040 $ — Municipal securities 77,033 — 77,033 — Agency mortgage-backed securities - residential 373,236 — 373,236 — Agency mortgage-backed securities - commercial 36,326 — 36,326 Private label mortgage-backed securities - residential 16,021 — 16,021 — Asset-backed securities 5,004 — 5,004 — Corporate securities 46,384 — 46,384 — Total available-for-sale securities $ 603,044 $ — $ 603,044 $ — Servicing asset 4,702 — — 4,702 Interest rate swaps liabilities (14,271) — (14,271) — Loans held-for-sale (mandatory pricing agreements) 23,233 — 23,233 — Forward contracts (30) (30) — — IRLCs 718 — — 718 December 31, 2020 Fair Value Measurements Using Fair Quoted Prices Significant Significant U.S. Government-sponsored agencies $ 60,545 $ — $ 60,545 $ — Municipal securities 82,489 — 82,489 — Agency mortgage-backed securities - residential 214,330 — 214,330 — Agency mortgage-backed securities - commercial 29,591 — 29,591 — Private label mortgage-backed securities - residential 58,116 — 58,116 — Asset-backed securities 4,961 — 4,961 — Corporate securities 47,596 — 47,596 — Total available-for-sale securities $ 497,628 $ — $ 497,628 $ — Servicing asset 3,569 — — 3,569 Interest rate swaps liabilities (29,750) — (29,750) — Loans held-for-sale (mandatory pricing agreements) 26,341 — 26,341 — Forward contracts (640) (640) — — IRLCs 3,361 — — 3,361 The following table reconciles the beginning and ending balances of recurring fair value measurements recognized in the accompanying consolidated balance sheets using significant unobservable (Level 3) inputs. Servicing Asset Interest Rate Lock Commitments Balance as of January 1, 2019 $ — $ 389 Total realized gains Additions 2,481 — Change in fair value — 521 Balance, December 31, 2019 2,481 910 Total realized gains Additions 1,520 — Paydowns (524) — Changes in fair value 92 2,451 Balance, December 31, 2020 3,569 3,361 Total realized gains Additions 2,202 — Paydowns (820) — Changes in fair value (249) (2,643) Balance, December 31, 2021 $ 4,702 $ 718 The following describes the valuation methodologies and inputs used for assets measured at fair value on a nonrecurring basis, as well as the general classification of such assets pursuant to the valuation hierarchy. Impaired Loans (Collateral Dependent) Loans for which it is probable that the Company will not collect all principal and interest due according to contractual terms are measured for impairment. The amount of the impairment may be determined based on the fair value of the underlying collateral, less costs to sell, the estimated present value of future cash flows or the loan’s observable market price. If the impaired loan is identified as collateral dependent, the fair value of the underlying collateral, less costs to sell, is used to measure impairment. This method requires obtaining a current independent appraisal of the collateral and applying a discount factor to the value. If the impaired loan is not collateral dependent, the Company utilizes a discounted cash flow analysis to measure impairment. Impaired loans with a specific valuation allowance based on the value of the underlying collateral or a discounted cash flow analysis are classified as Level 3 assets. 2021 Fair Value Measurements Using Fair Quoted Prices Significant Significant Impaired loans 1,228 — — 1,228 2020 Fair Value Measurements Using Fair Quoted Prices Significant Significant Impaired loans 4,026 — — 4,026 Unobservable (Level 3) Inputs The following tables present quantitative information about unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements other than goodwill. (dollars in thousands) Fair Value at Valuation Significant Unobservable Range Weighted-Average Range Impaired loans $ 1,228 Fair value of collateral Discount for type of property and current market conditions 0% - 35% 10.1% IRLCs 718 Discounted cash flow Loan closing rates 42% - 100% 89% Servicing asset 4,702 Discounted cash flow Prepayment speeds Discount rate 0% - 25% 10% 12.5% 10% (dollars in thousands) Fair Value at Valuation Unobservable Range Weighted - Average Range Impaired loans $ 4,026 Fair value of collateral Discount for type of property and current market conditions 10% 10% IRLCs 3,361 Discounted cash flow Loan closing rates 44% - 100% 87% Servicing asset 3,569 Discounted cash flow Prepayment speeds Discount rate 0% - 25% 10% 12.1% 10% The following methods were used to estimate the fair value of all other financial instruments recognized in the accompanying consolidated balance sheets at amounts other than fair value: Cash and Cash Equivalents For these instruments, the carrying amount is a reasonable estimate of fair value. Securities Held-to-Maturity Where quoted market prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities include highly liquid mutual funds. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows. Level 2 securities include municipal securities and corporate securities. Matrix pricing is a mathematical technique widely used in the banking industry to value investment securities without relying exclusively on quoted prices for specific investment securities but also on the investment securities’ relationship to other benchmark quoted investment securities. In certain cases where Level 1 or Level 2 inputs are not available, securities are classified within Level 3 of the hierarchy. Fair values are calculated using discounted cash flows. Discounted cash flows are calculated based off of the anticipated future cash flows updated to incorporate loss severities. Rating agency and industry research reports as well as default and deferral activity are reviewed and incorporated into the calculation. The Company did not own any securities classified within Level 3 of the hierarchy as of December 31, 2021 or December 31, 2020. Loans The fair value of loans is estimated on an exit price basis incorporating discounts for credit, liquidity and marketability factors. Accrued Interest Receivable The fair value of these financial instruments approximates carrying value. Federal Home Loan Bank of Indianapolis Stock The fair value approximates carrying value. Deposits The fair value of noninterest-bearing and interest-bearing demand deposits, savings and money market accounts approximates carrying value. The fair value of fixed maturity certificates of deposit and brokered deposits are estimated using rates currently offered for deposits of similar remaining maturities. Advances from Federal Home Loan Bank The fair value of fixed rate advances is estimated using rates currently offered for similar remaining maturities. The carrying value of variable rate advances approximates fair value. Subordinated Debt The fair value of the Company’s publicly traded subordinated debt is obtained from quoted market prices. The fair value of the Company’s remaining subordinated debt is estimated using discounted cash flow analysis, based on current borrowing rates for similar types of debt instruments. Accrued Interest Payable The fair value of these financial instruments approximates carrying value. Commitments The fair value of commitments to extend credit are based on fees currently charged to enter into similar agreements with similar maturities and interest rates. The Company determined that the fair value of commitments was zero based on the contractual value of outstanding commitments at December 31, 2021 and 2020. The following tables provide the carrying amounts and estimated fair values of the Company's financial instruments at December 31, 2021 and 2020: December 31, 2021 Fair Value Measurements Using Carrying Fair Value Quoted Prices Significant Significant Cash and cash equivalents $ 442,960 $ 442,960 $ 442,960 $ — $ — Securities held-to-maturity 59,565 61,468 — 61,468 — Loans held-for-sale (best efforts pricing agreements) 24,512 24,512 — 24,512 Net loans 2,859,821 2,880,024 — — 2,880,024 Accrued interest receivable 16,037 16,037 16,037 — — Federal Home Loan Bank of Indianapolis stock 25,650 25,650 — 25,650 — Deposits 3,178,959 3,190,000 1,909,432 — 1,280,568 Advances from Federal Home Loan Bank 514,922 526,143 — 526,143 — Subordinated debt 104,231 108,788 38,643 70,145 — Accrued interest payable 2,018 2,018 2,018 — — December 31, 2020 Fair Value Measurements Using Carrying Fair Value Quoted Prices Significant Significant Cash and cash equivalents $ 419,806 $ 419,806 $ 419,806 $ — $ — Securities held-to-maturity 68,223 69,452 — 69,452 — Loans held-for-sale (best efforts pricing agreements) 13,243 13,243 — 13,243 — Net loans 3,029,747 3,084,375 — — 3,084,375 Accrued interest receivable 17,416 17,416 17,416 — — Federal Home Loan Bank of Indianapolis stock 25,650 25,650 — 25,650 — Deposits 3,270,885 3,307,038 1,679,164 — 1,627,874 Advances from Federal Home Loan Bank 514,916 541,945 — 541,945 — Subordinated debt 79,603 83,682 63,325 20,357 — Accrued interest payable 1,439 1,439 1,439 — —

Mortgage Banking Activities

Mortgage Banking Activities	12 Months Ended
	Dec. 31, 2021
Mortgage Banking [Abstract]
Mortgage Banking Activities	Mortgage Banking ActivitiesThe Company’s residential real estate lending business originates mortgage loans for customers and sells a majority of the originated loans into the secondary market. The Company hedges its mortgage banking pipeline by entering into forward contracts for the future delivery of mortgage loans to third-party investors and entering into IRLCs with potential borrowers to fund specific mortgage loans that will be sold into the secondary market. To facilitate the hedging of the loans, the Company has elected the fair value option for loans originated and intended for sale in the secondary market under mandatory pricing agreements. Changes in the fair value of loans held-for-sale, IRLCs and forward contracts are recorded in the mortgage banking activities line item within noninterest income. Refer to Note 18 for further information on derivative financial instruments. During the years ended December 31, 2021, 2020, and 2019, the Company originated mortgage loans held-for-sale of $721.3 million, $878.2 million, and $627.6 million, respectively, and received $714.9 million, $923.8 million, and $601.2 million from the sale of mortgage loans, respectively, into the secondary market. The following table provides the components of income from mortgage banking activities for the years ended December 31, 2021, 2020, and 2019. Year Ended December 31, 2021 2020 2019 Gain on loans sold $ 17,803 $ 22,826 $ 10,275 (Loss) gain resulting from the change in fair value of loans held-for-sale (718) (94) 538 (Loss) gain resulting from the change in fair value of derivatives (2,035) 1,961 728 Net revenue from mortgage banking activities $ 15,050 $ 24,693 $ 11,541

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The Company uses derivative financial instruments to help manage exposure to interest rate risk and the effects that changes in interest rates may have on net income and the fair value of assets and liabilities. The Company enters into interest rate swap agreements as part of its asset/liability management strategy to help manage its interest rate risk position. Additionally, the Company enters into forward contracts for the future delivery of mortgage loans to third-party investors and enters into IRLCs with potential borrowers to fund specific mortgage loans that will be sold into the secondary market. The forward contracts are entered into in order to economically hedge the effect of changes in interest rates resulting from the Company’s commitment to fund the loans. The Company entered into various interest rate swap agreements designated and qualifying as accounting hedges during the reported periods. Designating an interest rate swap as an accounting hedge allows the Company to recognize gains and losses, less any ineffectiveness, in the income statement within the same period that the hedged item affects earnings. The Company includes the gain or loss on the hedged items in the same line item as the offsetting loss or gain on the related interest rate swaps. For derivative instruments that are designated and qualify as cash flow hedges, any gains or losses related to changes in fair value are recorded in accumulated other comprehensive loss, net of tax. The fair value of interest rate swaps with a positive fair value are reported in accrued income and other assets in the consolidated balance sheets while interest rate swaps with a negative fair value are reported in accrued expenses and other liabilities in the consolidated balance sheets. The IRLCs and forward contracts are not designated as accounting hedges and are recorded at fair value with changes in fair value reflected in noninterest income in the consolidated statements of income. The fair value of derivative instruments with a positive fair value are reported in accrued income and other assets in the consolidated balance sheets, while derivative instruments with a negative fair value are reported in accrued expenses and other liabilities in the consolidated balance sheets. The following table presents amounts that were recorded in the consolidated balance sheets related to cumulative basis adjustments for interest rate swap derivatives designated as fair value accounting hedges as of December 31, 2021 and 2020. Carrying amount of the hedged assets Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets Line item in the consolidated balance sheet in which the hedged item is included December 31, 2021 December 31, 2020 December 31, 2021 December 31, 2020 Securities available-for-sale 1 75,156 124,210 1,729 6,064 1 These amounts include the amortized cost basis of closed portfolios used to designate hedging relationships in which the hedged item is the last layer expected to be remaining at the end of the hedging relationship. The amounts of the designated hedged items were $50.0 million and $88.2 million, at December 31, 2021 and 2020, respectively. The following tables present a summary of interest rate swap derivatives designated as fair value accounting hedges of fixed-rate receivables used in the Company's asset/liability management activities at December 31, 2021 and December 31, 2020, identified by the underlying interest rate-sensitive instruments. December 31, 2021 Weighted Average Remaining Maturity (years) Weighted-Average Rate Instruments Associated With Notional Value Fair Value Receive Pay Securities available-for-sale 50,000 1.8 (1,731) 3 month LIBOR 2.33% Total swap portfolio at December 31, 2021 $ 50,000 1.8 $ (1,731) 3 month LIBOR 2.33% December 31, 2020 Weighted Average Remaining Maturity (years) Weighted-Average Rate Instruments Associated With Notional Value Fair Value Receive Pay Securities available-for-sale 88,200 3.1 (6,072) 3 month LIBOR 2.54% Total swap portfolio at December 31, 2020 $ 88,200 3.1 $ (6,072) 3 month LIBOR 2.54% In March 2021, the Company terminated the last layer of interest rate swaps associated with available-for-sale agency mortgage-backed securities - residential, which resulted in swap termination payments to counterparties totaling $1.9 million. The corresponding fair value hedging adjustment was allocated pro-rata to the underlying hedged securities and is being amortized over the remaining lives of the designated securities. During the year ended December 31, 2021, amortization expense totaling $1.1 million was recognized as a reduction to interest income on securities. In June 2020, the Company terminated all fair value hedging relationships associated with loans, which resulted in swap termination payments to counterparties totaling $46.1 million. The corresponding loan fair value hedging adjustment as of the date of termination is being amortized over the remaining lives of the designated loans, which have a weighted average term to maturity of 12.2 years as of December 31, 2021. During the years ended December 31, 2021 and 2020, amortization expense totaling $5.2 million and $3.4 million, respectively, related to these previously terminated fair value hedges was recognized as a reduction to interest income on loans. The following tables present a summary of interest rate swap derivatives designated as cash flow accounting hedges of variable-rate liabilities used in the Company's asset/liability management activities at December 31, 2021 and December 31, 2020. December 31, 2021 Weighted Average Remaining Maturity (years) Weighted-Average Rate Cash Flow Hedges Notional Value Fair Value Receive Pay Interest rate swaps $ 110,000 5.1 $ (8,560) 3 month LIBOR 2.88% Interest rate swaps 100,000 2.0 (3,980) 1 month LIBOR 2.88% December 31, 2020 Weighted Average Remaining Maturity (years) Weighted-Average Rate Cash Flow Hedges Notional Value Fair Value Receive Pay Interest rate swaps $ 110,000 6.1 $ (15,727) 3 month LIBOR 2.88% Interest rate swaps 100,000 3.0 (7,951) 1 month LIBOR 2.88% These derivative financial instruments were entered into for the purpose of managing the interest rate risk of certain assets and liabilities. The Company pledged $15.7 million and $30.6 million of cash collateral to counterparties as security for its obligations related to these interest rate swap transactions at December 31, 2021 and 2020, respectively. Collateral posted and received is dependent on the market valuation of the underlying hedges. The following table presents the notional amount and fair value of interest rate swaps, IRLCs and forward contracts utilized by the Company at December 31, 2021 and 2020. December 31, 2021 December 31, 2020 Notional Fair Notional Fair Asset Derivatives Derivatives not designated as hedging instruments IRLCs 62,789 718 108,095 3,361 Total contracts $ 62,789 $ 718 $ 108,095 $ 3,361 Liability Derivatives Derivatives designated as hedging instruments Interest rate swaps associated with securities available-for-sale 50,000 (1,731) 88,200 (6,072) Interest rate swaps associated with liabilities 210,000 (12,540) 210,000 (23,678) Derivatives not designated as hedging instruments Forward contracts 72,750 (30) 107,500 (640) Total contracts $ 332,750 $ (14,301) $ 405,700 $ (30,390) The fair values of interest rate swaps were estimated using a discounted cash flow method that incorporates current market interest rates as of the balance sheet date. Fair values of IRLCs and forward contracts were estimated using changes in mortgage interest rates from the date the Company entered into the IRLC and the balance sheet date. The following table presents the effects of the Company's cash flow hedge relationships on the consolidated statements of comprehensive income during the twelve months ended December 31, 2021, 2020, and 2019. Amount of Gain (loss) Recognized in Other Comprehensive Income in the Twelve Months Ended December 31, 2021 December 31, 2020 December 31, 2019 Interest rate swap agreements $ 11,138 $ (10,248) $ (9,071) The following table summarizes the periodic changes in the fair value of the derivative financial instruments on the consolidated statements of income for the twelve months ended December 31, 2021, 2020, and 2019. Amount of (Loss) / Gain Recognized in the Twelve Months Ended December 31, 2021 December 31, 2020 December 31, 2019 Asset Derivatives Derivatives not designated as hedging instruments IRLCs (2,643) 2,451 521 Forward contracts 610 (487) 207 The following table presents the effects of the Company's interest rate swap agreements on the consolidated statements of income during the twelve months ended December 31, 2021, 2020, and 2019. Line item in the consolidated statements of income Twelve Months Ended December 31, 2021 December 31, 2020 December 31, 2019 Interest income Loans $ — $ (2,445) $ (1,533) Securities - taxable (253) (722) (127) Securities - non-taxable (1,099) (741) 36 Total interest income (1,352) (3,908) (1,624) Interest expense Deposits 2,775 2,273 618 Other borrowed funds 3,028 2,374 473 Total interest expense 5,803 4,647 1,091 Net interest income $ (7,155) $ (8,555) $ (2,715)

Shareholders' Equity

Shareholders' Equity	12 Months Ended
	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
Shareholders' Equity	Shareholders’ EquityOn October 20, 2021, the Company's Board of Directors approved a stock repurchase program authorizing the repurchase of up to $30.0 million of its outstanding common stock from time to time on the open market or in privately negotiated transactions. The Company repurchased 100,000 shares under this program during the fourth quarter 2021. The stock repurchase authorization is scheduled to expire on December 31, 2022.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	12 Months Ended
	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) The components of accumulated other comprehensive loss, included in stockholders' equity, are presented in the table below. Available-For-Sale Securities Cash Flow Hedges Total Balance, January 1, 2019 $ (13,359) $ (3,182) $ (16,541) Net unrealized holding gains (losses) recorded within other comprehensive income before income tax 12,072 (9,071) 3,001 Reclassification of net loss realized and included in earnings 458 — 458 Other comprehensive income (loss) before tax 12,530 (9,071) 3,459 Income tax provision (benefit) 3,559 (2,450) 1,109 Other comprehensive income (loss) - net of tax 8,971 (6,621) 2,350 Balance, December 31, 2019 $ (4,388) $ (9,803) $ (14,191) Net unrealized holding gains (losses) recorded within other comprehensive income before income tax 6,551 (10,248) (3,697) Reclassification of net gain realized and included in earnings (139) — (139) Other comprehensive income (loss) before tax 6,412 (10,248) (3,836) Income tax provision (benefit) 1,556 (2,387) (831) Other comprehensive income (loss) - net of tax 4,856 (7,861) (3,005) Balance, December 31, 2020 $ 468 $ (17,664) $ (17,196) Net unrealized holding (gains) losses recorded within other comprehensive income before income tax (4,087) 11,138 7,051 Other comprehensive (loss) income before income tax (4,087) 11,138 7,051 Income tax (benefit) provision (1,064) 1,958 894 Other comprehensive (loss) income - net of tax (3,023) 9,180 6,157 Balance, December 31, 2021 $ (2,555) $ (8,484) $ (11,039)

Condensed Financial Information

Condensed Financial Information (Parent Company Only)	12 Months Ended
	Dec. 31, 2021
Condensed Financial Information Disclosure [Abstract]
Condensed Financial Information (Parent Company Only)	Condensed Financial Information (Parent Company Only) Presented below is condensed financial information as to financial position, results of operations, and cash flows of the Company on a non-consolidated basis: Condensed Balance Sheets Year Ended December 31, 2021 2020 Assets Cash and cash equivalents $ 52,857 $ 40,532 Investment in common stock of subsidiaries 428,021 366,463 Premises and equipment, net 176 5,910 Accrued income and other assets 5,868 2,658 Total assets $ 486,922 $ 415,563 Liabilities and shareholders’ equity Subordinated debt, net of unamortized discounts and debt issuance costs of $2,769 in 2021 and $2,397 in 2020 $ 104,231 $ 79,603 Note payable to the Bank — 3,000 Accrued expenses and other liabilities 2,353 2,016 Total liabilities 106,584 84,619 Shareholders’ equity 380,338 330,944 Total liabilities and shareholders’ equity $ 486,922 $ 415,563 Condensed Statements of Income Year Ended December 31, 2021 2020 2019 Income Gain on sale of premises and equipment $ 2,523 $ — $ — Other 75 — — Total income 2,598 — — Expenses Interest on borrowings $ 5,892 $ 4,924 $ 3,804 Salaries and employee benefits 1,037 904 804 Consulting and professional fees 2,178 1,678 1,610 Premises and equipment 548 295 285 Other 363 361 408 Total expenses 10,018 8,162 6,911 Loss before income tax and equity in undistributed net income of subsidiaries (7,420) (8,162) (6,911) Income tax benefit (1,687) (2,089) (1,783) Loss before equity in undistributed net income of subsidiaries (5,733) (6,073) (5,128) Equity in undistributed net income of subsidiaries 53,847 35,526 30,367 Net income $ 48,114 $ 29,453 $ 25,239 Condensed Statements of Comprehensive Income Year Ended December 31, 2021 2020 2019 Net income $ 48,114 $ 29,453 $ 25,239 Other comprehensive income (loss) Net unrealized holding (losses) gains on securities available-for-sale recorded within other comprehensive income before income tax (4,087) 6,551 12,072 Reclassification adjustment for (gains) losses realized — (139) 458 Net unrealized holding losses on cash flow hedging derivatives recorded within other comprehensive income before income tax 11,138 (10,248) (9,071) Other comprehensive income (loss) before tax 7,051 (3,836) 3,459 Income tax provision (benefit) 894 (831) 1,109 Other comprehensive income (loss) - net of tax 6,157 (3,005) 2,350 Comprehensive income $ 54,271 $ 26,448 $ 27,589 Condensed Statements of Cash Flows Year Ended December 31, 2021 2020 2019 Operating activities Net income $ 48,114 $ 29,453 $ 25,239 Adjustments to reconcile net income to net cash provided by operating activities: Equity in undistributed net income of subsidiaries (53,847) (35,526) (30,367) Depreciation and amortization 1,081 711 647 Share-based compensation expense 835 518 288 Gain on sale of premises and equipment (2,523) — — Net change in other assets (31) (502) (508) Net change in other liabilities 775 311 (87) Net cash used in operating activities (5,596) (5,035) (4,788) Investing activities Capital contribution to the Bank — — (25,000) Purchase of premises and equipment — — (13) Net proceeds from sale of premises and equipment 8,116 — — Other investing activities (3,561) — — Net cash provided by (used in) investing activities 4,555 — (25,013) Financing activities Cash dividends paid (2,415) (2,349) (2,418) Net proceeds from issuance of subordinated debt 58,658 9,765 35,418 Repayment of subordinated debt (35,000) — — Repayment of Bank loan (3,000) — (300) Repurchase of common stock (4,436) — (9,784) Other, net (441) (152) (93) Net cash provided by financing activities 13,366 7,264 22,823 Net increase (decrease) in cash and cash equivalents 12,325 2,229 (6,978) Cash and cash equivalents at beginning of year 40,532 38,303 45,281 Cash and cash equivalents at end of year $ 52,857 $ 40,532 $ 38,303

Acquisition

Acquisition	12 Months Ended
	Dec. 31, 2021
Business Combination and Asset Acquisition [Abstract]
Acquisition	Acquisition On November 2, 2021, the Company announced it has entered into a definitive agreement to acquire First Century Bancorp. (“First Century”), the parent company of First Century Bank, N.A., headquartered in Roswell, GA. According to the terms of the definitive agreement, First Internet will acquire all of the outstanding shares of First Century common stock for $80 million in cash, which First Internet will fund with available on-balance sheet cash. As of December 31, 2021, First Century had total assets of $486.7 million, total deposits of $409.4 million, and total loans of $25.2 million. The transaction, which remains subject to regulatory approvals, is expected to close in the second quarter 2022.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Description of Business	Description of Business The Company was incorporated on September 15, 2005, and consummated a plan of exchange on March 21, 2006, by which the Company became a bank holding company and 100% owner of First Internet Bank of Indiana (the “Bank”). The Bank offers a wide range of commercial, small business, consumer and municipal banking products and services. The Bank conducts its consumer and small business deposit operations primarily through digital channels on a nationwide basis and has no traditional branch offices. Residential mortgage products are offered nationwide primarily through a digital direct-to-consumer platform and are supplemented with Central Indiana-based mortgage and construction lending. Consumer lending products are primarily originated on a nationwide basis through relationships with dealerships and financing partners. The Bank is subject to competition from other financial institutions. The Bank is regulated by certain state and federal agencies and undergoes periodic examinations by those regulatory authorities. The Bank has three wholly owned subsidiaries. JKH Realty Services, LLC was established on August 20, 2012 as a single member limited liability company wholly owned by the Bank to manage other real estate owned properties as needed. First Internet Public Finance Corp., a wholly-owned subsidiary of the Bank, was incorporated on March 6, 2017 and was established to provide municipal finance lending and leasing products to government entities and to purchase, manage, service, and safekeep municipal securities. SPF15, Inc., a wholly-owned subsidiary of the Bank, was incorporated on August 31, 2018 and was established to acquire and hold real estate.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its direct and indirect subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The Company’s business activities are currently limited to one reporting unit and reportable segment, which is commercial banking.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company utilizes processes that involve the use of significant estimates and the judgment of management in determining the amount of the Company’s allowance for loan losses, income taxes, valuation and impairments of investment securities and goodwill, as well as fair value measurements of derivatives, loans held-for-sale and other real estate owned. Actual results could differ from those estimates.
Securities	Securities The Company classifies its securities in one of three categories and accounts for the investments as follows: • Securities that the Company has the positive intent and ability to hold to maturity are classified as “held-to-maturity” and reported at amortized cost. • Securities that are acquired and held principally for the purpose of selling them in the near term with the objective of generating economic profits on short-term differences in market characteristics are classified as “trading securities” and reported at fair value, with unrealized gains and losses included in earnings. The Company had no securities classified as “trading securities” at December 31, 2021 or 2020. • Securities not classified as either “held-to-maturity” or “trading securities” are classified as “available-for-sale” and reported at fair value, with unrealized gains and losses, after applicable taxes, excluded from earnings and reported in a separate component of shareholders’ equity. Declines in the value of debt securities and marketable equity securities that are considered to be other-than-temporary are recorded as an other-than-temporary impairment of securities available-for-sale with other-than-temporary impairment losses recorded in the consolidated statements of income. Interest and dividend income, adjusted by amortization of premium or discount, is included in earnings using the effective interest rate method. Purchases and sales of securities are recorded in the consolidated balance sheets on the trade date. Gains and losses from the sale or disposal of securities are recognized as of the trade date in the consolidated statements of income for the period in which securities are sold or otherwise disposed of. Gains and losses on sales of securities are determined using the specific-identification method.
Loans Held for Sale	Loans Held-for-Sale Loans originated and intended for sale in the secondary market under best-efforts pricing agreements are carried at the lower of cost or fair value in the aggregate. Net unrealized losses, if any, are recognized through a valuation allowance by charges to noninterest income. Loans originated and intended for sale in the secondary market under mandatory pricing agreements are carried at fair value to facilitate hedging of the loans. Gains and losses resulting from changes in fair value are recognized in noninterest income. Gains and losses on loan sales are recorded in noninterest income, and direct loan origination costs and fees are deferred at origination of the loan and are recognized in noninterest income upon sale of the loan.
Revenue Recognition	Revenue Recognition The Company recognizes revenues as they are earned based on contractual terms, as transactions occur, or as services are provided and collectability is reasonably assured. The Company's principal source of revenue is interest income from loans and leases and investment securities. Interest income on loans is accrued as earned using the interest method based on unpaid principal balances except for interest on loans in nonaccrual status. Interest on loans in nonaccrual status is recorded as a reduction of loan principal when received. Premiums and discounts are amortized using the effective interest rate method. Loan fees, net of certain direct origination costs, primarily salaries and wages, are deferred and amortized to interest income as a yield adjustment over the life of the loan.
Loans Receivable	Loans Loans that management intends to hold until maturity are reported at their outstanding principal balance adjusted for unearned income, charge-offs, the allowance for loan losses (“ALLL”), any unamortized deferred fees or costs on originated loans, unamortized premiums or discounts on purchased loans and any carrying value adjustments related to terminated interest rate swaps associated with loans.
Allowance for Loan Losses Methodology	Allowance for Loan Losses Methodology Company policy is designed to maintain an adequate ALLL. Primary responsibility for ensuring that the Company has processes in place to consistently assess the adequacy of the ALLL rests with the Board of Directors (the “Board”). The Board has charged management with responsibility for establishing the methodology to be used and to assess the adequacy of the ALLL. The Board reviews recommendations from management on a quarterly basis to adjust the allowance as appropriate. The methodology employed by management for each portfolio segment, at a minimum, contains the following: 1. Loans are segmented by type of loan. 2. The required ALLL for types of performing homogeneous loans which do not have a specific reserve is determined by applying a factor based on historical losses averaged over the past sixteen quarters. In those instances where the Company’s historical experience is not available, management develops factors based on industry experience and best practices. 3. All criticized, classified and impaired loans are tested for impairment by applying one of three methodologies: a. Present value of future cash flows; b. Fair value of collateral less costs to sell; or c. The loan’s observable market price. 4. All troubled debt restructurings (“TDR”) are considered impaired loans. 5. Loans tested for impairment are removed from other pools to prevent layering (double-counting). 6. The required ALLL for each group of loans are added together to determine the total required ALLL for the Company. The required ALLL is compared to the existing ALLL to determine the provision required to increase the ALLL or credit to decrease the ALLL. The historical loss experience is determined by portfolio segment and considers two weighted average net charge-off trends: 1) the Company’s average loss history over the previous sixteen quarters; and 2) the average loss history over the previous sixteen quarters for a peer group. Management believes the historical loss experience methodology is appropriate in the current economic environment, as it captures loss rates that are comparable to the current period being analyzed. The Company also factors in the following qualitative considerations: 1. Changes in national, regional, and local economic and business conditions; 2. Changes in national, regional, and local unemployment rates; 3. The existence and effect of any concentrations of credit, and changes in the levels of such concentrations; 4. Changes in the nature and volume of the portfolio, and in the terms of loans; 5. Changes in the risk grades assigned to loans; 6. The levels of and trends in charge-offs and recoveries; 7. The levels of and trends in delinquencies, nonaccrual loans, and impaired loans; and 8. Changes in lending policies and procedures, including changes in underwriting standards and collection, charge-off, and recovery practices.
Provision for Loan Losses	Provision for Loan Losses A provision for estimated losses on loans is charged to income based upon management’s evaluation of the potential losses. Such an evaluation, which includes a review of all loans for which full repayment may not be reasonably assured, considers, among other matters, the estimated net realizable value of the underlying collateral, as applicable, economic conditions, loan loss experience, and other factors that are particularly susceptible to changes that could result in a material adjustment in the near term. While management attempts to use the best information available in making its evaluations, future allowance adjustments may be necessary if economic conditions change substantially from the assumptions used in making the evaluations.
Nonaccrual Loans	Nonaccrual Loans Any loan which becomes 90 days delinquent or for which the full collection of principal and interest may be in doubt will be considered for nonaccrual status. At the time a loan is placed on nonaccrual status, all accrued but unpaid interest will be reversed from interest income. Placing the loan on nonaccrual status does not relieve the borrower of the obligation to repay interest. A loan placed on nonaccrual status may be restored to accrual status when all delinquent principal and interest has been brought current, and the Company expects full payment of the remaining contractual principal and interest.
Impaired Loans	Impaired Loans A loan is designated as impaired, in accordance with the impairment accounting guidance when, based on current information or events, it is probable that the Company will be unable to collect all amounts due (principal and interest) according to the contractual terms of the loan agreement. Payments with delays generally not exceeding 90 days outstanding are not considered impaired. Certain nonaccrual and substantially all delinquent loans more than 90 days past due may be considered to be impaired. Generally, loans are placed on nonaccrual status at 90 days past due and accrued interest is reversed against earnings, unless the loan is well secured and in the process of collection. The accrual of interest on impaired and nonaccrual loans is discontinued when, in management’s opinion, the borrower may be unable to meet payments as they become due. Impaired loans include nonperforming loans but also include loans modified in TDRs where concessions have been granted to borrowers experiencing financial difficulties. These concessions could include a reduction in the interest rate on the loan, payment extensions, forgiveness of principal, forbearance, or other actions intended to maximize collection. Accounting Standards Codification (“ASC”) Topic 310, Receivables , requires that impaired loans be measured based on the present value of expected future cash flows discounted at the loans’ effective interest rates or the fair value of the underlying collateral, less costs to sell, and allows existing methods for recognizing interest income.
Troubled Debt Restructurings	Troubled Debt Restructurings The loan portfolio includes certain loans that have been modified in a TDR, where economic concessions have been granted to borrowers who have experienced financial difficulties. These concessions typically result from loss mitigation efforts and could include reductions in the interest rate, payment extensions, forgiveness of principal, forbearance or other actions. Certain TDRs are classified as nonperforming at the time of restructuring and typically are returned to performing status after considering the borrower’s sustained repayment performance for a reasonable period, generally not less than six months. When loans are modified in a TDR, any possible impairment similar to other impaired loans is evaluated based on either the present value of expected future cash flows, discounted at the contractual interest rate of the original loan agreement, or the current fair value of the collateral, less selling costs for collateral-dependent loans. If it is
Policy for Charging Off Loans	Policy for Charging Off Loans The Company’s policy is to charge off a loan at any point in time when it no longer can be considered a bankable asset, meaning collectible within the parameters of policy. A secured loan is generally charged down to the estimated fair value of the collateral, less costs to sell, no later than when it is 120 days past due as to principal or interest. An unsecured loan generally is charged off no later than when it is 180 days past due as to principal or interest. A home improvement loan generally is charged off no later than when it is 90 days past due as to principal or interest.
Federal Home Loan Bank (FHLB) of Indianapolis Stock	Federal Home Loan Bank (“FHLB”) of Indianapolis Stock Federal law requires a member institution of the FHLB system to hold common stock of its district FHLB according to a predetermined formula. This investment is stated at cost, which represents redemption value, and may be pledged as collateral for FHLB advances.
Property and Equipment	Premises and Equipment Premises and equipment is stated at cost, less accumulated depreciation. Depreciation is computed on the straight-line method over the estimated useful lives, which range from three
Other Real Estate Owned	Other Real Estate Owned
Derivative Financial Instruments	Derivative Financial Instruments The Company uses derivative financial instruments to help manage exposure to interest rate risk and the effects that changes in interest rates may have on net income and the fair value of assets and liabilities. The Company enters into interest rate swap agreements as part of its asset liability management strategy to help manage its interest rate risk position. Additionally, the Company enters into forward contracts for the future delivery of mortgage loans to third-party investors and enters into interest rate lock commitments (“IRLCs”) with potential borrowers to fund specific mortgage loans that will be sold into the secondary market. The forward contracts are entered into in order to economically hedge the effect of changes in interest rates resulting from the Company’s commitment to fund the loans. Designating an interest rate swap as an accounting hedge allows the Company to recognize gains and losses, less any ineffectiveness, in the income statement within the same period that the hedged item affects earnings. The Company includes the gain or loss on the hedged items in the same line item as the offsetting loss or gain on the related interest rate swaps. For derivative instruments that are designated and qualify as cash flow hedges, any gains or losses related to changes in fair value are recorded in accumulated other comprehensive loss, net of tax. The fair value of interest rate swaps with a positive fair value are reported in accrued income and other assets in the consolidated balance sheets while interest rate swaps with a negative fair value are reported in accrued expenses and other liabilities in the consolidated balance sheets. The IRLCs and forward contracts are not designated as accounting hedges, and are recorded at fair value with changes in fair value reflected in noninterest income in the consolidated statements of income. The fair value of derivative instruments with a positive fair value are reported in accrued income and other assets in the consolidated balance
Fair Value Measurements	Fair Value Measurements The Company records or discloses certain assets and liabilities at fair value. ASC Topic 820, Fair Value Measurements , defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value measurements are classified within one of three levels in a valuation hierarchy. ASC Topic 820 describes three levels of inputs that may be used to measure fair value: Level 1 Quoted prices in active markets for identical assets or liabilities Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities Level 3 Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities
Income Taxes	Income Taxes Deferred income tax assets and liabilities reflect the impact of temporary differences between amounts of assets and liabilities for financial reporting purposes and the basis of such assets and liabilities as measured by tax laws and regulations. Deferred income tax expense or benefit is based upon the change in deferred tax assets and liabilities from period to period, subject to an ongoing assessment of realization of deferred tax assets. Deferred tax assets are reduced by a valuation allowance if, based on the weight of evidence available, it is more likely than not that some portion or all of a deferred tax asset will not be realized. The Company files income tax returns in the U.S. federal, Indiana, and other state jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal, state and local examinations by tax authorities for years before 2017. ASC Topic 740-10, Accounting for Uncertainty in Income Taxes , prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. It also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company did not identify any material uncertain tax positions that it believes should be recognized in the consolidated financial statements.
Earnings Per Share	Earnings Per Share Earnings per share of common stock is based on the weighted average number of basic shares and dilutive shares outstanding during the year.
Stock Compensation	Share-based Compensation The Company has a share-based compensation plan using the fair value recognition provisions of ASC Topic 718, Compensation - Stock Compensation . The plan is described more fully in Note 11.
Comprehensive Income	Comprehensive Income Comprehensive income consists of net income and other comprehensive income (loss). Other comprehensive income (loss) includes unrealized gains and losses on securities available-for-sale and unrealized gains and losses on cash flow hedges. Reclassification adjustments have been determined for all components of other comprehensive income or loss reported in the consolidated statements of changes in shareholders’ equity.
Statements of Cash Flows	Statements of Cash Flows Cash and cash equivalents are defined to include cash on-hand, noninterest and interest-bearing amounts due from other banks and federal funds sold. Generally, federal funds are sold for one-day periods. The Company reports net cash flows for customer loan transactions and deposit transactions.
Bank Owned Life Insurance	Bank-Owned Life Insurance Bank-owned life insurance policies are carried at their cash surrender value. The Company recognizes tax-free income from the periodic increases in the cash surrender value of these policies and from death benefits.
Goodwill	Goodwill Goodwill is tested at least annually for impairment. If the implied fair value of goodwill is lower than its carrying amount, goodwill impairment is indicated and goodwill is written down to its implied fair value. Subsequent increases in goodwill value are not recognized in the consolidated financial statements.
Servicing Asset	Servicing AssetThe servicing asset is related to small business lending loans sold. The servicing asset is recognized at the time of sale when servicing is retained and the income statement effect is recorded in loan servicing revenue. Servicing assets are recorded at fair value in accordance with ASC 860. Fair value is based on a third-party valuation model that calculates the present value of net servicing revenue.
Reclassifications	Reclassifications Certain reclassifications have been made to the 2020 and 2019 financial statements to conform to the 2021 financial statement presentation. These reclassifications had no effect on net income. Revision of Previously Issued Financial Statements The Company has revised amounts reported in previously issued notes to financial statements for the periods presented in this Annual Report on Form 10-K due to immaterial clerical errors. The clerical errors caused the fair value associated with interest rate swap liabilities to be understated in the notes to financial statements for the period ended December 31, 2020 and had no impact on the consolidated balance sheet, income statement or statement of cash flows. The Company evaluated the impact of the clerical errors to our previously issued financial statements in accordance with SEC Staff Accounting Bulletins No. 99 and No. 108 and, based upon quantitative and qualitative factors, determined that the clerical errors were not material to the previously issued financial statements and disclosures included in our Annual Report on Form 10-K for the year ended December 31, 2020.
Recent Accounting Pronouncements	Recent Accounting Pronouncements ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (June 2016) The main objective of this update is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The amendments affect entities holding financial assets that are not accounted for at fair value through net income. The amendments affect loans, debt securities, off-balance-sheet credit exposures, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amendments in this update affect an entity to varying degrees depending on the credit quality of the assets held by the entity, their duration, and how the entity applies current GAAP. There is diversity in practice in applying the incurred loss methodology, which means that before transition some entities may be more aligned under current GAAP than others to the new measure of expected credit losses. The following describes the main provisions of this update. • Assets Measured at Amortized Cost: The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. The statements of income reflect the measurement of credit losses for newly recognized financial assets, as well as the expected increase or decrease of credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances. • Available-for-Sale Debt Securities: Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. Available-for-sale accounting recognizes that value may be realized either through collection of contractual cash flows or through sale of the security. Therefore, the amendments limit the amount of the allowance for credit losses to the amount by which fair value is below amortized cost because the classification as available-for-sale is premised on an investment strategy that recognizes that the investment could be sold at fair value if cash collection would result in the realization of an amount less than fair value. • In May 2019, the FASB issued ASU 2019-05 - Financial Instruments - Credit Losses (Topic 326) - Targeted Transition Relief . This ASU allows an option for preparers to irrevocably elect the fair value option, on an instrument-by-instrument basis, for eligible financial assets measured at amortized cost basis upon adoption of the credit losses standard. This increases the comparability of financial statement information provided by institutions that otherwise would have reported similar financial instruments using different measurement methodologies, potentially decreasing costs for financial statement preparers while providing more useful information to investors and other users. For public business entities that are SEC filers, the amendments in this update are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. All entities may early adopt the amendments in this update as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. In November 2019, the FASB issued ASU 2019-10 - Financial Instruments - Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) - Effective Dates. This ASU delayed the effective date for public companies to fiscal years beginning after December 15, 2022. An entity will apply the amendments in this update through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (that is, a modified-retrospective approach). A prospective transition approach is required for debt securities for which an OTTI had been recognized before the effective date. The effect of a prospective transition approach is to maintain the same amortized cost basis before and after the effective date of this update. The Company does not expect to early adopt and is currently evaluating the impact of the amendments on the Company’s consolidated financial statements. The Company currently cannot determine or reasonably quantify the impact of the adoption of the amendments due to the complexity and extensive changes. The Company intends to develop processes and procedures prior to the effective date to ensure it is fully compliant with the amendments at the adoption date. The Company has formed an implementation committee and has engaged a third-party consultant to assist in developing current expected credit losses (“CECL”) models using appropriate methodologies. ASU 2017-04 - Intangibles - Goodwill and other (Topic 350) - Simplifying the Test for Goodwill Impairment (January 2017) The amendments in this update simplify the goodwill impairment test by eliminating Step 2 of the goodwill impairment process, which requires an entity to determine the implied fair value of its goodwill by assigning fair value to all its assets and liabilities. Under the new guidance, an entity will record an impairment charge if a reporting unit’s carrying amount exceeds its fair value. Entities still have the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment is necessary. The amendments in this ASU are effective for public companies for annual and interim impairment tests performed in periods beginning after December 15, 2022. Early adoption is permitted. The Company adopted this guidance effective July 1, 2020 and it did not have a material impact on the consolidated financial statements. ASU 2018-13 - Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (August 2018) The amendments in this update modify the disclosure requirements on fair value measurements in ASC Topic 820. This ASU eliminates the requirements to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels and the valuation processes for Level 3 fair value measurements. In addition, this ASU requires entities that calculate net asset value to disclose the timing of liquidation of an investee’s assets and the date when restrictions from redemption might lapse only if the investee has communicated the timing to the entity or announced the timing publicly. This ASU also adds new requirements, which include the disclosure of the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments in this ASU were effective for public companies for fiscal years, and interim fiscal periods within those fiscal years, beginning after December 15, 2019. The adoption of this guidance did not have a material impact on the consolidated financial statements. ASU 2019-04 - Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments (April 2019) The amendments in this ASU clarify or correct the guidance in ASC Topic 326, Topic 815 and Topic 825. With respect to Topic 326, ASU 2019-04 addresses a number of issues as it relates to the CECL standard including consideration of accrued interest, recoveries, variable-rate financial instruments, prepayments, extension and renewal options, among other things, in the measurement of expected credit losses. The amendments to Topic 326 have the same effective dates as ASU 2016-13 and the Company is currently evaluating the potential impact of these amendments on the consolidated financial statements. With respect to Topic 815, ASU 2019-04 clarifies issues related to partial-term hedges, hedged debt securities, and transitioning from a quantitative method of assessing hedge effectiveness to a more simplified method. The amendments to Topic 815 are effective for interim and annual reporting periods beginning after December 15, 2019 and are not expected to have a material impact on the consolidated financial statements. With respect to Topic 825, ASU 2019-04 addresses the scope of the guidance, the requirement for remeasurement under ASC Topic 820 when using the measurement alternative, certain disclosure requirements, and which equity securities must be remeasured at historical exchanges rates. The amendments to Topic 825 were effective for interim and annual reporting periods beginning after December 15, 2019 and the adoption of this guidance did not have a material impact on the consolidated financial statements. Coronavirus Aid, Relief and Economic Security Act (“CARES Act”) In March 2020 in connection with the implementation of the CARES Act and related provisions, the Company adopted the temporary relief issued under the CARES Act, thereby suspending the guidance in ASC 310-40 on accounting for TDRs to loan modifications related to COVID-19. Section 4013 of the CARES Act specifies that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief are in effect from the period beginning March 1, 2020 until the earlier of December 31, 2020 or 60 days after the date on which the national emergency related to the COVID-19 pandemic formally terminates. See the “Non-TDR Loan Modifications due to COVID-19” section of Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations for more information. ASU 2020-04 - Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (March 2020) In March 2020, FASB issued ASU 2020-04 to ease the potential burden in accounting for the transition away from LIBOR on financial reporting. The ASU provides optional expedients and exceptions for applying GAAP to contract modification and hedge accounting relationships. The guidance is effective March 12, 2020 through December 31, 2022. The Company is still evaluating the impact of reference rate reform and does not believe the adoption of this guidance will have a material impact on the consolidated financial statements.

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Schedule of Weighted Average Number of Shares	The following is a reconciliation of the weighted average common shares for the basic and diluted earnings per share computations. Year Ended December 31, 2021 2020 2019 Basic earnings per share Net income available to common shareholders $ 48,114 $ 29,453 $ 25,239 Weighted average common shares 9,918,083 9,840,205 10,041,581 Basic earnings per common share $ 4.85 $ 2.99 $ 2.51 Diluted earnings per share Net income available to common shareholders $ 48,114 $ 29,453 $ 25,239 Weighted average common shares 9,918,083 9,840,205 10,041,581 Dilutive effect of equity compensation 58,178 2,220 2,902 Weighted average common and incremental shares 9,976,261 9,842,425 10,044,483 Diluted earnings per common share (1) $ 4.82 $ 2.99 $ 2.51 (1) Potential dilutive common shares are excluded from the computation of diluted EPS in the periods where the effect would be antidilutive. Excluded from the computation of diluted EPS were weighted average antidilutive shares totaling 28, 18,524 and 15,758 for the years ended December 31, 2021, 2020 and 2019, respectively.

Securities (Tables)

Securities (Tables)	12 Months Ended
	Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Schedule of Available-for-sale Securities Reconciliation	The following tables summarize securities available-for-sale and securities held-to-maturity as of December 31, 2021 and 2020. December 31, 2021 Amortized Gross Unrealized Fair Cost Gains Losses Value Securities available-for-sale U.S. Government-sponsored agencies $ 50,013 $ 164 $ (1,137) $ 49,040 Municipal securities 75,158 1,940 (65) 77,033 Agency mortgage-backed securities - residential (1) 377,928 960 (5,652) 373,236 Agency mortgage-backed securities - commercial 36,024 441 (139) 36,326 Private label mortgage-backed securities - residential 15,902 122 (3) 16,021 Asset-backed securities 5,000 4 — 5,004 Corporate securities 46,482 597 (695) 46,384 Total available-for-sale $ 606,507 $ 4,228 $ (7,691) $ 603,044 December 31, 2020 Amortized Gross Unrealized Fair Cost Gains Losses Value Securities available-for-sale U.S. Government-sponsored agencies $ 61,765 $ 432 $ (1,652) $ 60,545 Municipal securities 82,757 463 (731) 82,489 Agency mortgage-backed securities - residential 213,408 3,387 (2,465) 214,330 Agency mortgage-backed securities - commercial 28,387 1,204 — 29,591 Private label mortgage-backed securities - residential 57,268 850 (2) 58,116 Asset-backed securities 5,000 — (39) 4,961 Corporate securities 48,419 771 (1,594) 47,596 Total available-for-sale $ 497,004 $ 7,107 $ (6,483) $ 497,628
Schedule Of Held-To-Maturity Securities Reconciliation	December 31, 2021 Amortized Gross Unrealized Fair Cost Gains Losses Value Securities held-to-maturity Municipal securities $ 13,992 $ 717 $ — $ 14,709 Corporate securities 45,573 1,186 — 46,759 Total held-to-maturity $ 59,565 $ 1,903 $ — $ 61,468 (1) Includes $0.8 million of additional premium related to terminated interest rate swaps associated with agency mortgage-backed securities - residential as of December 31, 2021. December 31, 2020 Amortized Gross Unrealized Fair Cost Gains Losses Value Securities held-to-maturity Municipal securities $ 14,571 $ 746 $ — $ 15,317 Corporate securities 53,652 610 (127) 54,135 Total held-to-maturity $ 68,223 $ 1,356 $ (127) $ 69,452
Investments Classified by Contractual Maturity Date	The carrying value of securities at December 31, 2021 is shown below by their contractual maturity date. Actual maturities will differ because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Available-for-Sale Amortized Fair Within one year $ — $ — One to five years 36,314 34,866 Five to ten years 58,962 58,602 After ten years 76,377 78,989 171,653 172,457 Agency mortgage-backed securities - residential 377,928 373,236 Agency mortgage-backed securities - commercial 36,024 36,326 Private label mortgage-backed securities - residential 15,902 16,021 Asset-backed securities 5,000 5,004 Total $ 606,507 $ 603,044 Held-to-Maturity Amortized Fair One to five years $ 7,289 $ 7,465 Five to ten years 41,135 42,502 After ten years 11,141 11,501 Total $ 59,565 $ 61,468
Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value	The following tables show the securities portfolio’s gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position at December 31, 2021 and 2020: December 31, 2021 Less Than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Securities available-for-sale U.S. Government-sponsored agencies $ 2,921 $ (79) $ 40,305 $ (1,058) $ 43,226 $ (1,137) Municipal securities 5,721 (65) — — 5,721 (65) Agency mortgage-backed securities - residential (1) 287,820 (3,694) 40,840 (1,958) 328,660 (5,652) Agency mortgage-backed securities - commercial 3,944 (139) — — 3,944 (139) Private label mortgage-backed securities - residential 374 (3) — — 374 (3) Corporate securities 11,813 (187) 9,491 (508) 21,304 (695) Total $ 312,593 $ (4,167) $ 90,636 $ (3,524) $ 403,229 $ (7,691) December 31, 2020 Less Than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Securities available-for-sale U.S. Government-sponsored agencies $ — $ — $ 52,351 $ (1,652) $ 52,351 $ (1,652) Municipals 18,731 (114) 23,519 (617) 42,250 (731) Agency mortgage-backed securities - residential 38,987 (276) 45,297 (2,189) 84,284 (2,465) Private label mortgage-backed securities - residential 1,277 (1) 558 (1) 1,835 (2) Asset-backed securities — — 4,961 (39) 4,961 (39) Corporate securities — — 20,406 (1,594) 20,406 (1,594) Total $ 58,995 $ (391) $ 147,092 $ (6,092) $ 206,087 $ (6,483)
Held to Maturity, Continuous Unrealized Loss Position, Fair Value	December 31, 2020 Less Than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Securities held-to-maturity Corporate securities $ 17,456 $ (126) $ 2,999 $ (1) $ 20,455 $ (127) Total $ 17,456 $ (126) $ 2,999 $ (1) $ 20,455 $ (127)
Schedule of Accumulated Other Comprehensive Income (Loss)	Amounts reclassified from accumulated other comprehensive loss and the affected line items in the consolidated statements of income during the years ended December 31, 2021, 2020 and 2019 were as follows: Details About Accumulated Other Comprehensive Loss Components Amounts Reclassified from Affected Line Item in the 2021 2020 2019 Unrealized gains and losses on securities available-for-sale Gain (loss) realized in earnings $ — $ 139 $ (458) Gain (loss) on sale of securities Total reclassified amount before tax — 139 (458) Income before income taxes Tax expense (benefit) — 38 (124) Income tax provision Total reclassifications out of accumulated other comprehensive loss $ — $ 101 $ (334) Net Income The components of accumulated other comprehensive loss, included in stockholders' equity, are presented in the table below. Available-For-Sale Securities Cash Flow Hedges Total Balance, January 1, 2019 $ (13,359) $ (3,182) $ (16,541) Net unrealized holding gains (losses) recorded within other comprehensive income before income tax 12,072 (9,071) 3,001 Reclassification of net loss realized and included in earnings 458 — 458 Other comprehensive income (loss) before tax 12,530 (9,071) 3,459 Income tax provision (benefit) 3,559 (2,450) 1,109 Other comprehensive income (loss) - net of tax 8,971 (6,621) 2,350 Balance, December 31, 2019 $ (4,388) $ (9,803) $ (14,191) Net unrealized holding gains (losses) recorded within other comprehensive income before income tax 6,551 (10,248) (3,697) Reclassification of net gain realized and included in earnings (139) — (139) Other comprehensive income (loss) before tax 6,412 (10,248) (3,836) Income tax provision (benefit) 1,556 (2,387) (831) Other comprehensive income (loss) - net of tax 4,856 (7,861) (3,005) Balance, December 31, 2020 $ 468 $ (17,664) $ (17,196) Net unrealized holding (gains) losses recorded within other comprehensive income before income tax (4,087) 11,138 7,051 Other comprehensive (loss) income before income tax (4,087) 11,138 7,051 Income tax (benefit) provision (1,064) 1,958 894 Other comprehensive (loss) income - net of tax (3,023) 9,180 6,157 Balance, December 31, 2021 $ (2,555) $ (8,484) $ (11,039)

Loans (Tables)

Loans (Tables)	12 Months Ended
	Dec. 31, 2021
Receivables [Abstract]
Schedule of Accounts, Notes, Loans and Financing Receivable	Categories of loans include: December 31, 2021 2020 Commercial loans Commercial and industrial $ 96,008 $ 75,387 Owner-occupied commercial real estate 66,732 89,785 Investor commercial real estate 28,019 13,902 Construction 136,619 110,385 Single tenant lease financing 865,854 950,172 Public finance 592,665 622,257 Healthcare finance 387,852 528,154 Small business lending 108,666 125,589 Franchise finance 81,448 — Total commercial loans 2,363,863 2,515,631 Consumer loans Residential mortgage 186,770 186,787 Home equity 17,665 19,857 Other consumer 265,478 275,692 Total consumer loans 469,913 482,336 Total commercial and consumer loans 2,833,776 2,997,967 Net deferred loan origination costs, premiums and discounts on purchased loans, and other (1) 53,886 61,264 Total loans 2,887,662 3,059,231 Allowance for loan losses (27,841) (29,484) Net loans $ 2,859,821 $ 3,029,747 (1) Includes carrying value adjustments of $37.5 million and $42.7 million related to terminated interest rate swaps associated with public finance loans as of December 31, 2021 and 2020, respectively.
Allowance for Credit Losses on Financing Receivables	The following tables present changes in the balance of the ALLL during the twelve months ended December 31, 2021, 2020, and 2019 Twelve Months Ended December 31, 2021 Balance, Beginning of Period Provision (Credit) Charged to Expense Losses Charged Off Recoveries Balance, End of Period Allowance for loan losses: Commercial and industrial $ 1,146 $ 684 $ (28) $ 89 $ 1,891 Owner-occupied commercial real estate 1,082 (340) — — 742 Investor commercial real estate 155 173 — — 328 Construction 1,192 420 — — 1,612 Single tenant lease financing 12,990 (214) (2,391) — 10,385 Public finance 1,732 44 — — 1,776 Healthcare finance 7,485 (1,545) — — 5,940 Small business lending 628 901 (222) 80 1,387 Franchise finance — 1,083 — — 1,083 Residential mortgage 519 67 (6) 63 643 Home equity 48 60 (51) 7 64 Other consumer 2,507 (303) (529) 315 1,990 Total $ 29,484 $ 1,030 $ (3,227) $ 554 $ 27,841 Twelve Months Ended December 31, 2020 Balance, Beginning of Period Provision (Credit) Charged to Expense Losses Charged Off Recoveries Balance, End of Period Allowance for loan losses: Commercial and industrial $ 1,521 $ 80 $ (461) $ 6 $ 1,146 Owner-occupied commercial real estate 561 545 (24) — 1,082 Investor commercial real estate 109 46 — — 155 Construction 380 812 — — 1,192 Single tenant lease financing 11,175 1,815 — — 12,990 Public finance 1,580 152 — — 1,732 Healthcare finance 3,247 4,894 (743) 87 7,485 Small business lending 54 665 (110) 19 628 Residential mortgage 657 (122) (20) 4 519 Home equity 46 (9) — 11 48 Other consumer 2,510 447 (804) 354 2,507 Total $ 21,840 $ 9,325 $ (2,162) $ 481 $ 29,484 Twelve Months Ended December 31, 2019 Balance, Beginning of Period Provision (Credit) Charged to Expense Losses Charged Off Recoveries Balance, End of Period Allowance for loan losses: Commercial and industrial $ 1,384 $ 1,029 $ (921) $ 29 $ 1,521 Owner-occupied commercial real estate 783 (222) — — 561 Investor commercial real estate 61 48 — — 109 Construction 251 129 — — 380 Single tenant lease financing 8,827 2,348 — — 11,175 Public finance 1,670 (90) — — 1,580 Healthcare finance 1,264 1,983 — — 3,247 Small business lending 203 (154) — 5 54 Residential mortgage 1,079 (350) (76) 4 657 Home equity 53 51 (68) 10 46 Other consumer 2,321 1,194 (1,292) 287 2,510 Total $ 17,896 $ 5,966 $ (2,357) $ 335 $ 21,840
Allowance For Credit Losses On Financing Receivables Portfolio Segment	The following tables present the balance in the allowance for loan losses and the recorded investment in loans based on portfolio segment and impairment method as of December 31, 2021 and 2020. Loans Allowance for Loan Losses December 31, 2021 Ending Balance: Ending Balance: Ending Balance Ending Balance: Ending Balance: Ending Balance Commercial and industrial $ 95,364 $ 644 $ 96,008 $ 1,441 $ 450 $ 1,891 Owner-occupied commercial real estate 63,387 3,345 66,732 742 — 742 Investor commercial real estate 28,019 — 28,019 328 — 328 Construction 136,619 — 136,619 1,612 — 1,612 Single tenant lease financing 864,754 1,100 865,854 10,290 95 10,385 Public finance 592,665 — 592,665 1,776 — 1,776 Healthcare finance 386,926 926 387,852 5,417 523 5,940 Small business lending 106,682 1,984 108,666 994 393 1,387 Franchise finance 81,448 — 81,448 1,083 — 1,083 Residential mortgage 183,852 2,918 186,770 643 — 643 Home equity 17,651 14 17,665 64 — 64 Other consumer 265,469 9 265,478 1,990 — 1,990 Total $ 2,822,836 $ 10,940 $ 2,833,776 $ 26,380 $ 1,461 $ 27,841 Loans Allowance for Loan Losses December 31, 2020 Ending Balance: Ending Balance: Ending Balance Ending Balance: Ending Balance: Ending Balance Commercial and industrial $ 74,870 $ 517 $ 75,387 $ 1,146 $ — $ 1,146 Owner-occupied commercial real estate 87,947 1,838 89,785 1,082 — 1,082 Investor commercial real estate 13,902 — 13,902 155 — 155 Construction 110,385 — 110,385 1,192 — 1,192 Single tenant lease financing 942,848 7,324 950,172 9,900 3,090 12,990 Public finance 622,257 — 622,257 1,732 — 1,732 Healthcare finance 527,144 1,010 528,154 7,485 — 7,485 Small business lending 125,589 — 125,589 628 — 628 Residential mortgage 185,241 1,546 186,787 519 — 519 Home equity 19,857 — 19,857 48 — 48 Other consumer 275,642 50 275,692 2,507 — 2,507 Total $ 2,985,682 $ 12,285 $ 2,997,967 $ 26,394 $ 3,090 $ 29,484
Financing Receivable Credit Quality Indicators	The following tables present the credit risk profile of the Company’s commercial and consumer loan portfolios based on rating category and payment activity as of December 31, 2021 and 2020. December 31, 2021 Pass Special Mention Substandard Total Commercial and industrial $ 82,412 $ 12,952 $ 644 $ 96,008 Owner-occupied commercial real estate 59,369 4,018 3,345 66,732 Investor commercial real estate 28,019 — — 28,019 Construction 124,578 12,041 — 136,619 Single tenant lease financing 859,612 5,142 1,100 865,854 Public finance 591,630 1,035 — 592,665 Healthcare finance 386,337 589 926 387,852 Small business lending 99,250 7,432 1,983 108,666 Franchise finance 81,448 — — 81,448 Total commercial loans $ 2,312,655 $ 43,209 $ 7,998 $ 2,363,863 December 31, 2021 Performing Nonaccrual Total Residential mortgage $ 185,544 $ 1,226 $ 186,770 Home equity 17,651 14 17,665 Other consumer 265,469 9 265,478 Total $ 468,664 $ 1,249 $ 469,913 December 31, 2020 Pass Special Mention Substandard Total Commercial and industrial $ 74,138 $ 732 $ 517 $ 75,387 Owner-occupied commercial real estate 84,292 3,655 1,838 89,785 Investor commercial real estate 13,902 — — 13,902 Construction 110,385 — — 110,385 Single tenant lease financing 932,830 10,018 7,324 950,172 Public finance 622,257 — — 622,257 Healthcare finance 526,517 627 1,010 528,154 Small business lending 117,474 2,930 5,185 125,589 Total commercial loans 2,481,795 17,962 15,874 2,515,631 December 31, 2020 Performing Nonaccrual Total Residential mortgage $ 185,604 $ 1,183 $ 186,787 Home equity 19,857 — 19,857 Other consumer 275,646 46 275,692 Total $ 481,107 $ 1,229 $ 482,336
Past Due Financing Receivables	The following tables present the Company’s loan portfolio delinquency analysis as of December 31, 2021 and 2020. December 31, 2021 30-59 60-89 90 Days Total Current Total loans Nonaccrual Total Loans Commercial and industrial $ — $ — $ — $ — $ 96,008 $ 96,008 $ 674 $ — Owner-occupied commercial real estate — — — — 66,732 66,732 — — Investor commercial real estate — — — — 28,019 28,019 3,419 — Construction — — — — 136,619 136,619 — — Single tenant lease financing — — — — 865,854 865,854 1,100 — Public finance — — — — 592,665 592,665 — — Healthcare finance — — — — 387,852 387,852 — — Small business lending — — 657 657 108,009 108,666 959 — Franchise Finance — — — — 81,448 81,448 — — Residential mortgage 51 226 106 383 186,387 186,770 1,226 — Home equity — — — — 17,665 17,665 14 — Other consumer 68 18 — 86 265,392 265,478 9 — Total $ 119 $ 244 $ 763 $ 1,126 $ 2,832,650 $ 2,833,776 $ 7,401 $ — December 31, 2020 30-59 60-89 90 Days Total Current Total loans Nonaccrual Total Loans Commercial and industrial $ — $ — $ — $ — $ 75,387 $ 75,387 $ — $ — Owner-occupied commercial real estate — — — — 89,785 89,785 1,838 — Investor commercial real estate — — — — 13,902 13,902 — — Construction — — — — 110,385 110,385 — — Single tenant lease financing — — 4,680 4,680 945,492 950,172 7,116 — Public finance — — — — 622,257 622,257 — — Healthcare finance — — — — 528,154 528,154 — — Small business lending — — — — 125,589 125,589 — — Residential mortgage 49 — 269 318 186,469 186,787 1,183 — Home equity — 15 — 15 19,842 19,857 — — Other consumer 176 51 5 232 275,460 275,692 46 — Total $ 225 $ 66 $ 4,954 $ 5,245 $ 2,992,722 $ 2,997,967 $ 10,183 $ —
Impaired Financing Receivables	The following tables present the Company’s impaired loans as of December 31, 2021 and 2020. December 31, 2021 December 31, 2020 Recorded Unpaid Specific Recorded Unpaid Specific Loans without a specific valuation allowance Commercial and industrial $ — $ — $ — $ 517 $ 517 $ — Owner-occupied commercial real estate 3,345 3,466 — 1,838 1,850 — Single tenant lease financing — — — 1,315 1,334 — Healthcare finance $ — $ — $ — $ 1,010 $ 1,010 $ — Small business lending 959 1,193 — — — Residential mortgage 2,918 3,063 — 1,546 1,652 — Home equity 14 15 — — — — Other consumer 9 44 — 50 120 — Total 7,245 7,781 — 6,276 6,483 — Loans with a specific valuation allowance Commercial and industrial $ 644 $ 677 $ 450 $ — $ — $ — Construction — — — — — — Single tenant lease financing 1,100 1,123 95 6,009 6,036 3,090 Healthcare finance 926 926 523 — — — Small business lending 1,025 1,025 393 — — — Total 3,695 3,751 1,461 6,009 6,036 3,090 Total impaired loans $ 10,940 $ 11,532 $ 1,461 $ 12,285 $ 12,519 $ 3,090 The following table presents average balances and interest income recognized for impaired loans during the twelve months ended December 31, 2021, 2020, and 2019. Twelve Months Ended December 31, 2021 December 31, 2020 December 31, 2019 Average Interest Average Interest Average Interest Loans without a specific valuation allowance Commercial and industrial $ 194 $ 9 $ 1,037 $ 57 $ 3,293 $ 289 Owner-occupied commercial real estate 3,324 — 3,790 60 3,292 170 Single tenant lease financing 75 5 — — — — Healthcare finance 252 — 386 16 — — Small business lending 1,215 — — — 331 94 Residential mortgage 2,264 67 1,333 — 2,265 — Home equity 13 — — — 10 — Other consumer 29 — 57 — 68 1 Total 7,366 81 6,603 133 9,259 554 Loans with a specific valuation allowance Commercial and industrial 675 — 169 3 1,077 — Owner-occupied commercial real estate 355 — — — — — Single tenant lease financing 3,931 — 5,671 4 1,464 — Healthcare finance 841 131 — — — — Small business lending 644 — — — — — Total 6,446 131 5,840 7 2,541 — Total impaired loans $ 13,812 $ 212 $ 12,443 $ 140 $ 11,800 $ 554

Premises and Equipment (Tables)

Premises and Equipment (Tables)	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Premises and Equipment	The following table summarizes premises and equipment at December 31, 2021 and 2020. December 31, 2021 2020 Land $ — $ 2,500 Construction in process 57,469 28,754 Right of use leased asset 208 819 Building and improvements 1,090 5,819 Furniture and equipment 7,800 10,671 Less: accumulated depreciation (6,725) (10,973) $ 59,842 $ 37,590

Servicing Asset (Tables)

Servicing Asset (Tables)	12 Months Ended
	Dec. 31, 2021
Transfers and Servicing [Abstract]
Schedule of Servicing Assets at Fair Value	Activity for the servicing asset and the related changes in fair value for the twelve months ended December 31, 2021, 2020 and 2019 are shown in the table below. Twelve Months Ended December 31, 2021 December 31, 2020 December 31, 2019 Beginning balance $ 3,569 $ 2,481 $ — Additions: Originated and purchased servicing 2,202 1,520 2,481 Subtractions: Paydowns (820) (524) — Changes in fair value due to changes in valuation inputs (249) 92 — Loan servicing asset revaluation (1,069) (432) — Ending balance $ 4,702 $ 3,569 $ 2,481
Schedule Of Unpaid Principal Balances Of Loans Serviced For Others	Loans serviced for others are not included in the consolidated balance sheets. The unpaid principal balances of these loans serviced for others as of December 31, 2021 and December 31, 2020 are shown in the table below. December 31, 2021 December 31, 2020 Loan portfolios serviced for: SBA guaranteed loans $ 230,514 $ 165,961 Total $ 230,514 $ 165,961

Deposits (Tables)

Deposits (Tables)	12 Months Ended
	Dec. 31, 2021
Deposits [Abstract]
Schedule of deposits	The following table presents the composition of the Company’s deposit base as of December 31, 2021 and 2020. December 31, 2021 2020 Noninterest-bearing demand deposit accounts $ 117,531 $ 96,753 Interest-bearing demand deposit accounts 247,967 188,645 Savings accounts 59,998 43,200 Money market accounts 1,483,936 1,350,566 Certificates of deposits 970,107 1,289,319 Brokered deposits 299,420 302,402 Total deposits $ 3,178,959 $ 3,270,885 Time deposits greater than $250 $ 327,490 $ 403,253
Schedule of certificates of deposits scheduled maturities	The following table presents time deposit maturities by year as of December 31, 2021. Certificates of Deposits Brokered Certificates of Deposits 2022 $ 618,091 $ 129,461 2023 190,045 18,628 2024 97,940 1,490 2025 29,452 — 2026 34,579 — $ 970,107 $ 149,579

FHLB Advances (Tables)

FHLB Advances (Tables)	12 Months Ended
	Dec. 31, 2021
Federal Home Loan Banks [Abstract]
Schedule of Federal Home Loan Bank, Advances, by Branch of FHLB Bank	The Company’s FHLB advances are scheduled to mature according to the following schedule: Amount 2022 $ 110,000 2023 35,000 2024 145,014 2025 90,000 2026 10,000 Thereafter 124,908 $ 514,922

Subordinated Debt Subordinated

Subordinated Debt Subordinated Debt (Tables)	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Schedule of Subordinated Borrowing	The following table presents the principal balance and unamortized discount and debt issuance costs for the 2025 Note, the 2026 Notes, the 2029 Notes, the 2030 Note, and the 2031 Notes as of December 31, 2021 and 2020. December 31, 2021 December 31, 2020 Principal Unamortized Discount and Debt Issuance Costs Principal Unamortized Discount and Debt Issuance Costs 2025 Note $ — $ — $ 10,000 $ (114) 2026 Notes — — 25,000 (715) 2029 Notes 37,000 (1,178) 37,000 (1,337) 2030 Note 10,000 (208) 10,000 (231) 2031 Notes 60,000 (1,383) — — Total $ 107,000 $ (2,769) $ 82,000 $ (2,397)

Benefit Plans (Tables)

Benefit Plans (Tables)	12 Months Ended
	Dec. 31, 2021
Retirement Benefits [Abstract]
Nonvested Restricted Stock Shares Activity	The following table summarizes the status of the 2013 Plan awards as of December 31, 2021, and activity for the year ended December 31, 2021: Restricted Stock Units Weighted-Average Grant Date Fair Value Per Share Restricted Stock Awards Weighted-Average Grant Date Fair Value Per Share Deferred Stock Units Weighted-Average Grant Date Fair Value Per Unit Unvested at January 1, 2021 112,985 $ 27.76 — $ — — $ — Granted 60,111 30.42 14,180 30.54 8 32.18 Vested (60,274) 29.64 (13,123) 30.58 (8) 32.18 Forfeited — — (1,057) 30.13 — — Unvested at December 31, 2021 112,822 $ 28.18 — $ — — $ —
Schedule Of Deferred Stock Option Plan	The following table summarizes the status of deferred stock rights related to the Directors Deferred Stock Plan for the year ended December 31, 2021. Deferred Rights Outstanding, beginning of year 83,835 Granted 701 Exercised — Outstanding, end of year 84,536

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit)	The provision for income taxes consists of the following: December 31, 2021 2020 2019 Current $ 6,024 $ 8,563 $ 6,319 Deferred 2,434 (4,118) (4,402) Total $ 8,458 $ 4,445 $ 1,917
Schedule of Effective Income Tax Rate Reconciliation	Income tax provision is reconciled to the statutory 21% rate applied to pre-tax income. December 31, 2021 2020 2019 Statutory rate times pre-tax income $ 11,880 $ 7,119 $ 5,703 (Subtract) add the tax effect of: Income from tax-exempt securities and loans (4,217) (4,464) (4,881) State income tax, net of federal tax effect 865 1,765 1,285 Bank-owned life insurance (199) (200) (198) Tax credits (175) (178) (181) Other differences 304 403 189 Total income taxes $ 8,458 $ 4,445 $ 1,917
Schedule of Deferred Tax Assets and Liabilities	The net deferred tax asset at December 31, 2021 and 2020 consists of the following: December 31, 2021 2020 Deferred tax assets (liabilities) Allowance for loan losses $ 7,517 $ 7,961 Net unrealized losses on available-for-sale securities and hedged items 4,835 5,800 Fair value adjustments (618) 1,117 Depreciation (100) (107) Deferred compensation and accrued payroll 1,577 1,533 Loan origination costs (1,311) (1,281) Prepaid assets (641) (553) Other 149 337 Total deferred tax assets, net $ 11,408 $ 14,807

Regulatory Capital Requiremen_2

Regulatory Capital Requirements (Tables)	12 Months Ended
	Dec. 31, 2021
Mortgage Banking [Abstract]
Schedule of Compliance with Regulatory Capital Requirements under Banking Regulations	The following tables present actual and required capital ratios as of December 31, 2021 and 2020 for the Company and the Bank under the Basel III Capital Rules. The minimum required capital amounts presented include the minimum required capital levels as of December 31, 2021 and 2020 based on the Basel III Capital Rules. Capital levels required to be considered well capitalized are based upon prompt corrective action regulations, as amended to reflect the changes under the Basel III Capital Rules. Actual Minimum Capital Required - Basel III Minimum Required to be Considered Well Capitalized Capital Amount Ratio Capital Amount Ratio Capital Amount Ratio As of December 31, 2021: Common equity tier 1 capital to risk-weighted assets Consolidated $ 384,499 12.93 % $ 208,202 7.00 % N/A N/A Bank 432,181 14.55 % 207,913 7.00 % 193,062 6.50 % Tier 1 capital to risk-weighted assets Consolidated 384,499 12.93 % 252,817 8.50 % N/A N/A Bank 432,181 14.55 % 252,466 8.50 % 237,615 8.00 % Total capital to risk-weighted assets Consolidated 516,571 17.37 % 312,303 10.50 % N/A N/A Bank 460,022 15.49 % 311,870 10.50 % 297,019 10.00 % Leverage ratio Consolidated 384,499 9.22 % 166,824 4.00 % N/A N/A Bank 432,181 10.37 % 166,693 4.00 % 208,366 5.00 % Actual Minimum Capital Required - Basel III Minimum Required to be Considered Well Capitalized Capital Amount Ratio Capital Amount Ratio Capital Amount Ratio As of December 31, 2020: Common equity tier 1 capital to risk-weighted assets Consolidated $ 342,159 11.31 % $ 211,828 7.00 % N/A N/A Bank 377,678 12.49 % 211,612 7.00 % 196,497 6.50 % Tier 1 capital to risk-weighted assets Consolidated 342,159 11.31 % 257,220 8.50 % N/A N/A Bank 377,678 12.49 % 256,957 8.50 % 241,842 8.00 % Total capital to risk-weighted assets Consolidated 451,246 14.91 % 317,742 10.50 % N/A N/A Bank 407,162 13.47 % 317,418 10.50 % 302,303 10.00 % Leverage ratio Consolidated 342,159 7.95 % 172,154 4.00 % N/A N/A Bank 377,678 8.78 % 172,036 4.00 % 215,045 5.00 %

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following tables present the fair value measurements of assets and liabilities recognized in the accompanying consolidated balance sheets measured at fair value on a recurring basis and the level within the fair value hierarchy in which the fair value measurements fall at December 31, 2021 and 2020. December 31, 2021 Fair Value Measurements Using Fair Quoted Prices Significant Significant U.S. Government-sponsored agencies $ 49,040 $ — $ 49,040 $ — Municipal securities 77,033 — 77,033 — Agency mortgage-backed securities - residential 373,236 — 373,236 — Agency mortgage-backed securities - commercial 36,326 — 36,326 Private label mortgage-backed securities - residential 16,021 — 16,021 — Asset-backed securities 5,004 — 5,004 — Corporate securities 46,384 — 46,384 — Total available-for-sale securities $ 603,044 $ — $ 603,044 $ — Servicing asset 4,702 — — 4,702 Interest rate swaps liabilities (14,271) — (14,271) — Loans held-for-sale (mandatory pricing agreements) 23,233 — 23,233 — Forward contracts (30) (30) — — IRLCs 718 — — 718 December 31, 2020 Fair Value Measurements Using Fair Quoted Prices Significant Significant U.S. Government-sponsored agencies $ 60,545 $ — $ 60,545 $ — Municipal securities 82,489 — 82,489 — Agency mortgage-backed securities - residential 214,330 — 214,330 — Agency mortgage-backed securities - commercial 29,591 — 29,591 — Private label mortgage-backed securities - residential 58,116 — 58,116 — Asset-backed securities 4,961 — 4,961 — Corporate securities 47,596 — 47,596 — Total available-for-sale securities $ 497,628 $ — $ 497,628 $ — Servicing asset 3,569 — — 3,569 Interest rate swaps liabilities (29,750) — (29,750) — Loans held-for-sale (mandatory pricing agreements) 26,341 — 26,341 — Forward contracts (640) (640) — — IRLCs 3,361 — — 3,361
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation	The following table reconciles the beginning and ending balances of recurring fair value measurements recognized in the accompanying consolidated balance sheets using significant unobservable (Level 3) inputs. Servicing Asset Interest Rate Lock Commitments Balance as of January 1, 2019 $ — $ 389 Total realized gains Additions 2,481 — Change in fair value — 521 Balance, December 31, 2019 2,481 910 Total realized gains Additions 1,520 — Paydowns (524) — Changes in fair value 92 2,451 Balance, December 31, 2020 3,569 3,361 Total realized gains Additions 2,202 — Paydowns (820) — Changes in fair value (249) (2,643) Balance, December 31, 2021 $ 4,702 $ 718
Schedule Of Impaired Loans, Including Valuation Allowance, Fair Value, Unobservable Inputs Reconciliation	Impaired loans with a specific valuation allowance based on the value of the underlying collateral or a discounted cash flow analysis are classified as Level 3 assets. 2021 Fair Value Measurements Using Fair Quoted Prices Significant Significant Impaired loans 1,228 — — 1,228 2020 Fair Value Measurements Using Fair Quoted Prices Significant Significant Impaired loans 4,026 — — 4,026
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques	The following tables present quantitative information about unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements other than goodwill. (dollars in thousands) Fair Value at Valuation Significant Unobservable Range Weighted-Average Range Impaired loans $ 1,228 Fair value of collateral Discount for type of property and current market conditions 0% - 35% 10.1% IRLCs 718 Discounted cash flow Loan closing rates 42% - 100% 89% Servicing asset 4,702 Discounted cash flow Prepayment speeds Discount rate 0% - 25% 10% 12.5% 10% (dollars in thousands) Fair Value at Valuation Unobservable Range Weighted - Average Range Impaired loans $ 4,026 Fair value of collateral Discount for type of property and current market conditions 10% 10% IRLCs 3,361 Discounted cash flow Loan closing rates 44% - 100% 87% Servicing asset 3,569 Discounted cash flow Prepayment speeds Discount rate 0% - 25% 10% 12.1% 10%
Fair Value, by Balance Sheet Grouping	The following tables provide the carrying amounts and estimated fair values of the Company's financial instruments at December 31, 2021 and 2020: December 31, 2021 Fair Value Measurements Using Carrying Fair Value Quoted Prices Significant Significant Cash and cash equivalents $ 442,960 $ 442,960 $ 442,960 $ — $ — Securities held-to-maturity 59,565 61,468 — 61,468 — Loans held-for-sale (best efforts pricing agreements) 24,512 24,512 — 24,512 Net loans 2,859,821 2,880,024 — — 2,880,024 Accrued interest receivable 16,037 16,037 16,037 — — Federal Home Loan Bank of Indianapolis stock 25,650 25,650 — 25,650 — Deposits 3,178,959 3,190,000 1,909,432 — 1,280,568 Advances from Federal Home Loan Bank 514,922 526,143 — 526,143 — Subordinated debt 104,231 108,788 38,643 70,145 — Accrued interest payable 2,018 2,018 2,018 — — December 31, 2020 Fair Value Measurements Using Carrying Fair Value Quoted Prices Significant Significant Cash and cash equivalents $ 419,806 $ 419,806 $ 419,806 $ — $ — Securities held-to-maturity 68,223 69,452 — 69,452 — Loans held-for-sale (best efforts pricing agreements) 13,243 13,243 — 13,243 — Net loans 3,029,747 3,084,375 — — 3,084,375 Accrued interest receivable 17,416 17,416 17,416 — — Federal Home Loan Bank of Indianapolis stock 25,650 25,650 — 25,650 — Deposits 3,270,885 3,307,038 1,679,164 — 1,627,874 Advances from Federal Home Loan Bank 514,916 541,945 — 541,945 — Subordinated debt 79,603 83,682 63,325 20,357 — Accrued interest payable 1,439 1,439 1,439 — —

Mortgage Banking Activities (Ta

Mortgage Banking Activities (Tables)	12 Months Ended
	Dec. 31, 2021
Mortgage Banking [Abstract]
Schedule of Participating Mortgage Loans	The following table provides the components of income from mortgage banking activities for the years ended December 31, 2021, 2020, and 2019. Year Ended December 31, 2021 2020 2019 Gain on loans sold $ 17,803 $ 22,826 $ 10,275 (Loss) gain resulting from the change in fair value of loans held-for-sale (718) (94) 538 (Loss) gain resulting from the change in fair value of derivatives (2,035) 1,961 728 Net revenue from mortgage banking activities $ 15,050 $ 24,693 $ 11,541

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule Of Derivative Instruments, Cumulative Basis Adjustments	The following table presents amounts that were recorded in the consolidated balance sheets related to cumulative basis adjustments for interest rate swap derivatives designated as fair value accounting hedges as of December 31, 2021 and 2020. Carrying amount of the hedged assets Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets Line item in the consolidated balance sheet in which the hedged item is included December 31, 2021 December 31, 2020 December 31, 2021 December 31, 2020 Securities available-for-sale 1 75,156 124,210 1,729 6,064 1 These amounts include the amortized cost basis of closed portfolios used to designate hedging relationships in which the hedged item is the last layer expected to be remaining at the end of the hedging relationship. The amounts of the designated hedged items were $50.0 million and $88.2 million, at December 31, 2021 and 2020, respectively.
Schedule Of Derivative Instruments Of Fixed Rate Receivables	The following tables present a summary of interest rate swap derivatives designated as fair value accounting hedges of fixed-rate receivables used in the Company's asset/liability management activities at December 31, 2021 and December 31, 2020, identified by the underlying interest rate-sensitive instruments. December 31, 2021 Weighted Average Remaining Maturity (years) Weighted-Average Rate Instruments Associated With Notional Value Fair Value Receive Pay Securities available-for-sale 50,000 1.8 (1,731) 3 month LIBOR 2.33% Total swap portfolio at December 31, 2021 $ 50,000 1.8 $ (1,731) 3 month LIBOR 2.33% December 31, 2020 Weighted Average Remaining Maturity (years) Weighted-Average Rate Instruments Associated With Notional Value Fair Value Receive Pay Securities available-for-sale 88,200 3.1 (6,072) 3 month LIBOR 2.54% Total swap portfolio at December 31, 2020 $ 88,200 3.1 $ (6,072) 3 month LIBOR 2.54%
Schedule Of Derivative Instruments Of Variable Rate Liabilities	The following tables present a summary of interest rate swap derivatives designated as cash flow accounting hedges of variable-rate liabilities used in the Company's asset/liability management activities at December 31, 2021 and December 31, 2020. December 31, 2021 Weighted Average Remaining Maturity (years) Weighted-Average Rate Cash Flow Hedges Notional Value Fair Value Receive Pay Interest rate swaps $ 110,000 5.1 $ (8,560) 3 month LIBOR 2.88% Interest rate swaps 100,000 2.0 (3,980) 1 month LIBOR 2.88% December 31, 2020 Weighted Average Remaining Maturity (years) Weighted-Average Rate Cash Flow Hedges Notional Value Fair Value Receive Pay Interest rate swaps $ 110,000 6.1 $ (15,727) 3 month LIBOR 2.88% Interest rate swaps 100,000 3.0 (7,951) 1 month LIBOR 2.88%
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	The following table presents the notional amount and fair value of interest rate swaps, IRLCs and forward contracts utilized by the Company at December 31, 2021 and 2020. December 31, 2021 December 31, 2020 Notional Fair Notional Fair Asset Derivatives Derivatives not designated as hedging instruments IRLCs 62,789 718 108,095 3,361 Total contracts $ 62,789 $ 718 $ 108,095 $ 3,361 Liability Derivatives Derivatives designated as hedging instruments Interest rate swaps associated with securities available-for-sale 50,000 (1,731) 88,200 (6,072) Interest rate swaps associated with liabilities 210,000 (12,540) 210,000 (23,678) Derivatives not designated as hedging instruments Forward contracts 72,750 (30) 107,500 (640) Total contracts $ 332,750 $ (14,301) $ 405,700 $ (30,390)
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)	The following table presents the effects of the Company's cash flow hedge relationships on the consolidated statements of comprehensive income during the twelve months ended December 31, 2021, 2020, and 2019. Amount of Gain (loss) Recognized in Other Comprehensive Income in the Twelve Months Ended December 31, 2021 December 31, 2020 December 31, 2019 Interest rate swap agreements $ 11,138 $ (10,248) $ (9,071)
Schedule Of Derivative Instruments In Statements Of Income Fair Value	The following table summarizes the periodic changes in the fair value of the derivative financial instruments on the consolidated statements of income for the twelve months ended December 31, 2021, 2020, and 2019. Amount of (Loss) / Gain Recognized in the Twelve Months Ended December 31, 2021 December 31, 2020 December 31, 2019 Asset Derivatives Derivatives not designated as hedging instruments IRLCs (2,643) 2,451 521 Forward contracts 610 (487) 207
Derivative Instruments, Gain (Loss)	The following table presents the effects of the Company's interest rate swap agreements on the consolidated statements of income during the twelve months ended December 31, 2021, 2020, and 2019. Line item in the consolidated statements of income Twelve Months Ended December 31, 2021 December 31, 2020 December 31, 2019 Interest income Loans $ — $ (2,445) $ (1,533) Securities - taxable (253) (722) (127) Securities - non-taxable (1,099) (741) 36 Total interest income (1,352) (3,908) (1,624) Interest expense Deposits 2,775 2,273 618 Other borrowed funds 3,028 2,374 473 Total interest expense 5,803 4,647 1,091 Net interest income $ (7,155) $ (8,555) $ (2,715)

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	12 Months Ended
	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	Amounts reclassified from accumulated other comprehensive loss and the affected line items in the consolidated statements of income during the years ended December 31, 2021, 2020 and 2019 were as follows: Details About Accumulated Other Comprehensive Loss Components Amounts Reclassified from Affected Line Item in the 2021 2020 2019 Unrealized gains and losses on securities available-for-sale Gain (loss) realized in earnings $ — $ 139 $ (458) Gain (loss) on sale of securities Total reclassified amount before tax — 139 (458) Income before income taxes Tax expense (benefit) — 38 (124) Income tax provision Total reclassifications out of accumulated other comprehensive loss $ — $ 101 $ (334) Net Income The components of accumulated other comprehensive loss, included in stockholders' equity, are presented in the table below. Available-For-Sale Securities Cash Flow Hedges Total Balance, January 1, 2019 $ (13,359) $ (3,182) $ (16,541) Net unrealized holding gains (losses) recorded within other comprehensive income before income tax 12,072 (9,071) 3,001 Reclassification of net loss realized and included in earnings 458 — 458 Other comprehensive income (loss) before tax 12,530 (9,071) 3,459 Income tax provision (benefit) 3,559 (2,450) 1,109 Other comprehensive income (loss) - net of tax 8,971 (6,621) 2,350 Balance, December 31, 2019 $ (4,388) $ (9,803) $ (14,191) Net unrealized holding gains (losses) recorded within other comprehensive income before income tax 6,551 (10,248) (3,697) Reclassification of net gain realized and included in earnings (139) — (139) Other comprehensive income (loss) before tax 6,412 (10,248) (3,836) Income tax provision (benefit) 1,556 (2,387) (831) Other comprehensive income (loss) - net of tax 4,856 (7,861) (3,005) Balance, December 31, 2020 $ 468 $ (17,664) $ (17,196) Net unrealized holding (gains) losses recorded within other comprehensive income before income tax (4,087) 11,138 7,051 Other comprehensive (loss) income before income tax (4,087) 11,138 7,051 Income tax (benefit) provision (1,064) 1,958 894 Other comprehensive (loss) income - net of tax (3,023) 9,180 6,157 Balance, December 31, 2021 $ (2,555) $ (8,484) $ (11,039)

Condensed Financial Informati_2

Condensed Financial Information (Parent Company Only) (Tables)	12 Months Ended
	Dec. 31, 2021
Condensed Financial Information Disclosure [Abstract]
Schedule Of Condensed Balance Sheet Of Parent Company Only	Condensed Balance Sheets Year Ended December 31, 2021 2020 Assets Cash and cash equivalents $ 52,857 $ 40,532 Investment in common stock of subsidiaries 428,021 366,463 Premises and equipment, net 176 5,910 Accrued income and other assets 5,868 2,658 Total assets $ 486,922 $ 415,563 Liabilities and shareholders’ equity Subordinated debt, net of unamortized discounts and debt issuance costs of $2,769 in 2021 and $2,397 in 2020 $ 104,231 $ 79,603 Note payable to the Bank — 3,000 Accrued expenses and other liabilities 2,353 2,016 Total liabilities 106,584 84,619 Shareholders’ equity 380,338 330,944 Total liabilities and shareholders’ equity $ 486,922 $ 415,563
Schedule Of Condensed Income Statement Of Parent Company Only	Year Ended December 31, 2021 2020 Assets Cash and cash equivalents $ 52,857 $ 40,532 Investment in common stock of subsidiaries 428,021 366,463 Premises and equipment, net 176 5,910 Accrued income and other assets 5,868 2,658 Total assets $ 486,922 $ 415,563 Liabilities and shareholders’ equity Subordinated debt, net of unamortized discounts and debt issuance costs of $2,769 in 2021 and $2,397 in 2020 $ 104,231 $ 79,603 Note payable to the Bank — 3,000 Accrued expenses and other liabilities 2,353 2,016 Total liabilities 106,584 84,619 Shareholders’ equity 380,338 330,944 Total liabilities and shareholders’ equity $ 486,922 $ 415,563
Comprehensive Income (Loss)	Condensed Statements of Comprehensive Income Year Ended December 31, 2021 2020 2019 Net income $ 48,114 $ 29,453 $ 25,239 Other comprehensive income (loss) Net unrealized holding (losses) gains on securities available-for-sale recorded within other comprehensive income before income tax (4,087) 6,551 12,072 Reclassification adjustment for (gains) losses realized — (139) 458 Net unrealized holding losses on cash flow hedging derivatives recorded within other comprehensive income before income tax 11,138 (10,248) (9,071) Other comprehensive income (loss) before tax 7,051 (3,836) 3,459 Income tax provision (benefit) 894 (831) 1,109 Other comprehensive income (loss) - net of tax 6,157 (3,005) 2,350 Comprehensive income $ 54,271 $ 26,448 $ 27,589
Schedule Of Condensed Cash Flow Statement Of Parent Company Only	Condensed Statements of Cash Flows Year Ended December 31, 2021 2020 2019 Operating activities Net income $ 48,114 $ 29,453 $ 25,239 Adjustments to reconcile net income to net cash provided by operating activities: Equity in undistributed net income of subsidiaries (53,847) (35,526) (30,367) Depreciation and amortization 1,081 711 647 Share-based compensation expense 835 518 288 Gain on sale of premises and equipment (2,523) — — Net change in other assets (31) (502) (508) Net change in other liabilities 775 311 (87) Net cash used in operating activities (5,596) (5,035) (4,788) Investing activities Capital contribution to the Bank — — (25,000) Purchase of premises and equipment — — (13) Net proceeds from sale of premises and equipment 8,116 — — Other investing activities (3,561) — — Net cash provided by (used in) investing activities 4,555 — (25,013) Financing activities Cash dividends paid (2,415) (2,349) (2,418) Net proceeds from issuance of subordinated debt 58,658 9,765 35,418 Repayment of subordinated debt (35,000) — — Repayment of Bank loan (3,000) — (300) Repurchase of common stock (4,436) — (9,784) Other, net (441) (152) (93) Net cash provided by financing activities 13,366 7,264 22,823 Net increase (decrease) in cash and cash equivalents 12,325 2,229 (6,978) Cash and cash equivalents at beginning of year 40,532 38,303 45,281 Cash and cash equivalents at end of year $ 52,857 $ 40,532 $ 38,303

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Net income	$ 48,114	$ 29,453	$ 25,239
Weighted-average common shares (in shares)	9,918,083	9,840,205	10,041,581
Basic earnings per share
Basic earnings per common share (in dollars per share)	$ 4.85	$ 2.99	$ 2.51
Diluted earnings per share
Dilutive effect of equity compensation (in shares)	58,178	2,220	2,902
Weighted-average common and incremental shares (in shares)	9,976,261	9,842,425	10,044,483
Diluted earnings per common share (in dollars per share)	$ 4.82	$ 2.99	$ 2.51
Antidilutive securities excluded from computation of earnings per share (in shares)	28	18,524	15,758

Basis of Presentation and Sum_5

Basis of Presentation and Summary of Significant Accounting Policies (Details Textual)	12 Months Ended
	Dec. 31, 2021subsidiaryreporting_unit	Dec. 31, 2006
Significant Accounting Policies [Line Items]
Date of incorporation	Sep. 15, 2005
Ownership (as a percent)		100.00%
Number of wholly owned subsidiaries | subsidiary	3
Number of reporting units	1
Number of reportable segments	1
Equipment | Minimum
Significant Accounting Policies [Line Items]
Estimated useful lives (in years)	3 years
Equipment | Maximum
Significant Accounting Policies [Line Items]
Estimated useful lives (in years)	5 years
Land Improvements
Significant Accounting Policies [Line Items]
Estimated useful lives (in years)	10 years
Buildings
Significant Accounting Policies [Line Items]
Estimated useful lives (in years)	39 years

Cash and Cash Equivalents (Deta

Cash and Cash Equivalents (Details Textual) $ in Millions	Dec. 31, 2021USD ($)
Cash and Cash Equivalents [Line Items]
Cash in excess of limits of FDIC insurance coverage	$ 56.1
Federal Home Loan Bank of Indianapolis
Cash and Cash Equivalents [Line Items]
Cash held	18.7
Federal Home Loan Bank of Chicago
Cash and Cash Equivalents [Line Items]
Cash held	$ 361.8

Securities (Details)

Securities (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Debt Securities, Available-for-sale [Abstract]
Amortized Cost	$ 606,507	$ 497,004
Gross Unrealized Gains	4,228	7,107
Gross Unrealized Losses	(7,691)	(6,483)
Fair Value	603,044	497,628
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Amortized Cost	59,565	68,223
Gross Unrealized Gains	1,903	1,356
Gross Unrealized Losses	0	(127)
Fair Value	61,468	69,452
U.S. Government-sponsored agencies
Debt Securities, Available-for-sale [Abstract]
Amortized Cost	50,013	61,765
Gross Unrealized Gains	164	432
Gross Unrealized Losses	(1,137)	(1,652)
Fair Value	49,040	60,545
Municipal securities
Debt Securities, Available-for-sale [Abstract]
Amortized Cost	75,158	82,757
Gross Unrealized Gains	1,940	463
Gross Unrealized Losses	(65)	(731)
Fair Value	77,033	82,489
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Amortized Cost	13,992	14,571
Gross Unrealized Gains	717	746
Gross Unrealized Losses	0	0
Fair Value	14,709	15,317
Agency mortgage-backed securities - residential
Debt Securities, Available-for-sale [Abstract]
Amortized Cost	377,928	213,408
Gross Unrealized Gains	960	3,387
Gross Unrealized Losses	(5,652)	(2,465)
Fair Value	373,236	214,330
Agency mortgage-backed securities - residential | Interest Rate Contract
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Premium related to terminated interest rate swaps	800
Agency mortgage-backed securities - commercial
Debt Securities, Available-for-sale [Abstract]
Amortized Cost	36,024	28,387
Gross Unrealized Gains	441	1,204
Gross Unrealized Losses	(139)	0
Fair Value	36,326	29,591
Private label mortgage-backed securities - residential
Debt Securities, Available-for-sale [Abstract]
Amortized Cost	15,902	57,268
Gross Unrealized Gains	122	850
Gross Unrealized Losses	(3)	(2)
Fair Value	16,021	58,116
Asset-backed securities
Debt Securities, Available-for-sale [Abstract]
Amortized Cost	5,000	5,000
Gross Unrealized Gains	4	0
Gross Unrealized Losses	0	(39)
Fair Value	5,004	4,961
Corporate securities
Debt Securities, Available-for-sale [Abstract]
Amortized Cost	46,482	48,419
Gross Unrealized Gains	597	771
Gross Unrealized Losses	(695)	(1,594)
Fair Value	46,384	47,596
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Amortized Cost	45,573	53,652
Gross Unrealized Gains	1,186	610
Gross Unrealized Losses	0	(127)
Fair Value	$ 46,759	$ 54,135

Securities - Carrying Value of

Securities - Carrying Value of Securities by Contractual Maturity Date (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Amortized Cost
Within one year	$ 0
One to five years	36,314
Five to ten years	58,962
Five to ten years	76,377
Amortized Cost	171,653
Totals	606,507	$ 497,004
Held-to-Maturity, Amortized Cost
One to five years	7,289
Five to ten years	41,135
After ten years	11,141
Total	59,565
Fair Value
Within one year	0
One to five years	34,866
Five to ten years	58,602
After ten years	78,989
Fair Value	172,457
Totals	603,044	497,628
Held-to-Maturity, Fair Value
Five to ten years	7,465
Five to ten years	42,502
After ten years	11,501
Total	61,468
Agency mortgage-backed securities - residential
Amortized Cost
Totals	377,928	213,408
Fair Value
Totals	373,236	214,330
Agency mortgage-backed securities - commercial
Amortized Cost
Totals	36,024	28,387
Fair Value
Totals	36,326	29,591
Private label mortgage-backed securities - residential
Amortized Cost
Totals	15,902	57,268
Fair Value
Totals	16,021	58,116
Asset-backed securities
Amortized Cost
Totals	5,000	5,000
Fair Value
Totals	$ 5,004	$ 4,961

Securities - Gross Unrealized L

Securities - Gross Unrealized Losses and Fair Value (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Debt Securities, Available-for-sale [Line Items]
Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Fair Value	$ 312,593	$ 58,995
Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Fair Value	90,636	147,092
Available-for-sale, Unrealized Loss Position, Fair Value	403,229	206,087
Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Unrealized Losses	(4,167)	(391)
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Unrealized Losses	(3,524)	(6,092)
Debt Securities, Available-for-sale, Unrealized Loss Position, Unrealized Losses	7,691	6,483
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, Fair Value [Abstract]
Held-to-maturity, Less Than 12 Months		17,456
Held-to-maturity, 12 Months or Longer		2,999
Held-to-maturity, Total		20,455
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position [Abstract]
Held-to-maturity, Less Than 12 Months		(126)
Held-to-maturity, 12 Months or Longer		(1)
Held-to-maturity, Total		(127)
U.S. Government-sponsored agencies
Debt Securities, Available-for-sale [Line Items]
Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Fair Value	2,921	0
Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Fair Value	40,305	52,351
Available-for-sale, Unrealized Loss Position, Fair Value	43,226	52,351
Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Unrealized Losses	(79)	0
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Unrealized Losses	(1,058)	(1,652)
Debt Securities, Available-for-sale, Unrealized Loss Position, Unrealized Losses	1,137	1,652
Municipal securities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Fair Value	5,721	18,731
Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Fair Value	0	23,519
Available-for-sale, Unrealized Loss Position, Fair Value	5,721	42,250
Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Unrealized Losses	(65)	(114)
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Unrealized Losses	0	(617)
Debt Securities, Available-for-sale, Unrealized Loss Position, Unrealized Losses	65	731
Agency mortgage-backed securities - residential
Debt Securities, Available-for-sale [Line Items]
Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Fair Value	287,820	38,987
Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Fair Value	40,840	45,297
Available-for-sale, Unrealized Loss Position, Fair Value	328,660	84,284
Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Unrealized Losses	(3,694)	(276)
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Unrealized Losses	(1,958)	(2,189)
Debt Securities, Available-for-sale, Unrealized Loss Position, Unrealized Losses	5,652	2,465
Agency mortgage-backed securities - commercial
Debt Securities, Available-for-sale [Line Items]
Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Fair Value	3,944
Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Fair Value	0
Available-for-sale, Unrealized Loss Position, Fair Value	3,944
Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Unrealized Losses	(139)
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Unrealized Losses	0
Debt Securities, Available-for-sale, Unrealized Loss Position, Unrealized Losses	139
Private label mortgage-backed securities - residential
Debt Securities, Available-for-sale [Line Items]
Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Fair Value	374	1,277
Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Fair Value	0	558
Available-for-sale, Unrealized Loss Position, Fair Value	374	1,835
Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Unrealized Losses	(3)	(1)
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Unrealized Losses	0	(1)
Debt Securities, Available-for-sale, Unrealized Loss Position, Unrealized Losses	3	2
Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Fair Value		0
Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Fair Value		4,961
Available-for-sale, Unrealized Loss Position, Fair Value		4,961
Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Unrealized Losses		0
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Unrealized Losses		(39)
Debt Securities, Available-for-sale, Unrealized Loss Position, Unrealized Losses		39
Corporate securities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Fair Value	11,813	0
Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Fair Value	9,491	20,406
Available-for-sale, Unrealized Loss Position, Fair Value	21,304	20,406
Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Unrealized Losses	(187)	0
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Unrealized Losses	(508)	(1,594)
Debt Securities, Available-for-sale, Unrealized Loss Position, Unrealized Losses	$ 695	1,594
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, Fair Value [Abstract]
Held-to-maturity, Less Than 12 Months		17,456
Held-to-maturity, 12 Months or Longer		2,999
Held-to-maturity, Total		20,455
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position [Abstract]
Held-to-maturity, Less Than 12 Months		(126)
Held-to-maturity, 12 Months or Longer		(1)
Held-to-maturity, Total		$ (127)

Securities - Amounts Reclassifi

Securities - Amounts Reclassified from Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Investments, Debt and Equity Securities [Abstract]
Gain (loss) realized in earnings	$ 0	$ 139,000	$ (458,000)
Total reclassified amount before tax	0	139,000	(458,000)
Tax expense (benefit)	0	38,000	(124,000)
Total reclassifications out of accumulated other comprehensive loss	$ 0	$ 101,000	$ (334,000)

Securities - Additional Informa

Securities - Additional Information (Details Textual)	12 Months Ended
	Dec. 31, 2021USD ($)security	Dec. 31, 2020USD ($)security	Dec. 31, 2019USD ($)
Debt Securities, Available-for-sale [Line Items]
Gain (loss) realized in earnings	$ 0	$ 139,000	$ (458,000)
Securities pledged as collateral	475,100,000
Total fair value	$ 403,200,000	$ 226,500,000
Percentage of available-for-sale portfolio	61.00%	40.00%
Number of securities with market value below cost basis | security	179	121

Loans (Details)

Loans (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Financial Instruments Owned and Pledged as Collateral [Line Items]
Total loans	$ 2,833,776	$ 2,997,967
Net deferred loan origination costs, premiums and discounts on purchased loans, and other(1)	53,886	61,264
Total loans	2,887,662	3,059,231
Allowance for loan losses	(27,841)	(29,484)	$ (21,840)	$ (17,896)
Net loans	2,859,821	3,029,747
Commercial and industrial
Financial Instruments Owned and Pledged as Collateral [Line Items]
Allowance for loan losses	(1,891)	(1,146)	(1,521)	(1,384)
Owner-occupied commercial real estate
Financial Instruments Owned and Pledged as Collateral [Line Items]
Allowance for loan losses	(742)	(1,082)	(561)	(783)
Investor commercial real estate
Financial Instruments Owned and Pledged as Collateral [Line Items]
Allowance for loan losses	(328)	(155)	(109)	(61)
Construction
Financial Instruments Owned and Pledged as Collateral [Line Items]
Allowance for loan losses	(1,612)	(1,192)	(380)	(251)
Single tenant lease financing
Financial Instruments Owned and Pledged as Collateral [Line Items]
Allowance for loan losses	(10,385)	(12,990)	(11,175)	(8,827)
Public finance
Financial Instruments Owned and Pledged as Collateral [Line Items]
Allowance for loan losses	(1,776)	(1,732)	(1,580)	(1,670)
Healthcare finance
Financial Instruments Owned and Pledged as Collateral [Line Items]
Allowance for loan losses	(5,940)	(7,485)	(3,247)	(1,264)
Small business lending
Financial Instruments Owned and Pledged as Collateral [Line Items]
Allowance for loan losses	(1,387)	(628)	(54)	(203)
Residential mortgage
Financial Instruments Owned and Pledged as Collateral [Line Items]
Allowance for loan losses	(643)	(519)	(657)	(1,079)
Home equity
Financial Instruments Owned and Pledged as Collateral [Line Items]
Allowance for loan losses	(64)	(48)	(46)	(53)
Other consumer
Financial Instruments Owned and Pledged as Collateral [Line Items]
Allowance for loan losses	(1,990)	(2,507)	$ (2,510)	$ (2,321)
Franchise finance
Financial Instruments Owned and Pledged as Collateral [Line Items]
Allowance for loan losses	(1,083)	0
Commercial loans
Financial Instruments Owned and Pledged as Collateral [Line Items]
Total loans	2,363,863	2,515,631
Commercial loans | Commercial and industrial
Financial Instruments Owned and Pledged as Collateral [Line Items]
Total loans	96,008	75,387
Commercial loans | Owner-occupied commercial real estate
Financial Instruments Owned and Pledged as Collateral [Line Items]
Total loans	66,732	89,785
Commercial loans | Investor commercial real estate
Financial Instruments Owned and Pledged as Collateral [Line Items]
Total loans	28,019	13,902
Commercial loans | Construction
Financial Instruments Owned and Pledged as Collateral [Line Items]
Total loans	136,619	110,385
Commercial loans | Single tenant lease financing
Financial Instruments Owned and Pledged as Collateral [Line Items]
Total loans	865,854	950,172
Commercial loans | Public finance
Financial Instruments Owned and Pledged as Collateral [Line Items]
Total loans	592,665	622,257
Commercial loans | Healthcare finance
Financial Instruments Owned and Pledged as Collateral [Line Items]
Total loans	387,852	528,154
Commercial loans | Small business lending
Financial Instruments Owned and Pledged as Collateral [Line Items]
Total loans	108,666	125,589
Commercial loans | Franchise finance
Financial Instruments Owned and Pledged as Collateral [Line Items]
Total loans	81,448	0
Consumer loans
Financial Instruments Owned and Pledged as Collateral [Line Items]
Total loans	469,913	482,336
Consumer loans | Residential mortgage
Financial Instruments Owned and Pledged as Collateral [Line Items]
Total loans	186,770	186,787
Consumer loans | Home equity
Financial Instruments Owned and Pledged as Collateral [Line Items]
Total loans	17,665	19,857
Consumer loans | Other consumer
Financial Instruments Owned and Pledged as Collateral [Line Items]
Total loans	265,478	275,692
Interest rate swaps assets | Commercial loans | Public finance
Financial Instruments Owned and Pledged as Collateral [Line Items]
Total loans	$ 37,500	$ 42,700

Loans - Allowance for Loan Loss

Loans - Allowance for Loan Losses and the Recorded Investment in Loans (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Balance, beginning of year
Balance, beginning of year	$ 29,484	$ 21,840	$ 17,896
Provision charged to expense	1,030	9,325	5,966
Losses charged off	(3,227)	(2,162)	(2,357)
Recoveries	554	481	335
Balance, end of year	27,841	29,484	21,840
Loans:
Ending balance: collectively evaluated for impairment	2,822,836	2,985,682
Ending balance: individually evaluated for impairment	10,940	12,285
Total loans	2,833,776	2,997,967
Ending balance: collectively evaluated for impairment	26,380	26,394
Ending balance: individually evaluated for impairment	1,461	3,090
Ending balance	27,841	29,484	21,840
Commercial and industrial
Balance, beginning of year
Balance, beginning of year	1,146	1,521	1,384
Provision charged to expense	684	80	1,029
Losses charged off	(28)	(461)	(921)
Recoveries	89	6	29
Balance, end of year	1,891	1,146	1,521
Loans:
Ending balance: collectively evaluated for impairment	95,364	74,870
Ending balance: individually evaluated for impairment	644	517
Ending balance: collectively evaluated for impairment	1,441	1,146
Ending balance: individually evaluated for impairment	450	0
Ending balance	1,891	1,146	1,521
Owner-occupied commercial real estate
Balance, beginning of year
Balance, beginning of year	1,082	561	783
Provision charged to expense	(340)	545	(222)
Losses charged off	0	(24)	0
Recoveries	0	0	0
Balance, end of year	742	1,082	561
Loans:
Ending balance: collectively evaluated for impairment	63,387	87,947
Ending balance: individually evaluated for impairment	3,345	1,838
Ending balance: collectively evaluated for impairment	742	1,082
Ending balance: individually evaluated for impairment	0	0
Ending balance	742	1,082	561
Investor commercial real estate
Balance, beginning of year
Balance, beginning of year	155	109	61
Provision charged to expense	173	46	48
Losses charged off	0	0	0
Recoveries	0	0	0
Balance, end of year	328	155	109
Loans:
Ending balance: collectively evaluated for impairment	28,019	13,902
Ending balance: individually evaluated for impairment	0	0
Ending balance: collectively evaluated for impairment	328	155
Ending balance: individually evaluated for impairment	0	0
Ending balance	328	155	109
Construction
Balance, beginning of year
Balance, beginning of year	1,192	380	251
Provision charged to expense	420	812	129
Losses charged off	0	0	0
Recoveries	0	0	0
Balance, end of year	1,612	1,192	380
Loans:
Ending balance: collectively evaluated for impairment	136,619	110,385
Ending balance: individually evaluated for impairment	0	0
Ending balance: collectively evaluated for impairment	1,612	1,192
Ending balance: individually evaluated for impairment	0	0
Ending balance	1,612	1,192	380
Single tenant lease financing
Balance, beginning of year
Balance, beginning of year	12,990	11,175	8,827
Provision charged to expense	(214)	1,815	2,348
Losses charged off	(2,391)	0	0
Recoveries	0	0	0
Balance, end of year	10,385	12,990	11,175
Loans:
Ending balance: collectively evaluated for impairment	864,754	942,848
Ending balance: individually evaluated for impairment	1,100	7,324
Ending balance: collectively evaluated for impairment	10,290	9,900
Ending balance: individually evaluated for impairment	95	3,090
Ending balance	10,385	12,990	11,175
Public finance
Balance, beginning of year
Balance, beginning of year	1,732	1,580	1,670
Provision charged to expense	44	152	(90)
Losses charged off	0	0	0
Recoveries	0	0	0
Balance, end of year	1,776	1,732	1,580
Loans:
Ending balance: collectively evaluated for impairment	592,665	622,257
Ending balance: individually evaluated for impairment	0	0
Ending balance: collectively evaluated for impairment	1,776	1,732
Ending balance: individually evaluated for impairment	0	0
Ending balance	1,776	1,732	1,580
Healthcare finance
Balance, beginning of year
Balance, beginning of year	7,485	3,247	1,264
Provision charged to expense	(1,545)	4,894	1,983
Losses charged off	0	(743)	0
Recoveries	0	87	0
Balance, end of year	5,940	7,485	3,247
Loans:
Ending balance: collectively evaluated for impairment	386,926	527,144
Ending balance: individually evaluated for impairment	926	1,010
Ending balance: collectively evaluated for impairment	5,417	7,485
Ending balance: individually evaluated for impairment	523	0
Ending balance	5,940	7,485	3,247
Small business lending
Balance, beginning of year
Balance, beginning of year	628	54	203
Provision charged to expense	901	665	(154)
Losses charged off	(222)	(110)	0
Recoveries	80	19	5
Balance, end of year	1,387	628	54
Loans:
Ending balance: collectively evaluated for impairment	106,682	125,589
Ending balance: individually evaluated for impairment	1,984	0
Ending balance: collectively evaluated for impairment	994	628
Ending balance: individually evaluated for impairment	393	0
Ending balance	1,387	628	54
Franchise finance
Balance, beginning of year
Balance, beginning of year	0
Provision charged to expense	1,083
Losses charged off	0
Recoveries	0
Balance, end of year	1,083	0
Loans:
Ending balance: collectively evaluated for impairment	81,448
Ending balance: individually evaluated for impairment	0
Ending balance: collectively evaluated for impairment	1,083
Ending balance: individually evaluated for impairment	0
Ending balance	1,083	0
Residential mortgage
Balance, beginning of year
Balance, beginning of year	519	657	1,079
Provision charged to expense	67	(122)	(350)
Losses charged off	(6)	(20)	(76)
Recoveries	63	4	4
Balance, end of year	643	519	657
Loans:
Ending balance: collectively evaluated for impairment	183,852	185,241
Ending balance: individually evaluated for impairment	2,918	1,546
Ending balance: collectively evaluated for impairment	643	519
Ending balance: individually evaluated for impairment	0	0
Ending balance	643	519	657
Home equity
Balance, beginning of year
Balance, beginning of year	48	46	53
Provision charged to expense	60	(9)	51
Losses charged off	(51)	0	(68)
Recoveries	7	11	10
Balance, end of year	64	48	46
Loans:
Ending balance: collectively evaluated for impairment	17,651	19,857
Ending balance: individually evaluated for impairment	14	0
Ending balance: collectively evaluated for impairment	64	48
Ending balance: individually evaluated for impairment	0	0
Ending balance	64	48	46
Other consumer
Balance, beginning of year
Balance, beginning of year	2,507	2,510	2,321
Provision charged to expense	(303)	447	1,194
Losses charged off	(529)	(804)	(1,292)
Recoveries	315	354	287
Balance, end of year	1,990	2,507	2,510
Loans:
Ending balance: collectively evaluated for impairment	265,469	275,642
Ending balance: individually evaluated for impairment	9	50
Ending balance: collectively evaluated for impairment	1,990	2,507
Ending balance: individually evaluated for impairment	0	0
Ending balance	1,990	2,507	$ 2,510
Commercial loans
Loans:
Total loans	2,363,863	2,515,631
Commercial loans | Commercial and industrial
Loans:
Total loans	96,008	75,387
Commercial loans | Owner-occupied commercial real estate
Loans:
Total loans	66,732	89,785
Commercial loans | Investor commercial real estate
Loans:
Total loans	28,019	13,902
Commercial loans | Construction
Loans:
Total loans	136,619	110,385
Commercial loans | Single tenant lease financing
Loans:
Total loans	865,854	950,172
Commercial loans | Public finance
Loans:
Total loans	592,665	622,257
Commercial loans | Healthcare finance
Loans:
Total loans	387,852	528,154
Commercial loans | Small business lending
Loans:
Total loans	108,666	125,589
Commercial loans | Franchise finance
Loans:
Total loans	81,448	0
Consumer loans
Loans:
Total loans	469,913	482,336
Consumer loans | Residential mortgage
Loans:
Total loans	186,770	186,787
Consumer loans | Home equity
Loans:
Total loans	17,665	19,857
Consumer loans | Other consumer
Loans:
Total loans	$ 265,478	$ 275,692

Loans - Credit Risk Profile (De

Loans - Credit Risk Profile (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	$ 2,833,776	$ 2,997,967
Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	7,401	10,183
Commercial loans
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	2,363,863	2,515,631
Commercial loans | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	2,312,655	2,481,795
Commercial loans | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	43,209	17,962
Commercial loans | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	7,998	15,874
Commercial loans | Commercial and industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	96,008	75,387
Commercial loans | Commercial and industrial | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	82,412	74,138
Commercial loans | Commercial and industrial | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	12,952	732
Commercial loans | Commercial and industrial | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	644	517
Commercial loans | Commercial and industrial | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	674	0
Commercial loans | Owner-occupied commercial real estate
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	66,732	89,785
Commercial loans | Owner-occupied commercial real estate | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	59,369	84,292
Commercial loans | Owner-occupied commercial real estate | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	4,018	3,655
Commercial loans | Owner-occupied commercial real estate | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	3,345	1,838
Commercial loans | Owner-occupied commercial real estate | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	0	1,838
Commercial loans | Investor commercial real estate
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	28,019	13,902
Commercial loans | Investor commercial real estate | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	28,019	13,902
Commercial loans | Investor commercial real estate | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	0	0
Commercial loans | Investor commercial real estate | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	0	0
Commercial loans | Investor commercial real estate | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	3,419	0
Commercial loans | Construction
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	136,619	110,385
Commercial loans | Construction | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	124,578	110,385
Commercial loans | Construction | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	12,041	0
Commercial loans | Construction | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	0	0
Commercial loans | Construction | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	0	0
Commercial loans | Single tenant lease financing
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	865,854	950,172
Commercial loans | Single tenant lease financing | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	859,612	932,830
Commercial loans | Single tenant lease financing | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	5,142	10,018
Commercial loans | Single tenant lease financing | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	1,100	7,324
Commercial loans | Single tenant lease financing | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	1,100	7,116
Commercial loans | Public finance
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	592,665	622,257
Commercial loans | Public finance | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	591,630	622,257
Commercial loans | Public finance | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	1,035	0
Commercial loans | Public finance | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	0	0
Commercial loans | Public finance | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	0	0
Commercial loans | Healthcare finance
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	387,852	528,154
Commercial loans | Healthcare finance | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	386,337	526,517
Commercial loans | Healthcare finance | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	589	627
Commercial loans | Healthcare finance | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	926	1,010
Commercial loans | Healthcare finance | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	0	0
Commercial loans | Small business lending
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	108,666	125,589
Commercial loans | Small business lending | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	99,250	117,474
Commercial loans | Small business lending | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	7,432	2,930
Commercial loans | Small business lending | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	1,983	5,185
Commercial loans | Small business lending | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	959	0
Commercial loans | Franchise finance
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	81,448	0
Commercial loans | Franchise finance | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	81,448
Commercial loans | Franchise finance | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	0
Commercial loans | Franchise finance | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	0
Commercial loans | Franchise finance | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	0
Consumer loans
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	469,913	482,336
Consumer loans | Performing
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	468,664	481,107
Consumer loans | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	1,249	1,229
Consumer loans | Residential mortgage
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	186,770	186,787
Consumer loans | Residential mortgage | Performing
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	185,544	185,604
Consumer loans | Residential mortgage | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	1,226	1,183
Consumer loans | Home equity
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	17,665	19,857
Consumer loans | Home equity | Performing
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	17,651	19,857
Consumer loans | Home equity | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	14	0
Consumer loans | Other consumer
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	265,478	275,692
Consumer loans | Other consumer | Performing
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	265,469	275,646
Consumer loans | Other consumer | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans	$ 9	$ 46

Loans - Loan Portfolio Aging An

Loans - Loan Portfolio Aging Analysis (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Financing Receivable, Past Due [Line Items]
Total loans	$ 2,833,776	$ 2,997,967
Total Loans 90 Days or More Past  Due and Accruing	0	0
Commercial and industrial
Financing Receivable, Past Due [Line Items]
Total Loans 90 Days or More Past  Due and Accruing	0	0
Owner-occupied commercial real estate
Financing Receivable, Past Due [Line Items]
Total Loans 90 Days or More Past  Due and Accruing	0	0
Investor commercial real estate
Financing Receivable, Past Due [Line Items]
Total Loans 90 Days or More Past  Due and Accruing	0	0
Construction
Financing Receivable, Past Due [Line Items]
Total Loans 90 Days or More Past  Due and Accruing	0	0
Single tenant lease financing
Financing Receivable, Past Due [Line Items]
Total Loans 90 Days or More Past  Due and Accruing	0	0
Public finance
Financing Receivable, Past Due [Line Items]
Total Loans 90 Days or More Past  Due and Accruing	0	0
Healthcare finance
Financing Receivable, Past Due [Line Items]
Total Loans 90 Days or More Past  Due and Accruing	0	0
Small business lending
Financing Receivable, Past Due [Line Items]
Total Loans 90 Days or More Past  Due and Accruing	0	0
Franchise finance
Financing Receivable, Past Due [Line Items]
Total Loans 90 Days or More Past  Due and Accruing	0
Residential mortgage
Financing Receivable, Past Due [Line Items]
Total Loans 90 Days or More Past  Due and Accruing	0	0
Home equity
Financing Receivable, Past Due [Line Items]
Total Loans 90 Days or More Past  Due and Accruing	0	0
Other consumer
Financing Receivable, Past Due [Line Items]
Total Loans 90 Days or More Past  Due and Accruing	0	0
Total  Past Due
Financing Receivable, Past Due [Line Items]
Total loans	1,126	5,245
30-59 Days Past Due
Financing Receivable, Past Due [Line Items]
Total loans	119	225
60-89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total loans	244	66
90 Days  or More Past Due
Financing Receivable, Past Due [Line Items]
Total loans	763	4,954
Current
Financing Receivable, Past Due [Line Items]
Total loans	2,832,650	2,992,722
Nonaccrual
Financing Receivable, Past Due [Line Items]
Total loans	7,401	10,183
Commercial loans
Financing Receivable, Past Due [Line Items]
Total loans	2,363,863	2,515,631
Commercial loans | Commercial and industrial
Financing Receivable, Past Due [Line Items]
Total loans	96,008	75,387
Commercial loans | Owner-occupied commercial real estate
Financing Receivable, Past Due [Line Items]
Total loans	66,732	89,785
Commercial loans | Investor commercial real estate
Financing Receivable, Past Due [Line Items]
Total loans	28,019	13,902
Commercial loans | Construction
Financing Receivable, Past Due [Line Items]
Total loans	136,619	110,385
Commercial loans | Single tenant lease financing
Financing Receivable, Past Due [Line Items]
Total loans	865,854	950,172
Commercial loans | Public finance
Financing Receivable, Past Due [Line Items]
Total loans	592,665	622,257
Commercial loans | Healthcare finance
Financing Receivable, Past Due [Line Items]
Total loans	387,852	528,154
Commercial loans | Small business lending
Financing Receivable, Past Due [Line Items]
Total loans	108,666	125,589
Commercial loans | Franchise finance
Financing Receivable, Past Due [Line Items]
Total loans	81,448	0
Commercial loans | Total  Past Due | Commercial and industrial
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | Total  Past Due | Owner-occupied commercial real estate
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | Total  Past Due | Investor commercial real estate
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | Total  Past Due | Construction
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | Total  Past Due | Single tenant lease financing
Financing Receivable, Past Due [Line Items]
Total loans	0	4,680
Commercial loans | Total  Past Due | Public finance
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | Total  Past Due | Healthcare finance
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | Total  Past Due | Small business lending
Financing Receivable, Past Due [Line Items]
Total loans	657	0
Commercial loans | Total  Past Due | Franchise finance
Financing Receivable, Past Due [Line Items]
Total loans	0
Commercial loans | 30-59 Days Past Due | Commercial and industrial
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 30-59 Days Past Due | Owner-occupied commercial real estate
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 30-59 Days Past Due | Investor commercial real estate
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 30-59 Days Past Due | Construction
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 30-59 Days Past Due | Single tenant lease financing
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 30-59 Days Past Due | Public finance
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 30-59 Days Past Due | Healthcare finance
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 30-59 Days Past Due | Small business lending
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 30-59 Days Past Due | Franchise finance
Financing Receivable, Past Due [Line Items]
Total loans	0
Commercial loans | 60-89 Days Past Due | Commercial and industrial
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 60-89 Days Past Due | Owner-occupied commercial real estate
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 60-89 Days Past Due | Investor commercial real estate
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 60-89 Days Past Due | Construction
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 60-89 Days Past Due | Single tenant lease financing
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 60-89 Days Past Due | Public finance
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 60-89 Days Past Due | Healthcare finance
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 60-89 Days Past Due | Small business lending
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 60-89 Days Past Due | Franchise finance
Financing Receivable, Past Due [Line Items]
Total loans	0
Commercial loans | 90 Days  or More Past Due | Commercial and industrial
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 90 Days  or More Past Due | Owner-occupied commercial real estate
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 90 Days  or More Past Due | Investor commercial real estate
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 90 Days  or More Past Due | Construction
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 90 Days  or More Past Due | Single tenant lease financing
Financing Receivable, Past Due [Line Items]
Total loans	0	4,680
Commercial loans | 90 Days  or More Past Due | Public finance
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 90 Days  or More Past Due | Healthcare finance
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | 90 Days  or More Past Due | Small business lending
Financing Receivable, Past Due [Line Items]
Total loans	657	0
Commercial loans | 90 Days  or More Past Due | Franchise finance
Financing Receivable, Past Due [Line Items]
Total loans	0
Commercial loans | Current | Commercial and industrial
Financing Receivable, Past Due [Line Items]
Total loans	96,008	75,387
Commercial loans | Current | Owner-occupied commercial real estate
Financing Receivable, Past Due [Line Items]
Total loans	66,732	89,785
Commercial loans | Current | Investor commercial real estate
Financing Receivable, Past Due [Line Items]
Total loans	28,019	13,902
Commercial loans | Current | Construction
Financing Receivable, Past Due [Line Items]
Total loans	136,619	110,385
Commercial loans | Current | Single tenant lease financing
Financing Receivable, Past Due [Line Items]
Total loans	865,854	945,492
Commercial loans | Current | Public finance
Financing Receivable, Past Due [Line Items]
Total loans	592,665	622,257
Commercial loans | Current | Healthcare finance
Financing Receivable, Past Due [Line Items]
Total loans	387,852	528,154
Commercial loans | Current | Small business lending
Financing Receivable, Past Due [Line Items]
Total loans	108,009	125,589
Commercial loans | Current | Franchise finance
Financing Receivable, Past Due [Line Items]
Total loans	81,448
Commercial loans | Nonaccrual | Commercial and industrial
Financing Receivable, Past Due [Line Items]
Total loans	674	0
Commercial loans | Nonaccrual | Owner-occupied commercial real estate
Financing Receivable, Past Due [Line Items]
Total loans	0	1,838
Commercial loans | Nonaccrual | Investor commercial real estate
Financing Receivable, Past Due [Line Items]
Total loans	3,419	0
Commercial loans | Nonaccrual | Construction
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | Nonaccrual | Single tenant lease financing
Financing Receivable, Past Due [Line Items]
Total loans	1,100	7,116
Commercial loans | Nonaccrual | Public finance
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | Nonaccrual | Healthcare finance
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Commercial loans | Nonaccrual | Small business lending
Financing Receivable, Past Due [Line Items]
Total loans	959	0
Commercial loans | Nonaccrual | Franchise finance
Financing Receivable, Past Due [Line Items]
Total loans	0
Consumer loans
Financing Receivable, Past Due [Line Items]
Total loans	469,913	482,336
Consumer loans | Residential mortgage
Financing Receivable, Past Due [Line Items]
Total loans	186,770	186,787
Consumer loans | Home equity
Financing Receivable, Past Due [Line Items]
Total loans	17,665	19,857
Consumer loans | Other consumer
Financing Receivable, Past Due [Line Items]
Total loans	265,478	275,692
Consumer loans | Total  Past Due | Residential mortgage
Financing Receivable, Past Due [Line Items]
Total loans	383	318
Consumer loans | Total  Past Due | Home equity
Financing Receivable, Past Due [Line Items]
Total loans	0	15
Consumer loans | Total  Past Due | Other consumer
Financing Receivable, Past Due [Line Items]
Total loans	86	232
Consumer loans | 30-59 Days Past Due | Residential mortgage
Financing Receivable, Past Due [Line Items]
Total loans	51	49
Consumer loans | 30-59 Days Past Due | Home equity
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Consumer loans | 30-59 Days Past Due | Other consumer
Financing Receivable, Past Due [Line Items]
Total loans	68	176
Consumer loans | 60-89 Days Past Due | Residential mortgage
Financing Receivable, Past Due [Line Items]
Total loans	226	0
Consumer loans | 60-89 Days Past Due | Home equity
Financing Receivable, Past Due [Line Items]
Total loans	0	15
Consumer loans | 60-89 Days Past Due | Other consumer
Financing Receivable, Past Due [Line Items]
Total loans	18	51
Consumer loans | 90 Days  or More Past Due | Residential mortgage
Financing Receivable, Past Due [Line Items]
Total loans	106	269
Consumer loans | 90 Days  or More Past Due | Home equity
Financing Receivable, Past Due [Line Items]
Total loans	0	0
Consumer loans | 90 Days  or More Past Due | Other consumer
Financing Receivable, Past Due [Line Items]
Total loans	0	5
Consumer loans | Current | Residential mortgage
Financing Receivable, Past Due [Line Items]
Total loans	186,387	186,469
Consumer loans | Current | Home equity
Financing Receivable, Past Due [Line Items]
Total loans	17,665	19,842
Consumer loans | Current | Other consumer
Financing Receivable, Past Due [Line Items]
Total loans	265,392	275,460
Consumer loans | Nonaccrual
Financing Receivable, Past Due [Line Items]
Total loans	1,249	1,229
Consumer loans | Nonaccrual | Residential mortgage
Financing Receivable, Past Due [Line Items]
Total loans	1,226	1,183
Consumer loans | Nonaccrual | Home equity
Financing Receivable, Past Due [Line Items]
Total loans	14	0
Consumer loans | Nonaccrual | Other consumer
Financing Receivable, Past Due [Line Items]
Total loans	$ 9	$ 46

Loans - Impaired Loans (Details

Loans - Impaired Loans (Details)	12 Months Ended
	Dec. 31, 2021USD ($)loancontract	Dec. 31, 2020USD ($)contract	Dec. 31, 2019USD ($)contract
Loans without a specific valuation allowance
Recorded Balance	$ 7,245,000	$ 6,276,000
Unpaid Principal Balance	7,781,000	6,483,000
Average Balance	7,366,000	6,603,000	$ 9,259,000
Interest Income	81,000	133,000	554,000
Loans with a specific valuation allowance
Recorded Balance	3,695,000	6,009,000
Unpaid Principal Balance	3,751,000	6,036,000
Specific Allowance	1,461,000	3,090,000
Average Balance	6,446,000	5,840,000	2,541,000
Interest Income	131,000	7,000	0
Total impaired loans
Recorded Balance	10,940,000	12,285,000
Unpaid Principal Balance	11,532,000	12,519,000
Specific Allowance	1,461,000	3,090,000
Average Balance	13,812,000	12,443,000	11,800,000
Interest Income	212,000	140,000	554,000
Other real estate owned	$ 1,188,000	0
Mortgage loans in process of foreclosure, number of loans | loan	1
Mortgage loans in process of foreclosure, amount	$ 100,000	0
Modifications, recorded Investment			2,000,000
Commercial and industrial
Loans without a specific valuation allowance
Recorded Balance	0	517,000
Unpaid Principal Balance	0	517,000
Average Balance	194,000	1,037,000	3,293,000
Interest Income	9,000	57,000	289,000
Loans with a specific valuation allowance
Recorded Balance	644,000	0
Unpaid Principal Balance	677,000	0
Specific Allowance	450,000	0
Average Balance	675,000	169,000	1,077,000
Interest Income	$ 0	$ 3,000	$ 0
Total impaired loans
OREO number of loans | loan	1
Modifications, number of contracts | contract	2	3	4
Modifications, recorded Investment	$ 1,600,000	$ 2,600,000
Owner-occupied commercial real estate
Loans without a specific valuation allowance
Recorded Balance	3,345,000	1,838,000
Unpaid Principal Balance	3,466,000	1,850,000
Average Balance	3,324,000	3,790,000	$ 3,292,000
Interest Income	0	60,000	170,000
Loans with a specific valuation allowance
Average Balance	355,000	0	0
Interest Income	0	0	0
Single tenant lease financing
Loans without a specific valuation allowance
Recorded Balance	0	1,315,000
Unpaid Principal Balance	0	1,334,000
Average Balance	75,000	0	0
Interest Income	5,000	0	0
Loans with a specific valuation allowance
Recorded Balance	1,100,000	6,009,000
Unpaid Principal Balance	1,123,000	6,036,000
Specific Allowance	95,000	3,090,000
Average Balance	3,931,000	5,671,000	1,464,000
Interest Income	0	4,000	0
Healthcare finance
Loans without a specific valuation allowance
Recorded Balance	0	1,010,000
Unpaid Principal Balance	0	1,010,000
Average Balance	252,000	386,000	0
Interest Income	0	16,000	0
Loans with a specific valuation allowance
Recorded Balance	926,000	0
Unpaid Principal Balance	926,000	0
Specific Allowance	523,000	0
Average Balance	841,000	0	0
Interest Income	131,000	0	0
Small business lending
Loans without a specific valuation allowance
Recorded Balance	959,000	0
Unpaid Principal Balance	1,193,000	0
Average Balance	1,215,000	0	331,000
Interest Income	0	0	94,000
Loans with a specific valuation allowance
Recorded Balance	1,025,000	0
Unpaid Principal Balance	1,025,000	0
Specific Allowance	393,000	0
Average Balance	644,000	0	0
Interest Income	0	0	0
Residential mortgage
Loans without a specific valuation allowance
Recorded Balance	2,918,000	1,546,000
Unpaid Principal Balance	3,063,000	1,652,000
Average Balance	2,264,000	1,333,000	2,265,000
Interest Income	67,000	0	0
Home equity
Loans without a specific valuation allowance
Recorded Balance	14,000	0
Unpaid Principal Balance	15,000	0
Average Balance	13,000	0	10,000
Interest Income	0	0	0
Other consumer
Loans without a specific valuation allowance
Recorded Balance	9,000	50,000
Unpaid Principal Balance	44,000	120,000
Average Balance	29,000	57,000	68,000
Interest Income	0	0	$ 1,000
Construction
Loans with a specific valuation allowance
Recorded Balance	0	0
Unpaid Principal Balance	0	0
Specific Allowance	$ 0	$ 0

Loans - Non-TDR Loan Modificati

Loans - Non-TDR Loan Modifications due to COVID-19 (Details) $ in Millions	Dec. 31, 2021USD ($)
Payment Deferral | COVID-19 Modification
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-TDR loan modifications due to COVID-19	$ 10.5

Premises and Equipment (Details

Premises and Equipment (Details) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Less: accumulated depreciation		$ (6,725)	$ (10,973)
Premises and equipment, Net		59,842	37,590
Gain on sale of premises and equipment		2,523	0	$ 0
Land
Property, Plant and Equipment [Line Items]
Premises and equipment		0	2,500
Construction in process
Property, Plant and Equipment [Line Items]
Premises and equipment		57,469	28,754
Right of use leased asset
Property, Plant and Equipment [Line Items]
Premises and equipment		208	819
Building and improvements
Property, Plant and Equipment [Line Items]
Premises and equipment		1,090	5,819
Furniture and equipment
Property, Plant and Equipment [Line Items]
Premises and equipment		7,800	$ 10,671
Fishers Town Hall Building Corporation | Land Acquisition | SPF15, Inc.
Property, Plant and Equipment [Line Items]
Payments to acquire land	$ 11,200
Fishers Town Hall Building Corporation | Parking Garage | SPF15, Inc.
Property, Plant and Equipment [Line Items]
Payments to acquire parking garage	$ 15,000
Third Parties
Property, Plant and Equipment [Line Items]
Gain on sale of premises and equipment		$ 2,500

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 4,687	$ 4,687

Servicing Asset (Details)

Servicing Asset (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Servicing Asset at Fair Value, Amount [Roll Forward]
Beginning balance			$ 3,569	$ 2,481	$ 0
Additions			2,202	1,520	2,481
Paydowns	$ (820)	$ (524)			0
Changes in fair value	(249)	92			0
Loan servicing asset revaluation	(1,069)	(432)			0
Ending balance	$ 4,702	$ 3,569	$ 4,702	$ 3,569	$ 2,481

Servicing Asset - Unpaid princi

Servicing Asset - Unpaid principal balance (Details) - Loan servicing - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Servicing Assets at Fair Value [Line Items]
Loans serviced for others	$ 230,514	$ 165,961
SBA guaranteed loans
Servicing Assets at Fair Value [Line Items]
Loans serviced for others	$ 230,514	$ 165,961

Servicing Asset - Narrative (De

Servicing Asset - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Servicing Assets at Fair Value [Line Items]
Changes in fair value	$ (249)	$ 92			$ 0
Loan servicing
Servicing Assets at Fair Value [Line Items]
Noninterest income			$ 1,934	$ 1,159	$ 166
Changes in fair value			$ 1,100	$ 400

Deposits (Details)

Deposits (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Deposits [Abstract]
Noninterest-bearing demand deposit accounts	$ 117,531	$ 96,753
Interest-bearing demand deposit accounts	247,967	188,645
Savings accounts	59,998	43,200
Money market accounts	1,483,936	1,350,566
Certificates of deposits	970,107	1,289,319
Brokered deposits	299,420	302,402
Total deposits	3,178,959	3,270,885
Time deposits greater than $250	$ 327,490	$ 403,253

Deposits - Scheduled Maturities

Deposits - Scheduled Maturities (Details) $ in Thousands	Dec. 31, 2021USD ($)
Certificates of Deposits
Cash and Cash Equivalents [Line Items]
2022	$ 618,091
2023	190,045
2024	97,940
2025	29,452
2026	34,579
Time Deposits, Total	970,107
Brokered Certificates of Deposits
Cash and Cash Equivalents [Line Items]
2022	129,461
2023	18,628
2024	1,490
2025	0
2026	0
Time Deposits, Total	$ 149,579

Deposits (Details Textual)

Deposits (Details Textual) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Deposits [Abstract]
Time deposits greater than $250	$ 327,490	$ 403,253

FHLB Advances (Details)

FHLB Advances (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Federal Home Loan Banks [Abstract]
2022	$ 110,000
2023	35,000
2024	145,014
2025	90,000
2026	10,000
Thereafter	124,908
Total	$ 514,922	$ 514,900

FHLB Advances (Details Textual)

FHLB Advances (Details Textual) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
FHLB Advances	$ 514,922,000	$ 514,900,000
Investment securities pledged	474,500,000	351,000,000
Maximum borrowing capacity	$ 579,900,000
Minimum
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
Interest rate (as a percent)	0.25%
Maximum
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
Interest rate (as a percent)	3.26%
Weighted Average
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
Interest rate (as a percent)	1.65%
Federal Home Loan Bank, Advances, Putable Option
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
Variable rate advances	$ 125,000,000
Residential mortgage
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
Loans pledged	128,800,000	125,100,000
Commercial and industrial
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
Loans pledged	$ 920,900,000	$ 960,500,000

Subordinated Debt (Details Text

Subordinated Debt (Details Textual) - Subordinated Debt - USD ($)	1 Months Ended
	Aug. 31, 2021	Oct. 31, 2020	Jun. 30, 2019	Sep. 30, 2016	Oct. 20, 2015
6.4375% Notes Due 2025
Debt Instrument [Line Items]
Principal amount					$ 10,000,000
Annual rate (as a percent)					6.4375%
6.0% Fixed To Floating Rate Subordinated Notes Due 2026
Debt Instrument [Line Items]
Principal amount				$ 25,000,000
Annual rate (as a percent)				6.00%
6% Fixed To Floating Rate Subordinated Notes Due 2029
Debt Instrument [Line Items]
Principal amount			$ 37,000,000
Annual rate (as a percent)			6.00%
6.0% Term Note Due 2030
Debt Instrument [Line Items]
Principal amount		$ 10,000,000
Annual rate (as a percent)		6.00%
3.75% Notes Due 2031
Debt Instrument [Line Items]
Principal amount	$ 60,000,000
Annual rate (as a percent)	3.75%
LIBOR | 6.0% Fixed To Floating Rate Subordinated Notes Due 2026
Debt Instrument [Line Items]
Basis spread on variable rate				4.85%
LIBOR | 6% Fixed To Floating Rate Subordinated Notes Due 2029
Debt Instrument [Line Items]
Basis spread on variable rate			4.11%
SOFR | 6.0% Term Note Due 2030
Debt Instrument [Line Items]
Basis spread on variable rate		5.795%
SOFR | 3.75% Notes Due 2031
Debt Instrument [Line Items]
Basis spread on variable rate	3.11%

Subordinated Debt - Schedule Of

Subordinated Debt - Schedule Of Subordinated Debt (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Principal	$ 514,922	$ 514,916
Unamortized Discount and Debt Issuance Costs	(2,769)	(2,397)
Subordinated Debt
Debt Instrument [Line Items]
Principal	107,000	82,000
Unamortized Discount and Debt Issuance Costs	(2,769)	(2,397)
Subordinated Debt | 6.4375% Notes Due 2025
Debt Instrument [Line Items]
Principal	0	10,000
Unamortized Discount and Debt Issuance Costs	0	(114)
Subordinated Debt | 6.0% Fixed To Floating Rate Subordinated Notes Due 2026
Debt Instrument [Line Items]
Principal	0	25,000
Unamortized Discount and Debt Issuance Costs	0	(715)
Subordinated Debt | 6% Fixed To Floating Rate Subordinated Notes Due 2029
Debt Instrument [Line Items]
Principal	37,000	37,000
Unamortized Discount and Debt Issuance Costs	(1,178)	(1,337)
Subordinated Debt | 6.0% Term Note Due 2030
Debt Instrument [Line Items]
Principal	10,000	10,000
Unamortized Discount and Debt Issuance Costs	(208)	(231)
Subordinated Debt | 3.75% Notes Due 2031
Debt Instrument [Line Items]
Principal	60,000	0
Unamortized Discount and Debt Issuance Costs	$ (1,383)	$ 0

Benefit Plans - Restricted Stoc

Benefit Plans - Restricted Stock (Details)	12 Months Ended
	Dec. 31, 2021$ / sharesshares
Restricted Stock Units
Restricted Stock Awards (in shares)
Nonvested at beginning of period | shares	112,985
Granted | shares	60,111
Vested | shares	(60,274)
Forfeited | shares	0
Nonvested at end of period | shares	112,822
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)
Weighted-Average Grant Date Fair Value Per Share Nonvested, Beginning Balance (in dollars per share) | $ / shares	$ 27.76
Weighted-Average Grant Date Fair Value Per Share Granted (in dollars per share) | $ / shares	30.42
Weighted-Average Grant Date Fair Value Per Share Vested (in dollars per share) | $ / shares	29.64
Weighted-Average Grant Date Fair Value Per Share Forfeited (in dollars per share) | $ / shares	0
Weighted-Average Grant Date Fair Value Per Share Nonvested, Ending Balance (in dollars per share) | $ / shares	$ 28.18
Restricted Stock Awards
Restricted Stock Awards (in shares)
Nonvested at beginning of period | shares	0
Granted | shares	14,180
Vested | shares	(13,123)
Forfeited | shares	(1,057)
Nonvested at end of period | shares	0
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)
Weighted-Average Grant Date Fair Value Per Share Nonvested, Beginning Balance (in dollars per share) | $ / shares	$ 0
Weighted-Average Grant Date Fair Value Per Share Granted (in dollars per share) | $ / shares	30.54
Weighted-Average Grant Date Fair Value Per Share Vested (in dollars per share) | $ / shares	30.58
Weighted-Average Grant Date Fair Value Per Share Forfeited (in dollars per share) | $ / shares	30.13
Weighted-Average Grant Date Fair Value Per Share Nonvested, Ending Balance (in dollars per share) | $ / shares	$ 0
Deferred Stock Units
Restricted Stock Awards (in shares)
Nonvested at beginning of period | shares	0
Granted | shares	8
Vested | shares	(8)
Forfeited | shares	0
Nonvested at end of period | shares	0
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)
Weighted-Average Grant Date Fair Value Per Share Nonvested, Beginning Balance (in dollars per share) | $ / shares	$ 0
Weighted-Average Grant Date Fair Value Per Share Granted (in dollars per share) | $ / shares	32.18
Weighted-Average Grant Date Fair Value Per Share Vested (in dollars per share) | $ / shares	32.18
Weighted-Average Grant Date Fair Value Per Share Forfeited (in dollars per share) | $ / shares	0
Weighted-Average Grant Date Fair Value Per Share Nonvested, Ending Balance (in dollars per share) | $ / shares	$ 0

Benefit Plans - Deferred Stock

Benefit Plans - Deferred Stock Rights (Details)	12 Months Ended
	Dec. 31, 2021shares
Deferred Rights (in shares)
Outstanding, beginning of year	83,835
Granted	701
Exercised	0
Outstanding, end of year	84,536

Benefit Plans (Details Textual)

Benefit Plans (Details Textual) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contributions	$ 0.9	$ 0.8	$ 0.6
Vesting (as a percent)	50.00%
Unrecognized compensation cost	$ 2
Weighted average expense recognition period (in years)	1 year 7 months 6 days
Employer matching contribution description	The Company has a 401(k) plan established for substantially all full-time employees, as defined. Employee contributions are limited to the maximum established by the Internal Revenue Service on an annual basis. The Company has elected to match contributions equal to 100% of the first 1% of employee deferrals and then 50% on deferrals over 1% up to a maximum of 6% of an individuals total eligible salary, as defined by the plan.
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee deferral (as a percent)	1.00%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee deferral (as a percent)	6.00%
Vesting period (in years)	2 years
Equity Incentive Plan 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized	750,000
Share-based compensation expense	$ 2.4	$ 2.1	$ 1.7
Directors Deferred Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contributions (as a percent)	100.00%
Employee deferral (as a percent)	1.00%
Number of shares available for future issuance	180,000

Income Taxes - Provisions (Cred

Income Taxes - Provisions (Credit) for Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Current	$ 6,024	$ 8,563	$ 6,319
Deferred	2,434	(4,118)	(4,402)
Total	$ 8,458	$ 4,445	$ 1,917

Income Taxes - Income Tax Recon

Income Taxes - Income Tax Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Statutory rate times pre-tax income	$ 11,880	$ 7,119	$ 5,703
(Subtract) add the tax effect of:
Income from tax-exempt securities and loans	(4,217)	(4,464)	(4,881)
State income tax, net of federal tax effect	865	1,765	1,285
Bank-owned life insurance	(199)	(200)	(198)
Tax credits	(175)	(178)	(181)
Other differences	304	403	189
Total	$ 8,458	$ 4,445	$ 1,917

Income Taxes - Net Deferred Tax

Income Taxes - Net Deferred Taxes (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Deferred tax assets (liabilities)
Allowance for loan losses	$ 7,517	$ 7,961
Net unrealized losses on available-for-sale securities and hedged items	4,835	5,800
Fair value adjustments	(618)	1,117
Depreciation	(100)	(107)
Deferred compensation and accrued payroll	1,577	1,533
Loan origination costs	(1,311)	(1,281)
Prepaid assets	(641)	(553)
Other	149	337
Total deferred tax assets, net	$ 11,408	$ 14,807

Related Party Transactions (Det

Related Party Transactions (Details Textual) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Related Party Transactions [Abstract]
Deposits	$ 40.2	$ 33

Regulatory Capital Requiremen_3

Regulatory Capital Requirements - Required Ratios (Details)	Jan. 01, 2019
Mortgage Banking [Abstract]
Minimum ratio of Common Equity Tier 1 capital to risk-weighed assets	4.50%
Minimum ratio of Common Equity Tier 1 capital to risk-weighed assets, capital conservation buffer	2.50%
Tier 1 common equity, (to risk-weighted assets), Minimum Capital Requirement, Ratio (as a percent)	7.00%
Minimum ratio of Tier 1 capital to risk-weighted assets	6.00%
Tier 1 capital (to risk-weighted assets), Minimum Capital Requirement, Ratio (as a percent)	0.085
Minimum ratio of Total capital to risk-weighted assets	8.00%
Capital Required for Capital Adequacy to Risk Weighted Assets	0.105
Tier 1 capital (to average assets), Minimum Capital Requirement, Ratio (as a percent)	0.040

Regulatory Capital Requiremen_4

Regulatory Capital Requirements (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Jan. 01, 2019
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
Tier 1 common equity, (to risk-weighted assets), Actual Amount	$ 384,499	$ 342,159
Tier 1 common equity, (to risk-weighted assets), Actual Ratio (as a percent)	12.93%	11.31%
Tier 1 common equity, (to risk-weighted assets), Minimum Capital Requirement, Ratio (as a percent)			7.00%
Capital	$ 516,571	$ 451,246
Capital to Risk Weighted Assets	0.1737	0.1491
Capital Required for Capital Adequacy to Risk Weighted Assets			0.105
Tier 1 capital (to risk-weighted assets), Actual Amount	$ 384,499	$ 342,159
Tier 1 capital (to risk-weighted assets), Actual Ratio (as a percent)	0.1293	0.1131
Tier 1 capital (to risk-weighted assets), Minimum Capital Requirement, Ratio (as a percent)			0.085
Tier 1 capital (to average assets), Actual Amount	$ 384,499	$ 342,159
Tier 1 capital (to average assets), Actual Ratio (as a percent)	0.0922	0.0795
Tier 1 capital (to average assets), Minimum Capital Requirement, Ratio (as a percent)			0.040
Bank
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
Tier 1 common equity, (to risk-weighted assets), Actual Amount	$ 432,181	$ 377,678
Tier 1 common equity, (to risk-weighted assets), Actual Ratio (as a percent)	14.55%	12.49%
Tier One Common Equity Required to be Well Capitalized	$ 193,062	$ 196,497
Tier One Common Equity Required to be Well Capitalized to Risk Weighted Assets	6.50%	6.50%
Capital	$ 460,022	$ 407,162
Capital to Risk Weighted Assets	0.1549	0.1347
Capital Required to be Well Capitalized	$ 297,019	$ 302,303
Capital Required to be Well Capitalized to Risk Weighted Assets	0.1000	0.1000
Tier 1 capital (to risk-weighted assets), Actual Amount	$ 432,181	$ 377,678
Tier 1 capital (to risk-weighted assets), Actual Ratio (as a percent)	0.1455	0.1249
Tier 1 capital (to risk-weighted assets), Minimum to be Wel Capitalized Under Prompt Corrective Actions, Amount	$ 237,615	$ 241,842
Tier 1 capital (to risk-weighted assets), Minimum to be Wel Capitalized Under Prompt Corrective Actions, Ratio (as a percent)	0.0800	0.0800
Tier 1 capital (to average assets), Actual Amount	$ 432,181	$ 377,678
Tier 1 capital (to average assets), Actual Ratio (as a percent)	0.1037	0.0878
Tier 1 capital (to average assets), Minimum to be Well Capitalized Under Prompt Corrective Actions, Amount	$ 208,366	$ 215,045
Tier 1 capital (to average assets), Minimum to be Well Capitalized Under Prompt Corrective Actions, Ratio (as a percent)	0.0500	0.0500
2016 Period
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
Tier 1 common equity, (to risk-weighted assets), Minimum Capital Requirement, Actual Amount			$ 208,202
Tier 1 common equity, (to risk-weighted assets), Minimum Capital Requirement, Ratio (as a percent)			7.00%
Capital Required for Capital Adequacy			$ 312,303
Capital Required for Capital Adequacy to Risk Weighted Assets			0.1050
Tier 1 capital (to risk-weighted assets), Minimum Capital Requirement, Amount			$ 252,817
Tier 1 capital (to risk-weighted assets), Minimum Capital Requirement, Ratio (as a percent)			0.0850
Tier 1 capital (to average assets), Minimum Capital Requirement, Amount			$ 166,824
Tier 1 capital (to average assets), Minimum Capital Requirement, Ratio (as a percent)			0.0400
2016 Period | Bank
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
Tier 1 common equity, (to risk-weighted assets), Minimum Capital Requirement, Actual Amount			$ 207,913
Tier 1 common equity, (to risk-weighted assets), Minimum Capital Requirement, Ratio (as a percent)			7.00%
Capital Required for Capital Adequacy			$ 311,870
Capital Required for Capital Adequacy to Risk Weighted Assets			0.1050
Tier 1 capital (to risk-weighted assets), Minimum Capital Requirement, Amount			$ 252,466
Tier 1 capital (to risk-weighted assets), Minimum Capital Requirement, Ratio (as a percent)			0.0850
Tier 1 capital (to average assets), Minimum Capital Requirement, Amount			$ 166,693
Tier 1 capital (to average assets), Minimum Capital Requirement, Ratio (as a percent)			0.0400
Two Thousand Fifteen Period
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
Tier 1 common equity, (to risk-weighted assets), Minimum Capital Requirement, Actual Amount			$ 211,828
Tier 1 common equity, (to risk-weighted assets), Minimum Capital Requirement, Ratio (as a percent)			7.00%
Capital Required for Capital Adequacy			$ 317,742
Capital Required for Capital Adequacy to Risk Weighted Assets			0.1050
Tier 1 capital (to risk-weighted assets), Minimum Capital Requirement, Amount			$ 257,220
Tier 1 capital (to risk-weighted assets), Minimum Capital Requirement, Ratio (as a percent)			0.0850
Tier 1 capital (to average assets), Minimum Capital Requirement, Amount			$ 172,154
Tier 1 capital (to average assets), Minimum Capital Requirement, Ratio (as a percent)			0.0400
Two Thousand Fifteen Period | Bank
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]
Tier 1 common equity, (to risk-weighted assets), Minimum Capital Requirement, Actual Amount			$ 211,612
Tier 1 common equity, (to risk-weighted assets), Minimum Capital Requirement, Ratio (as a percent)			7.00%
Capital Required for Capital Adequacy			$ 317,418
Capital Required for Capital Adequacy to Risk Weighted Assets			0.1050
Tier 1 capital (to risk-weighted assets), Minimum Capital Requirement, Amount			$ 256,957
Tier 1 capital (to risk-weighted assets), Minimum Capital Requirement, Ratio (as a percent)			0.0850
Tier 1 capital (to average assets), Minimum Capital Requirement, Amount			$ 172,036
Tier 1 capital (to average assets), Minimum Capital Requirement, Ratio (as a percent)			0.0400

Commitments and Credit Risk (De

Commitments and Credit Risk (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Other Commitments [Line Items]
Loan commitments	$ 324.3	$ 263.9
Capital Addition Purchase Commitments
Other Commitments [Line Items]
Construction related contract commitment	68.3
Construction related contract commitment, not yet incurred	$ 14.8
Construction related contract commitment, term	1 year

Fair Value of Financial Instr_3

Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Debt Securities, Available-for-sale [Line Items]
Fair Value	$ 603,044	$ 497,628
Servicing asset, at fair value	4,702	3,569
Loans held-for-sale (mandatory pricing agreements)	23,233	26,341
Derivative, fair value	(14,301)	(30,390)
Loans held for sale
Debt Securities, Available-for-sale [Line Items]
Loans held-for-sale (mandatory pricing agreements)	23,233	26,341
Interest rate swaps assets | Interest rate swaps assets
Debt Securities, Available-for-sale [Line Items]
Derivative liability, fair value	(14,271)	(29,750)
Forward contracts | Forward contracts
Debt Securities, Available-for-sale [Line Items]
Derivative, fair value	(30)	(640)
U.S. Government-sponsored agencies
Debt Securities, Available-for-sale [Line Items]
Fair Value	49,040	60,545
Municipal securities
Debt Securities, Available-for-sale [Line Items]
Fair Value	77,033	82,489
Agency mortgage-backed securities - residential
Debt Securities, Available-for-sale [Line Items]
Fair Value	373,236	214,330
Private label mortgage-backed securities - residential
Debt Securities, Available-for-sale [Line Items]
Fair Value	16,021	58,116
Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Fair Value	5,004	4,961
Corporate securities
Debt Securities, Available-for-sale [Line Items]
Fair Value	46,384	47,596
IRLCs
Debt Securities, Available-for-sale [Line Items]
Derivative, fair value	718	3,361
Agency mortgage-backed securities - commercial
Debt Securities, Available-for-sale [Line Items]
Fair Value	36,326	29,591
Quoted Prices in Active Markets for Identical Assets (Level 1)
Debt Securities, Available-for-sale [Line Items]
Fair Value	0	0
Servicing asset, at fair value	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Loans held for sale
Debt Securities, Available-for-sale [Line Items]
Loans held-for-sale (mandatory pricing agreements)	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Interest rate swaps assets | Interest rate swaps assets
Debt Securities, Available-for-sale [Line Items]
Derivative liability, fair value	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Forward contracts | Forward contracts
Debt Securities, Available-for-sale [Line Items]
Derivative, fair value	(30)	(640)
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. Government-sponsored agencies
Debt Securities, Available-for-sale [Line Items]
Fair Value	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Municipal securities
Debt Securities, Available-for-sale [Line Items]
Fair Value	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Agency mortgage-backed securities - residential
Debt Securities, Available-for-sale [Line Items]
Fair Value	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Private label mortgage-backed securities - residential
Debt Securities, Available-for-sale [Line Items]
Fair Value	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Fair Value	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate securities
Debt Securities, Available-for-sale [Line Items]
Fair Value	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | IRLCs
Debt Securities, Available-for-sale [Line Items]
Derivative, fair value	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Agency mortgage-backed securities - commercial
Debt Securities, Available-for-sale [Line Items]
Fair Value	0	0
Significant Other Observable Inputs (Level 2)
Debt Securities, Available-for-sale [Line Items]
Fair Value	603,044	497,628
Servicing asset, at fair value	0	0
Significant Other Observable Inputs (Level 2) | Loans held for sale
Debt Securities, Available-for-sale [Line Items]
Loans held-for-sale (mandatory pricing agreements)	23,233	26,341
Significant Other Observable Inputs (Level 2) | Interest rate swaps assets | Interest rate swaps assets
Debt Securities, Available-for-sale [Line Items]
Derivative liability, fair value	(14,271)	(29,750)
Significant Other Observable Inputs (Level 2) | Forward contracts | Forward contracts
Debt Securities, Available-for-sale [Line Items]
Derivative, fair value	0	0
Significant Other Observable Inputs (Level 2) | U.S. Government-sponsored agencies
Debt Securities, Available-for-sale [Line Items]
Fair Value	49,040	60,545
Significant Other Observable Inputs (Level 2) | Municipal securities
Debt Securities, Available-for-sale [Line Items]
Fair Value	77,033	82,489
Significant Other Observable Inputs (Level 2) | Agency mortgage-backed securities - residential
Debt Securities, Available-for-sale [Line Items]
Fair Value	373,236	214,330
Significant Other Observable Inputs (Level 2) | Private label mortgage-backed securities - residential
Debt Securities, Available-for-sale [Line Items]
Fair Value		58,116
Significant Other Observable Inputs (Level 2) | Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Fair Value	5,004	4,961
Significant Other Observable Inputs (Level 2) | Corporate securities
Debt Securities, Available-for-sale [Line Items]
Fair Value	46,384	47,596
Significant Other Observable Inputs (Level 2) | IRLCs
Debt Securities, Available-for-sale [Line Items]
Derivative, fair value	0	0
Significant Other Observable Inputs (Level 2) | Agency mortgage-backed securities - commercial
Debt Securities, Available-for-sale [Line Items]
Fair Value	36,326	29,591
Significant Unobservable Inputs (Level 3)
Debt Securities, Available-for-sale [Line Items]
Fair Value	0	0
Servicing asset, at fair value	4,702	3,569
Significant Unobservable Inputs (Level 3) | Loans held for sale
Debt Securities, Available-for-sale [Line Items]
Loans held-for-sale (mandatory pricing agreements)	0	0
Significant Unobservable Inputs (Level 3) | Interest rate swaps assets | Interest rate swaps assets
Debt Securities, Available-for-sale [Line Items]
Derivative liability, fair value	0	0
Significant Unobservable Inputs (Level 3) | Forward contracts | Forward contracts
Debt Securities, Available-for-sale [Line Items]
Derivative, fair value	0	0
Significant Unobservable Inputs (Level 3) | U.S. Government-sponsored agencies
Debt Securities, Available-for-sale [Line Items]
Fair Value	0	0
Significant Unobservable Inputs (Level 3) | Municipal securities
Debt Securities, Available-for-sale [Line Items]
Fair Value	0	0
Significant Unobservable Inputs (Level 3) | Agency mortgage-backed securities - residential
Debt Securities, Available-for-sale [Line Items]
Fair Value	0	0
Significant Unobservable Inputs (Level 3) | Private label mortgage-backed securities - residential
Debt Securities, Available-for-sale [Line Items]
Fair Value	0	0
Significant Unobservable Inputs (Level 3) | Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Fair Value	0	0
Significant Unobservable Inputs (Level 3) | Corporate securities
Debt Securities, Available-for-sale [Line Items]
Fair Value	0	0
Significant Unobservable Inputs (Level 3) | IRLCs
Debt Securities, Available-for-sale [Line Items]
Derivative, fair value	718	3,361
Significant Unobservable Inputs (Level 3) | Agency mortgage-backed securities - commercial
Debt Securities, Available-for-sale [Line Items]
Fair Value		$ 0

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Fair Value Roll Forward (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Servicing asset
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 3,569	$ 2,481	$ 0
Additions	2,202	1,520	2,481
Paydowns	(820)	(524)
Changes in fair value	(249)	92	0
Ending balance	4,702	3,569	2,481
IRLCs
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	3,361	910	389
Additions	0	0	0
Paydowns	0	0
Changes in fair value	(2,643)	2,451	521
Ending balance	$ 718	$ 3,361	$ 910

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Quantative Information About Unobservable Inputs (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Impaired loans	$ 3,695	$ 6,009
Servicing asset	4,702	3,569
Quoted Prices in Active Markets for Identical Assets (Level 1)
Servicing asset	0	0
Significant Other Observable Inputs (Level 2)
Servicing asset	0	0
Significant Unobservable Inputs (Level 3)
Servicing asset	4,702	3,569
Impaired loans | Significant Unobservable Inputs (Level 3)
Impaired loans	1,228	4,026
IRLCs | Significant Unobservable Inputs (Level 3)
IRLCs Fair Value	718	3,361
Servicing asset | Significant Unobservable Inputs (Level 3)
Servicing asset	$ 4,702	$ 3,569
Discount for type of property and current market conditions | Fair value of collateral | Impaired loans | Significant Unobservable Inputs (Level 3)
Impaired Financing Receivable, Measurement Input		10.00%
Discount for type of property and current market conditions | Fair value of collateral | Impaired loans | Significant Unobservable Inputs (Level 3) | Minimum
Impaired Financing Receivable, Measurement Input	0.00%
Discount for type of property and current market conditions | Fair value of collateral | Impaired loans | Significant Unobservable Inputs (Level 3) | Maximum
Impaired Financing Receivable, Measurement Input	35.00%
Discount for type of property and current market conditions | Fair value of collateral | Impaired loans | Significant Unobservable Inputs (Level 3) | Weighted Average
Impaired Financing Receivable, Measurement Input	10.10%	10.00%
Loan closing rates | Discounted cash flow | IRLCs | Significant Unobservable Inputs (Level 3) | Minimum
IRLC, Range, Loan closing rates (as a percent)	42.00%	44.00%
Loan closing rates | Discounted cash flow | IRLCs | Significant Unobservable Inputs (Level 3) | Maximum
IRLC, Range, Loan closing rates (as a percent)	100.00%	100.00%
Loan closing rates | Discounted cash flow | IRLCs | Significant Unobservable Inputs (Level 3) | Weighted Average
IRLC, Range, Loan closing rates (as a percent)	89.00%	87.00%
Discount rate | Discounted cash flow | Servicing asset | Significant Unobservable Inputs (Level 3)
Servicing asset, discount rate	10.00%	10.00%
Discount rate | Discounted cash flow | Servicing asset | Significant Unobservable Inputs (Level 3) | Weighted Average
Servicing asset, discount rate	10.00%	10.00%
Prepayment rate | Discounted cash flow | Servicing asset | Significant Unobservable Inputs (Level 3) | Minimum
Servicing asset, discount rate	0.00%	0.00%
Prepayment rate | Discounted cash flow | Servicing asset | Significant Unobservable Inputs (Level 3) | Maximum
Servicing asset, discount rate	25.00%	25.00%
Prepayment rate | Discounted cash flow | Servicing asset | Significant Unobservable Inputs (Level 3) | Weighted Average
Servicing asset, discount rate	12.50%	12.10%

Fair Value of Financial Instr_6

Fair Value of Financial Instruments - Carrying Value and Estimated Fair Value (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Carrying Value	$ 442,960	$ 419,806
Debt Securities, Held-to-maturity	59,565	68,223
Held-to-maturity securities, fair value	61,468	69,452
Loans held-for-sale, Carrying Amount	24,512	13,243
Loans held-for-sale, Fair Value	23,233	26,341
Loans	2,887,662	3,059,231
Net loans, Carrying Amount	2,859,821	3,029,747
Accrued interest receivable, Carrying Amount	16,037	17,416
FHLB stock, Carrying Amount	25,650	25,650
Deposits, Carrying Amount	3,178,959	3,270,885
FHLB advances, Carrying Amount	514,922	514,916
Subordinated Debt, Carrying Value	104,231	79,603
Accrued interest payable	2,018	1,439
Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents, Fair Value	442,960	419,806
Held-to-maturity securities, fair value	61,468	69,452
Loans held-for-sale, Fair Value	24,512	13,243
Loans receivable - net, Fair Value	2,880,024	3,084,375
Accrued interest receivable, Fair Value	16,037	17,416
FHLB stock, Fair Value	25,650	25,650
Deposits, Fair Value	3,190,000	3,307,038
FHLB advances, Fair Value	526,143	541,945
Subordinated Debt, Fair Value	108,788	83,682
Accrued interest payable, Fair Value	2,018	1,439
Fair Value | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents, Fair Value	442,960	419,806
Held-to-maturity securities, fair value	0	0
Loans held-for-sale, Fair Value	0	0
Loans receivable - net, Fair Value	0	0
Accrued interest receivable, Fair Value	16,037	17,416
FHLB stock, Fair Value	0	0
Deposits, Fair Value	1,909,432	1,679,164
FHLB advances, Fair Value	0	0
Subordinated Debt, Fair Value	38,643	63,325
Accrued interest payable, Fair Value	2,018	1,439
Fair Value | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents, Fair Value	0	0
Held-to-maturity securities, fair value	61,468	69,452
Loans held-for-sale, Fair Value	24,512	13,243
Loans receivable - net, Fair Value	0	0
Accrued interest receivable, Fair Value	0	0
FHLB stock, Fair Value	25,650	25,650
Deposits, Fair Value	0	0
FHLB advances, Fair Value	526,143	541,945
Subordinated Debt, Fair Value	70,145	20,357
Accrued interest payable, Fair Value	0	0
Fair Value | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents, Fair Value	0	0
Held-to-maturity securities, fair value	0	0
Loans held-for-sale, Fair Value		0
Loans receivable - net, Fair Value	2,880,024	3,084,375
Accrued interest receivable, Fair Value	0	0
FHLB stock, Fair Value	0	0
Deposits, Fair Value	1,280,568	1,627,874
FHLB advances, Fair Value	0	0
Subordinated Debt, Fair Value	0	0
Accrued interest payable, Fair Value	$ 0	$ 0

Mortgage Banking Activities (De

Mortgage Banking Activities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Principal Transaction Revenue [Line Items]
Loans originated for sale	$ 721,300	$ 878,200	$ 627,600
Proceeds from sale of loans originated for sale	714,900	923,800	601,200
Mortgage banking activities
Principal Transaction Revenue [Line Items]
Gain on loans sold	17,803	22,826	10,275
(Loss) gain resulting from the change in fair value of loans held-for-sale	(718)	(94)	538
(Loss) gain resulting from the change in fair value of derivatives	(2,035)	1,961	728
Net revenue from mortgage banking activities	$ 15,050	$ 24,693	$ 11,541

Derivative Financial Instrume_3

Derivative Financial Instruments - Carrying Amount and Adjustment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amortized cost, at fair value	$ 606,507	$ 497,004
Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amortized cost, at fair value	50,000	88,200
Securities available-for-sale | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Carrying amount of the hedged assets	75,156	124,210
Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets	$ 1,729	$ 6,064

Derivative Financial Instrume_4

Derivative Financial Instruments - Interest Swap Derivatives (Details) - USD ($) $ in Thousands	1 Months Ended		12 Months Ended
	Mar. 31, 2021	Jun. 30, 2020	Dec. 31, 2021	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value			$ 332,750	$ 405,700
Derivative, fair value			(14,301)	(30,390)
Interest rate swaps assets | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value			$ 50,000	$ 88,200
Weighted Average Remaining Maturity (years)			1 year 9 months 18 days	3 years 1 month 6 days
Fair Value			$ (1,731)	$ (6,072)
Weighted-Average Rate			2.33%	2.54%
Cash pledged as collateral			$ 15,700	$ 30,600
Loans | Interest rate swaps assets | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Weighted Average Remaining Maturity (years)			12 years 2 months 12 days
Payments for swap termination payments		$ 46,100
Amortization expense			$ 5,200	3,400
Securities available-for-sale | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Fair Value			1,729	6,064
Securities available-for-sale | Interest rate swaps assets | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value			$ 50,000	$ 88,200
Weighted Average Remaining Maturity (years)			1 year 9 months 18 days	3 years 1 month 6 days
Fair Value			$ (1,731)	$ (6,072)
Weighted-Average Rate			2.33%	2.54%
Payments for swap termination payments	$ 1,900
Amortization expense			$ 1,100
3 Month LIBOR | Interest rate swaps assets | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value			$ 110,000	$ 110,000
Weighted Average Remaining Maturity (years)			5 years 1 month 6 days	6 years 1 month 6 days
Derivative, fair value			$ (8,560)	$ (15,727)
Derivative, variable interest rate			2.88%	2.88%
1 Month LIBOR | Interest rate swaps assets | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value			$ 100,000	$ 100,000
Weighted Average Remaining Maturity (years)			2 years	3 years
Derivative, fair value			$ (3,980)	$ (7,951)
Derivative, variable interest rate			2.88%	2.88%

Derivative Financial Instrume_5

Derivative Financial Instruments - Notional Amounts and Fair Value (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Asset Derivatives
Notional Amount	$ 62,789	$ 108,095
Fair Value	718	3,361
Derivative Liability [Abstract]
Notional Amount	332,750	405,700
Fair Value	(14,301)	(30,390)
IRLCs
Derivative Liability [Abstract]
Fair Value	718	3,361
Forward contracts
Derivative Liability [Abstract]
Notional Amount	72,750	107,500
Fair Value	(30)	(640)
Derivatives designated as hedging instruments | Interest rate swaps assets
Derivative Liability [Abstract]
Notional Amount	50,000	88,200
Derivatives designated as hedging instruments | Interest rate swaps associated with securities available-for-sale
Derivative Liability [Abstract]
Notional Amount	50,000	88,200
Fair Value	(1,731)	(6,072)
Derivatives not designated as hedging instruments | IRLCs
Asset Derivatives
Notional Amount	62,789	108,095
Fair Value	718	3,361
Securities available-for-sale | Derivatives designated as hedging instruments | Interest rate swaps assets
Derivative Liability [Abstract]
Notional Amount	50,000	88,200
Liability | Derivatives designated as hedging instruments | Interest rate swaps assets
Derivative Liability [Abstract]
Notional Amount	210,000	210,000
Fair Value	$ (12,540)	$ (23,678)

Derivative Financial Instrume_6

Derivative Financial Instruments - Gain (Loss) Recognized (Details) - Asset Derivatives - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
IRLCs
Asset Derivatives
Derivatives not designated as hedging instruments	$ (2,643)	$ 2,451	$ 521
Forward contracts
Asset Derivatives
Derivatives not designated as hedging instruments	$ 610	$ (487)	$ 207

Derivative Financial Instrume_7

Derivative Financial Instruments - Effect of Derivatives on Income (Details) - Interest rate swaps assets - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (loss) Recognized in Other Comprehensive Income in the Twelve Months Ended	$ 11,138	$ (10,248)	$ (9,071)
Loans
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	0	(2,445)	(1,533)
Securities - taxable
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	(253)	(722)	(127)
Securities - non-taxable
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	(1,099)	(741)	36
Total interest income
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	(1,352)	(3,908)	(1,624)
Deposits
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	2,775	2,273	618
Other borrowed funds
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	3,028	2,374	473
Total interest expense
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	5,803	4,647	1,091
Net interest income
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	$ (7,155)	$ (8,555)	$ (2,715)

Shareholders' Equity (Details T

Shareholders' Equity (Details Textual) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Oct. 20, 2021
Shareholders Equity [Line Items]
Stock Repurchase Program, Authorized Amount		$ 30
Treasury Stock, Shares, Acquired	100,000

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance	$ 330,944	$ 304,913	$ 288,735
Net unrealized holding (gains) losses recorded within other comprehensive income before income tax	7,051	(3,697)	458
Reclassification of certain tax effects 1		(139)	3,001
Other comprehensive income (loss) before tax	7,051	(3,836)	3,459
Income tax provision (benefit)	894	(831)	1,109
Other comprehensive income (loss) - net of tax	6,157	(3,005)	2,350
Balance	380,338	330,944	304,913
Accumulated Other Comprehensive Loss
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance	(17,196)	(14,191)	(16,541)
Other comprehensive income (loss) - net of tax	6,157	(3,005)	2,350
Balance	(11,039)	(17,196)	(14,191)
Available-For-Sale Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance	468	(4,388)	(13,359)
Net unrealized holding (gains) losses recorded within other comprehensive income before income tax	(4,087)	6,551	458
Reclassification of certain tax effects 1		(139)	12,072
Other comprehensive income (loss) before tax	(4,087)	6,412	12,530
Income tax provision (benefit)	(1,064)	1,556	3,559
Other comprehensive income (loss) - net of tax	(3,023)	4,856	8,971
Balance	(2,555)	468	(4,388)
Cash Flow Hedges
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance	(17,664)	(9,803)	(3,182)
Net unrealized holding (gains) losses recorded within other comprehensive income before income tax	11,138	(10,248)	0
Reclassification of certain tax effects 1		0	(9,071)
Other comprehensive income (loss) before tax	11,138	(10,248)	(9,071)
Income tax provision (benefit)	1,958	(2,387)	(2,450)
Other comprehensive income (loss) - net of tax	9,180	(7,861)	(6,621)
Balance	$ (8,484)	$ (17,664)	$ (9,803)

Condensed Financial Informati_3

Condensed Financial Information (Parent Company Only) - Condensed Balance Sheets (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Assets
Cash and Cash Equivalents, at Carrying Value	$ 442,960	$ 419,806
Premises and equipment, net	59,842	37,590
Accrued income and other assets	46,853	64,304
Total assets	4,210,994	4,246,156
Liabilities and shareholders’ equity
Subordinated debt, net of unamortized discounts and debt issuance costs of $2,769 in 2021 and $2,397 in 2020	104,231	79,603
Accrued expenses and other liabilities	30,526	48,369
Total liabilities	3,830,656	3,915,212
Total shareholders’ equity	380,338	330,944	$ 304,913	$ 288,735
Total liabilities and shareholders’ equity	4,210,994	4,246,156
Unamortized discounts and debt issuance costs	2,769	2,397
Parent Company
Assets
Cash and Cash Equivalents, at Carrying Value	52,857	40,532
Investment in common stock of subsidiaries	428,021	366,463
Premises and equipment, net	176	5,910
Accrued income and other assets	5,868	2,658
Total assets	486,922	415,563
Liabilities and shareholders’ equity
Subordinated debt, net of unamortized discounts and debt issuance costs of $2,769 in 2021 and $2,397 in 2020	104,231	79,603
Note payable to the Bank	0	3,000
Accrued expenses and other liabilities	2,353	2,016
Total liabilities	106,584	84,619
Total shareholders’ equity	380,338	330,944
Total liabilities and shareholders’ equity	486,922	$ 415,563
Unamortized discounts and debt issuance costs	$ 2,769

Condensed Financial Informati_4

Condensed Financial Information (Parent Company Only) - Condensed Statements of Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Condensed Financial Statements, Captions [Line Items]
Gain on sale of premises and equipment	$ 2,523	$ 0	$ 0
Other	1,694	1,655	2,581
Total noninterest income	32,844	36,336	16,789
Expenses
Interest on borrowings	17,505	16,342	15,134
Salaries and employee benefits	38,223	34,231	27,014
Consulting and professional fees	4,054	3,511	3,669
Premises and equipment	7,063	6,396	6,059
Income tax benefit	8,458	4,445	1,917
Net income	48,114	29,453	25,239
Parent Company
Condensed Financial Statements, Captions [Line Items]
Gain on sale of premises and equipment	2,523	0	0
Other	75	0	0
Total noninterest income	2,598	0	0
Expenses
Interest on borrowings	5,892	4,924	3,804
Salaries and employee benefits	1,037	904	804
Consulting and professional fees	2,178	1,678	1,610
Premises and equipment	548	295	285
Other	363	361	408
Total expenses	10,018	8,162	6,911
Loss before income tax and equity in undistributed net income of subsidiaries	(7,420)	(8,162)	(6,911)
Income tax benefit	(1,687)	(2,089)	(1,783)
Loss before equity in undistributed net income of subsidiaries	(5,733)	(6,073)	(5,128)
Equity in undistributed net income of subsidiaries	53,847	35,526	30,367
Net income	$ 48,114	$ 29,453	$ 25,239

Condensed Financial Informati_5

Condensed Financial Information (Parent Company Only) - Condensed Statements of Comprehensive Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule Of Condensed Comprehensive Income [Line Items]
Net income	$ 48,114	$ 29,453	$ 25,239
Other comprehensive income (loss)
Net unrealized holding (losses) gains on securities available-for-sale recorded within other comprehensive income before income tax	(4,087)	6,551	12,072
Reclassification adjustment for (gains) losses realized	0	(139)	458
Net unrealized holding gains (losses) on cash flow hedging derivatives recorded within other comprehensive income before income tax	11,138	(10,248)	(9,071)
Other comprehensive income (loss) before tax	7,051	(3,836)	3,459
Income tax provision (benefit)	894	(831)	1,109
Other comprehensive income (loss) - net of tax	6,157	(3,005)	2,350
Comprehensive income	54,271	26,448	27,589
Parent Company
Schedule Of Condensed Comprehensive Income [Line Items]
Net income	48,114	29,453	25,239
Other comprehensive income (loss)
Net unrealized holding (losses) gains on securities available-for-sale recorded within other comprehensive income before income tax	(4,087)	6,551	12,072
Reclassification adjustment for (gains) losses realized	0	(139)	458
Net unrealized holding gains (losses) on cash flow hedging derivatives recorded within other comprehensive income before income tax	11,138	(10,248)	(9,071)
Other comprehensive income (loss) before tax	7,051	(3,836)	3,459
Other comprehensive income (loss) - net of tax	6,157	(3,005)	2,350
Comprehensive income	$ 54,271	$ 26,448	$ 27,589

Condensed Financial Informati_6

Condensed Financial Information (Parent Company Only) - Condensed Statements of Cash Flows (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Operating Activities
Net income	$ 48,114	$ 29,453	$ 25,239
Depreciation and amortization	8,775	7,831	6,926
Share-based compensation expense	2,393	2,110	1,680
Gain on sale of premises and equipment	(2,523)	0	0
Net change in other assets	7,028	7,163	(42,079)
Net change in other liabilities	(921)	(4,983)	5,999
Net cash provided by (used in) operating activities		13,068	(43,577)
Investing activities
Purchase of premises and equipment	(29,892)	(25,559)	(4,105)
Net proceeds from sale of premises and equipment	8,116	0	0
Other investing activities	4,434	0	11,068
Net cash provided by (used in) investing activities		(44,809)	(313,273)
Financing activities
Cash dividends paid	(2,415)	(2,349)	(2,418)
Net proceeds from issuance of subordinated debt	58,658	9,765	35,418
Repurchase of common stock	(4,436)	0	(9,784)
Other, net	(441)	(152)	(329)
Net cash provided by financing activities		124,186	495,499
Net increase in cash and cash equivalents	23,154	92,445	138,649
Cash and cash equivalents, beginning of year	419,806	327,361	188,712
Cash and cash equivalents, end of year	442,960	419,806	327,361
Parent Company
Operating Activities
Net income	48,114	29,453	25,239
Equity in undistributed net income of subsidiaries	(53,847)	(35,526)	(30,367)
Depreciation and amortization	1,081	711	647
Share-based compensation expense	835	518	288
Gain on sale of premises and equipment	(2,523)	0	0
Net change in other assets	(31)	(502)	(508)
Net change in other liabilities	775	311	(87)
Net cash provided by (used in) operating activities	(5,596)	(5,035)	(4,788)
Investing activities
Capital contribution to the Bank	0	0	(25,000)
Purchase of premises and equipment	0	0	(13)
Net proceeds from sale of premises and equipment	8,116	0	0
Other investing activities	(3,561)	0	0
Net cash provided by (used in) investing activities	4,555	0	(25,013)
Financing activities
Cash dividends paid	(2,415)	(2,349)	(2,418)
Net proceeds from issuance of subordinated debt	58,658	9,765	35,418
Repayment of subordinated debt	(35,000)	0	0
Repayment of Bank loan	(3,000)	0	(300)
Repurchase of common stock	(4,436)	0	(9,784)
Other, net	(441)	(152)	(93)
Net cash provided by financing activities	13,366	7,264	22,823
Net increase in cash and cash equivalents	12,325	2,229	(6,978)
Cash and cash equivalents, beginning of year	40,532	38,303	45,281
Cash and cash equivalents, end of year	$ 52,857	$ 40,532	$ 38,303

Business Combinations and Asset

Business Combinations and Asset Acquisitions (Details) - First Century Bancorp $ in Millions	Nov. 02, 2021USD ($)
Business Acquisition [Line Items]
Purchase price	$ 80
Assets of acquired entity	486.7
Deposits of acquired entity	409.4
Loans of acquired entity	$ 25.2